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Abstract
Neuropsychiatric disorders, e.g. autism spectrum disorders and depression,
present an increasing burden on society. Diagnoses are on the rise and despite
a constantly increasing body of research, causes and mechanisms of disease
generation remain elusive. To date, treatment is either difficult or unavailable.
mRNA translation is an essential process for normal cell function. It is tightly
regulated on both a global and local scale in cells. Local translation is partic-
ularly important for highly compartmentalised cells, such as neurons. mRNA
translation is essential to the most basic processes in the brain, which include
memory formation. Furthermore, dysregulation of translation, due to mutations
in components of the translational machinery, has been shown to be both con-
tributing and causal to some of the key phenotypes observed in neuropsychiatric
disorders, e.g. autism spectrum disorders (ASD) or depression.
For the work presented in my thesis, we employed a novel method based
on deep sequencing, known as ribosome profiling, to quantitatively measure
changes in mRNA ribosome occupancy, which can be used to predict changes
in translation of individual transcripts at an omic scale. We applied ribosome
profiling to a novel neuropsychiatric model resembling fragile X syndrome (FXS)
phenotypes, TgMMP9. FXS is a genetic syndrome, in which patients show
severe neurological and physiological symptoms and the currently most com-
mon known cause of ASDs. TgMMP9 is a mouse line overexpressing human
matrix metalloproteinase 9 (MMP-9), conditionally in the brain. MMP-9 is a key
molecule in the extracellular matrix of the brain and has been associated with
memory, ASDs (FXS in particular), Alzheimer’s disease, and memory formation
in the brain. We characterised translational regulation in TgMMP9 animals, us-
ing methods to study both global changes in translation and activation levels of
known upstream regulators of translation. Furthermore, we carried out ribosome
profiling of a well established mouse model of FXS, the Fmr1 knock-out.
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Likewise, we used ribosome profiling to study changes in translation in a
novel mouse model of depression, eIF4ESer209Ala, entailing a mutation in an
important molecular regulator of cap-dependent translation (eukaryotic initiation
factor 4E, eIF4E), leaving the protein unphosphorylatable. Phosphorylation of
eIF4E has previously been shown to be key in regulating transcript-specific
translation. We also identified molecular pathways in these animals that impinge
on translation and the dysregulation of which may in part be causative for the
behavioural phenotypes we observe.
Additionally, we identified genes important in early fear memory formation
by carrying out ribosome profiling on hippocampal tissue from fear conditioned
animals. To dissect the effect of the electrical shock and the actual memory
formation, we profiled changes in mRNA expression and translation in two
controls (naïve and shock only). We identified genes and confirmed their
expression using quantitative real-time PCR, that change expression specifically
in fearful memory formation.
Finally, we adapted the ribosome profiling method for use in synaptoneu-
rosomes, allowing us to study localised translation at synaptic terminals. In a
brief experiment, we show that it is feasible to profile ribosome occupancy of
mRNAs in biochemically isolated synaptic terminals, using two different proto-
cols. This provides a powerful technique to study local translation at the synaptic
compartment in both health and disease.
Altogether, the work contained in this thesis, highlights the importance of
mRNA translation regulation to the development of diverse neuropsychiatric
disorders. We show regulation of specific subsets of mRNAs in these disorders
both at a global and more local scale, as well as changes in the activation of
pathways upstream of translation.
Lay summary
Psychiatric disorders, such as autism and depression occur frequently in our
population and have great socio-economic impacts. Affected individuals may
require long-term medical treatment and/or care, which puts a considerable
burden on relatives and patients themselves, as well as the healthcare system.
Although some pharmacological intervention is available, it is not efficient in all
patients, partially due to a lack of understanding of how these disorders work at
a molecular level. To make matters worse, most psychiatric disorders present
themselves as a “spectrum”, which refers to the immense heterogeneity among
them and that almost no two patients will show the exact same symptoms,
let alone causes. Therefore, gaining a better understanding at the molecular
level and identifying common druggable cellular mechanisms is of extreme
importance to improve treatment of neuropsychiatric disorders.
Brain cells are highly specialised cells that need to be able to respond timely
to minimal signals at connections with other cells and synthesise or break down
protein. Therefore, they are more sensitive to changes in the way proteins are
synthesised and broken down. A very basic process in cells, the translation of
genes from mRNA (which serves as a template) into proteins, has been shown
to be altered in neuropsychiatric disorders. Thus, by studying mRNA translation
and how this process is changed from the baseline in e.g. disease or memory
forming experiences, we can gain a better understanding of the basic process
and how it contributes to the generation of neuropsychiatric disorders.
Since several neuropsychiatric disorders show a link to altered protein syn-
thesis, working towards this thesis, we investigated the activation status of
diverse proteins in the cell that are known to regulate the translation of mRNA
into protein. Furthermore, we explored how the mRNA translation in neurons is
altered in models of autism and depression (genetically modified mice, carrying
mutations that predispose them to the development of neuropsychiatric traits
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related to autism and depression). We used a novel method to investigate
how translation of each individual mRNA into protein by cellular machinery
is changed in these disorder models compared to healthy control animals, in
the brain. These experiments resulted in lists of genes that show different
abundances between our disorder models and healthy controls, that we anal-
ysed for common features in terms of function, cellular and tissue location, and
involvement in cellular pathways or diseases. This provided us with important
information with regard to which regulatory elements within cells may be in-
volved in the generation of the disorder and therefore may be targeted for novel
drug development.
Intact protein synthesis is also key to the formation of novel memories, so
we proceeded to investigate which mRNAs need to be translated in a classical
Pavlovian conditioning paradigm. In classical conditioning, two stimuli are paired
in the experience of the animal to form a memory that will later elicit a reaction
to one of the stimuli, without the presence of the second stimulus. In fear
conditioning, an association between an originally neutral, but novel; context
and an electrical shock (aversive/fearful stimulus) is formed. When placed
in the same context later, the animal will exhibit fearful behaviour because
it remembers receiving a painful, although harmless electrical shock. How
translation of specific mRNAs affects memory formation is highly relevant to our
understanding of its basic mechanism and still poorly defined.
Taken together, the work presented in this thesis, shows novel (groups
of) genes which are involved in the generation of neuropsychiatric disorders
and whose translation is specifically regulated by changing the availability of
proteins that have previously been associated with psychiatric disorders. This
is important because it will further our understanding of said disorders and
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1.1 Neuropsychiatric disorders and their socioe-
conomic impact
Neuropsychiatric disorders is an umbrella term for a group of mental disor-
ders, grouped into several disorders, but generally characterised by a combina-
tion of abnormal perceptions, emotions, thoughts, behaviours, and relationships
with other individuals. They include, but are not limited to, major depression
disorder (MDD), bipolar affective disorder, schizophrenia, dementia, intellectual
disabilities, and autism spectrum disorders (ASDs). The burden of neuropsychi-
atric disorders keeps growing (Table 1.1), affecting variables such as premature
death, ability to work, and mental heath of caretakers. Treatments are available,
but often have a major impact on patients’ quality of life, in spite of treating
the disorder or are ineffective. Therefore, it is pivotal to gain a better under-
standing of these disorders, in order to provide support for people affected by
them (Global Burden of Disease Collaborative Network, 2018; World Health
Organization, 2017b).
MDD is the most common form of mental disorders, with 163 million (esti-
mates of undiagnosed depression reach 350 million) affected by it (Table 1.1).
More females show signs of depression than males, according to World Health
Organisation (WHO) estimates, and MDDs are one of the top 10 causes of
disability. Depression comes in many shapes and forms, hence it is described
as a spectrum of disorders, rather than a single disorder. MDDs are defined
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Table 1.1 Prevalence of generalised mental disorders, MDD, and ASD at global, UK,
and Scottish scales. Retrieved from Global Burden of Disease Collaborative Network
(2018)
Region Parameter Mental disorders MDD ASD
Global Number of people affected 970,812,351 163,044,068 31,179,664
Global Prevalence 13.17% 2.21% 0.42%
United Kingdom Number of people affected 9,352,703 1,809,421 394,580
United Kingdom Prevalence 14.87% 2.88% 0.63%
Scotland Number of people affected 772,606 152,620 30,107
Scotland Prevalence 14.70% 2.90% 0.57%
by low self-worth, sadness, tiredness, loss of interest or pleasure in every-
day activities, poor concentration, and disturbed sleep or appetite. A person
can experience a single depressive episode during their life, have recurrent
episodes, or even chronic symptoms. Being in a depressed state severely
affects a person’s ability to cope with normal daily life and in severe cases can
lead to suicide. Thus, the impact on the healthcare system and the economy
is considerable. Effective therapies include psychotherapy/talking therapy and
antidepressants, depending on the severity of symptoms (Global Burden of
Disease Collaborative Network, 2018; World Health Organization, 2017b). Due
to the high variability in symptoms that patients present with and individual in
differences physiology, however, antidepressants are not effective in all patients.
This highlights the need to better understand antidepressant action, as well as
the molecular background of depression and how different forms of the disorder
converge to result in similar symptoms. Answering these questions may support
the development of more specialised and effective treatments.
ASDs are a heterogeneous group of neurodevelopmental disorders that
usually have a childhood onset, but persist into adulthood. Patients with ASDs
display impairments in three key domains: social behaviour, communication,
and repetitive/stereotypic behaviours (American Psychiatric Association, 2000).
The prevalence of ASDs globally is about 0.42% (Table 1.1), with a higher
incidence in males than in females, and has increased drastically over the past
decades (Baxter et al., 2014; Global Burden of Disease Collaborative Network,
2018). Currently, treatment options are scarce and, depending on the severity
of the disorder in the individual patient, individuals with ASD may never be able
to live a self-sufficient life and require long-term specialised care. Therefore,
the need to better understand the aetiology of ASDs and find novel treatment
and management options is of great importance.
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1.2 Regulation of mRNA translation
mRNA translation is pivotal for the survival and normal function of cells.
Therefore, it is a tightly regulated process, both globally and locally. Most
eukaryotic mRNAs contain a cap-structure at the 5’-UTR (m7G-cap) (Jung
et al., 2014), which can bind to the cap-binding protein eIF4E (eukaryotic
initiation factor 4E) to subsequently recruit the translation initiation complex.
Cap-dependent translation is a form of translation regulated by eIF4E. It is
the main form of mRNA translation and requires the formation of the eIF4F
complex, containing eIF4E (cap-binding protein), eIF4G (modular scaffolding
protein interacting with eIF3 to recruit the 40S ribosomal subunit), and eIF4A
(ATP-dependent helicase that unwinds secondary structures in the 5’-UTR), to
initiate translation (Gkogkas et al., 2010). eIF4E is mainly regulated through
phosphorylation of its repressors 4E-BPs (eIF4E binding proteins; 4E-BP2 is
the predominant isoform in brain), and through direct phosphorylation by Mnk
kinases (Figure 1.1) (Gkogkas et al., 2010; Hay and Sonenberg, 2004).
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Figure 1.1 Schematic of how cap-dependent translation is regulated. Extracellular
signals activate second messenger cascades intracellularly. Two major signalling
pathways are involved: The Ras/ERK/Mnk pathway phosphorylates the cap-binding
protein eIF4E directly and thereby activates translation, whereas activation of the
PI3K/Akt/mTOR pathways leads to hyperphosphorylation of 4E-BPs, leading to their
dissociation from eIF4E, thus stimulating assembly of the initiation complex (Hay and
Sonenberg, 2004). mTORC1 furthermore phosphorylates S6 kinases (S6K1/2), which
in turn phosphorylate ribosomal protein S6 and stimulate activity of eIF4B, a factor of
the eIF4F complex that facilitates ribosome recruitment.
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1.2.1 The mTOR and Mnk/eIF4E signalling axes
mTOR (mechanistic target of rapamycin) is a kinase that is a major compo-
nent of two molecular complexes. mTORC1 (mechanistic target of rapamycin
complex 1) and 2 are molecularly distinct and carry out different functions
in the cell, relating to energy homeostasis and cell growth (including protein
synthesis and lipid & nucleotide biosynthesis). These complexes function as
integrators of external stimuli that are relayed into the cell to adapt to the current
physiological needs (Laplante and Sabatini, 2012; Saxton and Sabatini, 2017).
Extrinsic cues activate the PI3K/Akt pathway, which in turn regulates the activity
of tuberous sclerosis complex 1 and 2 (TSC1/2), an inhibitor of mTORC1 activity
(Figure 1.1 and 1.3). When mTORC1 is activated, it stimulates the translation
of mRNAs through two main avenues, phosphorylation of ribosomal protein
S6 kinases, which phosphorylate ribosomal protein S6, and phosphorylation
of 4E-BPs, which leads to release of eIF4E and allows cap complex formation
(Figure 1.1 and 1.3). Mutations in several of the proteins involved in theses
signalling cascades have been implicated in the development of neuropsychi-
atric disorders (including ASD, schizophrenia and depression), e.g. TSC1/2;
PTEN, another inhibitor of mTOR activity; and 4E-BPs (Figure 1.2 and 1.3)
(Amorim et al., 2018b; Costa-Mattioli and Monteggia, 2013). Memory formation
is mTORC1-dependent and inhibited by rapamycin, which has been extensively
used to show varying aspects of memory depend on proper mTORC1 function.
Furthermore, downstream effectors of mTOR are commonly phosphorylated
after memory-forming experiences (Roesler, 2017).
A second major pathway that regulates mRNA translation in response to
extracellular stimuli is the Ras/Raf/MEK/ERK pathway. Extracellular signals
are integrated through Ras activation, which elicits a phosphorylation cascade,
activating first Raf, followed by MEK, ERK, and the Mnk kinases. The mRNA
cap-binding protein eIF4E is phosphorylated by the Mnk kinases on serine
residue 209 to stimulate translation (Figure 1.1 and 1.3). Dysregulated trans-
lation downstream of eIF4E has been associated with depression, ASD, and
schizophrenia (Amorim et al., 2018a,b; Gkogkas et al., 2013; Santini et al.,
2013).
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Figure 1.2 mTOR and neuropsychiatric disorders. The protein mTOR is part of two
distinct molecular protein complexes, both of which, including upstream regulators and
downstream effectors, have been implicated in several neurodevelopmental and neu-
ropsychiatric disorders. Left the components of mTORC1 and a list of neuropsychiatric
disorders that have been connected with its dysregulation. Right the components of
mTORC2 and a list of neuropsychiatric disorders that have been connected with its
dysregulation. Figure taken from Costa-Mattioli and Monteggia (2013)
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Figure 1.3 eIF4E in neurodevelopmental and neuropsychiatric disorders. Dia-
gram of eIF4E function and how it is regulated by the ERK/Mnk and mTOR signalling
axes. The insets highlight the roles that eIF4E has been shown to play in the generation
of several neurodevelopmental and neuropsychiatric disorders. Top left: Impaired
phosphorylation of eIF4E relieves repression of inflammatory mRNA translation through
the GAIT complex and promotes depressive and anxiety behaviours. Bottom left: after
maternal immune activation (MIA), eIF4E and mTOR are dysregulated in gene expres-
sion profiles. MIA is a known risk factor for ASD. Top right: eIF4E is required for RAN
translation, a process that synthesises toxic polypeptides from polynucleotide repeat
expansion containing transcripts, such as Fmr1. Bottom right: eIF4E and 4E-T interact
in P-bodies to sequester and repress translation of pro-neurogenic mRNAs during early
development. 4E-BPs, eIF4E-binding proteins; 4E-T, eIF4E transporter; ASD, Autism
Spectrum Disorders; CYFIP1, cytoplasmic FMRP interacting protein; eIF3, eukaryotic
initiation factor 3; eIF4A, eukaryotic translation initiation factor 4A; eIF4E, eukaryotic
translation initiation factor 4E; eIF4G, eukaryotic translation initiation factor 4G; ERK,
extracellular signal–regulated kinase, also known as mitogen-activated protein kinase
(MAPK); FMRP, Fragile X mental retardation protein; FXS, Fragile X Syndrome; GAIT
complex, interferon (IFN)-g-activated inhibitor of translation complex; MNK 1/2, mitogen-
activated protein (MAP) kinase-interacting serine/threonine-protein kinases 1/2; MIA,
maternal immune activation; mTORC1, mechanistic target of rapamycin complex 1; off,
repression of translation; on, active translation; P, phosphorylation site; PABPs, poly-A
binding proteins; PTEN, phosphatase and tensin homolog; RAN, repeat-associated
non-AUG; SCZ, Schizophrenia; TSC1/2, Tuberous sclerosis proteins 1/2. Figure taken
from Amorim et al. (2018b)
1.2 Regulation of mRNA translation 8
1.2.2 The importance of mRNA translation in the brain
mRNA translation is particularly important in neurons, as their various com-
partments, such as synapses and dendritic spines, require differential levels
of regulation to adequately process information (Gkogkas et al., 2010; Jung
et al., 2014). Synthesis of new proteins and translational control are essential
for several forms of synaptic plasticity and for the remodelling of connections
between neurons (Gkogkas et al., 2010; Kandel, 2001; Richter and Klann,
2009). Aberrant regulation of translation in the brain has been associated with
neuropsychiatric, neurodegenerative, and neurodevelopmental diseases (Jung
et al., 2014).
The requirement of de novo protein synthesis (mRNA translation) for mem-
ory formation was hypothesised as early as 1948 (Monné, 2006). However, only
after the discovery of protein synthesis inhibitors in the late 1950s (Yarmolinsky
and Haba, 1959), protein synthesis dependency for novel memory formation
was first demonstrated in mice performing a simple Y-maze avoidance memory
task after injection with the translation inhibitor puromycin in 1963 (Flexner et al.,
1965). In the following two decades, researchers made every effort to show in
different species and various memory-dependent behavioural tasks that protein
synthesis is required for several forms of memory and synaptic plasticity (Davis
and Squire, 1984). These experiments further evidenced that the storage of
long-term memories is dependent on a critical period of de novo protein syn-
thesis shortly after the relevant experience (Davis and Squire, 1984; Sutton
and Schuman, 2006). Later, when genetic approaches became more feasible,
mutations in key protein synthesis regulators were shown to severely affect
memory performance as well, further supporting the role of mRNA translation in
memory formation (Banko et al., 2006; Costa-Mattioli et al., 2005; Kelleher et al.,
2004). Moreover, injecting protein synthesis inhibitors during different stages
of training and memory formation narrowed the critical windows of protein syn-
thesis dependency during memory formation to a two-phase pattern, more
precisely during training and ~3-4 h after training (Bourtchouladze et al., 1998;
Grecksch and Matthies, 1980; Quevedo et al., 1999). Most of the attention was
focussed on the requirement of protein synthesis for memory formation for a
long time, but more recently, scientists have tried to dissect the regulatory mech-
anisms behind it (Buffington et al., 2014; Costa-Mattioli et al., 2009; Kelleher
et al., 2004; Santini et al., 2014). Learning new behaviours results in specific
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neuronal activity, which in turn activates cell-surface receptors upstream of
intracellular signalling pathways. Activation of these pathways then regulate
gene expression and de novo protein synthesis through various mechanisms
(Alberini, 2009; Kandel et al., 2014; McGaugh, 2000). Translation, which is one
of the most important steps during de novo protein synthesis, is comprised of
three main phases, initiation, elongation, and termination and disruption of any
of these can result in aberrant protein synthesis rates and memory formation.
It follows that several translation initiation and elongation factors are of key
importance for synaptic plasticity and during memory consolidation, as has
been shown through pharmacogenetic inhibition of said factors (Buffington
et al., 2014; Costa-Mattioli et al., 2009; Gal-Ben-Ari et al., 2012; Kelleher et al.,
2004; Santini et al., 2014). Furthermore, gene specific mechanisms have been
described, that may regulate translation rates of specific transcripts, such as
UTR elements. An example are cytoplasmic polyadenylation elements (CPE),
which are usually located at the end of the distal UTR. CPEs can be bound by
CPE binding protein (CPEB), which suppresses the translation of the transcript.
Upon phosphorylation, CPEB releases the bound mRNA and translation is
de-repressed (Kelleher et al., 2004; Macdonald, 2001; Mayford et al., 1996).
Lastly, non-coding mRNAs, in particular microRNAs, have also been implicated
as regulatory mechanisms in synaptic plasticity and memory formation through
recent work (Bicker et al., 2014; Gao et al., 2010; Griggs et al., 2013; Konopka
et al., 2010; Saab and Mansuy, 2014; Thomas et al., 2014).
Due to their high specialisation and compartmentalisation, neurons require
tight spatiotemporal control of protein synthesis to maintain their basic functions
and respond efficiently to activity and other external stimuli. The dendrites
and presynaptic regions are situated at a considerable distance from the cell
soma (Figure 1.4). Therefore, specific mechanisms are required to ensure
proteins are at the location where they are needed. To cope with this challenge,
neurons have developed mechanisms that transport mRNAs to the different
compartments and initiate protein synthesis in a local and timely manner (Holt
and Schuman, 2013; Rangaraju et al., 2017). Dysregulated local translation
plays a key role in several neuropsychiatric and neurodegenerative disorders
(Liu-Yesucevitz et al., 2011).
Protein synthesis was believed to be localised solely to the cell body in
neurons (with the exception of mitochondrial translation), until Bodian (1965)
demonstrated the presence of ribosomal particles in the proximal dendrites of
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Figure 1.4 Cell compartments of neurons that require differential regulation of
translation. Diagram of neuronal cells, highlighting different structural compartments
of the cell that may require localised translation. Showing the cell body (gray) and
neurites - composed of dendrites (blue) and axons (red). In the inset is a more detailed
view of a synapse, formed by a presynaptic (red) and a postsynaptic (blue) terminal.
All of these compartments may require newly synthesised protein independently from
each other or co-dependently. Figure from Rangaraju et al. (2017).
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monkey spinal chord motor neurons. The first evidence of translation at the
synapse, however, was not found until Steward and Levy (1982) used electron
microscopy to show that polyribosomes localised to the distal dendrites of
dentate granule cell neurons. Following up on these experiments, localising
components of the translational machinery to the synapse, incorporation of
radioactively labelled amino acids in biochemically isolated synapses (Rao and
Steward, 1991; Torre and Steward, 1992; Weiler and Greenough, 1991) and
in live slice preparations (Feig and Lipton, 1993) was shown, providing the
first evidence of active translation independent of the cell soma. Furthermore,
measuring response times to stimuli in these experiments showed that time
frames were too short (within minutes) to support a hypothesis in which proteins
are synthesised in the cell bodies and transported to the synapse. The first
functional association of dendritic protein synthesis and neuronal activity was
discovered in 1996, demonstrating that dendritic translation is required for
the strengthening of synaptic transmission after stimulation with brain derived
neurotrophic factor (BDNF) (Kang and Schuman, 1996). Later work evidenced
that while the translation in dendrites is critical to normal neuronal function,
somatic translation may even be dispensable (Sutton and Schuman, 2006).
Synaptic plasticity is a term used to describe both long term potentiation (LTP,
a strengthening of individual synaptic connections) and long term depression
(LTD, a weakining of individual synaptic connections) and generally believed
to be the basis of memory formation. It is comprised of two phases, an early
phase (1-3 h) that is independent of de novo protein synthesis and a late phase
that is more persistent and dependent on de novo protein synthesis (Frey et al.,
1988; Stanton and Sarvey, 1984). Isolated hippocampal dendritic fields have
been shown to be able to support late LTP formation, suggesting that somatic
translation can be neglected for this process (Cracco et al., 2005; Huang and
Kandel, 2005; Vickers et al., 2005). Furthermore, the focal application of
protein synthesis inhibitors on dendrites resulted in inhibition of late LTP, while
application of the inhibitor to the soma did not result in any significant changes
in synaptic plasticity (Bradshaw et al., 2003).
Most of the work on localised translation at the synapse has been fo-
cussed on the post-synapse/dendrite, due to it being the "response element"
of the synapse and the sheer technical challenge of studying translation at
the pre-synapse. However, recent work has produced significant evidence for
pre-synaptic translation using expansion microscopy to visualise both synap-
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tic compartments and contained translational machinery. PolyA mRNAs and
ribosomes were shown to be localised to both the pre- and post-synapse and
biochemical isolation of excitatory pre-synaptic terminals and following RNA ex-
traction and next generation sequencing demonstrated presence of synaptically
relevant transcripts that are likely to be translated locally (Hafner et al., 2019).
Studying localised translation in a tissue context still proves challenging,
since neurons and their different compartments are fully intermingled. Moreover,
most of the published work has used mRNA abundance as a measurement
of gene expression, which does not necessarily correlate with final protein
expression levels (Hafner et al., 2019; Rangaraju et al., 2017; Tushev et al.,
2018).
1.2.3 Ribosome profiling as a method to study translation
in the brain
Ribosome profiling was established as a technique to study translation
fairly recently (Ingolia et al., 2012, 2009), but has been used extensively since.
The rationale behind it is that translating ribosomes can be isolated from cells
with their associated mRNA (polysomes). The extracted polysomes are then
digested using RNase I, in a classical footprinting assay, where mRNA that
is inaccessible to the nuclease because of a bound ribosome remains intact.
These ribosomal footprints, which are generally between 28 and 32 nucleotides
in length, can then be purified and used for sequencing library generation.
To gain a general insight into the transcriptional state of the cells or tissue
under investigation, total mRNA from the same sample (undigested) is prepared
into libraries, after random fragmentation into similarly sized pieces to the
footprints, and sequenced along with the footprinting libraries. After aligning the
sequencing results to the genome, counts and reads per kilobase of transcript
per million mapped reads (RPKM) values can be extracted/calculated from the
data. These quantitative values can then be used to assess firstly, which genes
are present as mRNAs, and secondly, by dividing RPKM values of the footprints
by the RPKM values of the total mRNA, the translational efficiency (TE, a value
to represent ribosome occupancy of each gene normalised to its abundance)
can be calculated (Figure 1.5). mRNA expression levels can be statistically
compared between conditions using standard RNA-Seq frameworks, such as
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DESeq2 (Love et al., 2014), or z-scores (Quackenbush, 2002) and TE with
z-scores or especially developed tools such as Xtail (Xiao et al., 2016). All of
these tools provide means to compare two sets of replicates, baseline/wildtype
versus treatment/genetic model, calculate p-values, and filter for statistically
significantly changed genes.
Ribosome profiling is a very powerful tool to study translation in an omics
approach and it creates rich datasets, that can be analysed in various ways. It is
particularly valuable for neuroscience research, because translation is a tightly
regulated process in neurons and several diseases and disorders affecting the
nervous system have been linked to dysregulated translation (Amorim et al.,
2018b; Costa-Mattioli and Monteggia, 2013).
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Figure 1.5 Schematic of the ribosome profiling method. Polysomes are extracted
from cells or tissue and two aliquots are prepared from the lysate. One aliquot is
digested with RNase I, leaving only fragments protected from digestion by the ribosomes
("ribosomal footprints" or ribosome protected fragments) intact. These fragments
are purified and size selected before cDNA library generation for next generation
sequencing. The other aliquot is processed for RNA Seq by random fragmentation and
library generation (total RNA sample), and provides an overview over the transcriptional
state of the cells/tissue. After bioinformatic processing of the sequencing results,
normalised count values for sequencing reads aligning to each gene (RPKM, reads
per kilobase of transcript per million mapped reads) are obtained. RPKM values for
the total RNA sample can be used to assess transcriptional changes, whereas by
dividing RPKM values of the ribosome foot prints by RPKM values of total RNA for each
gene yield translational efficiency (TE) values, which resemble the translational state of
genes.
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1.2.4 Aims
With this thesis, I aimed to answer several questions, to gain a better
general understanding of how translation, both globally and of specific mRNAs,
contributes to the aetiology of neuropsychiatric disorders, such as ASD and
MDD. Furthermore, we developed a strategy to study translation locally in
biochemically extracted synaptic compartments.
Specifically the aims were:
Aim 1 To dissect the molecular contribution of MMP-9 to the exaggerated
translation phenotypes observed in FXS.
Aim 2 To elucidate the role of cap-dependent translation in MDD, with a focus
on the Mnk/eIF4E signalling axis.
Aim 3 To describe the transcriptional and translational landscape of contextual
fear memories in the dorsal hippocampus and examine the used footshock
for its contribution to the elicited gene expression.
Aim 4 To establish ribosome profiling as a method to study local translation at
the synapse.
Chapter 2
General materials and methods
2.1 Transgenic mouse lines
All procedures were performed in accordance with United Kingdom Home
Office (Scientific Procedures Act 1986) and the Canadian Council on Animal
Care regulations and were approved by the University of Edinburgh and McGill
University, respectively. Animals were kept under standard husbandry conditions
and food and water were provided ad libitum. Pups were kept with their dams
until weaning at postnatal day 21. After weaning, mice were group housed
(maximum of 4 per cage) by sex. Cages were maintained in ventilated racks
in temperature (20°C - 21°C) and humidity (55%) controlled rooms, on a 12 h
circadian cycle (7:00 AM to 7:00 PM light period). For all behavioural testing,
mice were handled/habituated for 3 to 4 consecutive days before experimental
testing.
All mouse lines were on a C57BL/6J background. Wildtype (WT) mice
were obtained from a C57BL/6J colony at the animal facility at the Centre for
Discovery Brain Sciences. Mice were genotyped in-house using conventional
PCR on genomic DNA extracted from ear clips.
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2.2 Ribosome profiling
Tissue was homogenised in an appropriate volume of lysis buffer, in a glass
dounce homogenizer on ice, containing the following:
Table 2.1 TruSeq Polysome Lysis Buffer 1 ml
Reagent Volume [µl]
5X TruSeq Mammalian Polysome Buffer (Illumina) 200
DNase I (1U/µl) 10
Cycloheximide (50 mg/ml) 2
RNAse-free water 788
DTT (1 mM final concentration), Triton X-100 (1% final concentration), and
NP-40 (0.1% final concentration) were added to the homogenate and mixed well
to support cell lysis. After incubation on ice for 10 min, with periodic inversions,
lysates were centrifuged for 10 min at 20,000 RCF at 4°C. A260 was measured
(on a NanoDrop™ 2000) for the supernatant.
For ribosome footprinting aliquots, 5 units of TruSeq Ribo Profile Nuclease
(Illumina) were added per A260/ml. Samples were then footprinted for 45 min
at 4°C with constant agitation. Nuclease digestions were quenched by adding
1.5 U SUPERase•In per µl digested lysate (ThermoFisher).
Ribosome protected fragments (RPFs) were purified using Illustra MicroSpin
S-400 columns. Columns were equilibrated by letting 300 µl of 1X Mammalian
Polysome Buffer drip through the column under gravity. To ensure all buffer
had left the columns, they were centrifuged for 4 min at 600 RCF at room
temperature (RT). 100 µl of the nuclease-digested sample were applied imme-
diately and the columns centrifuged for 2 min at 600 RCF at RT, collecting the
flow-through. SDS was added to both the nuclease-digested sample and an
equivalent volume of undigested lysate to a final concentration of 1% and the
RNA extracted using the RNA Clean & Concentrator™-25 Kit (Zymo Research).
All samples were quantified using a Nanodrop and balanced for the rRNA
depletion reaction using the Ribo-Zero Gold Kit (Illumina). rRNA depletion was
followed by a purification using the RNA Clean & Concentrator™-5 Kit (Zymo
Research).
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At this point, RPFs of 28-32 nt were size selected on a 15% TBE-Urea Poly-
acrylamide gel (ThermoFisher) and purified. Total RNA samples were randomly
heat-fragmented and both samples were end-repaired using a Polynucleotide-
kinase (Illumina, Promega), following the manufacturer’s instructions. cDNA
libraries for sequencing were generated with either the TruSeq® Riboprofiling Kit
(Mammalian) (Illumina) or NEXTflex® Small RNA Sequencing Kit v3 for Illumina
Platforms (Bioo Scientific).
2.2.1 TruSeq® Riboprofiling Kit (Mammalian) (Illumina)
Following the end-repair and purification with the RNA Clean & Concen-
trator™-5 Kit (Zymo Research), a 3’ Adapter was ligated to the all samples.
Excess adapter was digested with the TruSeq Ribo Profile Adapter Removal
Enzyme.
The samples were then reverse transcribed into cDNA and purified using
a RNA Clean & Concentrator™-5 Kit (Zymo Research). To minimise adapter
contamination, samples were separated on a 10% TBE-Urea Polyacrylamide
gel (ThermoFisher) and cDNA fragments cut and purified from the gel.
The cDNA was then circularised using TruSeq Ribo Profile CircLigase.
cDNA libraries were amplified using rolling circle amplification, according to the
manufacturers instructions, for 9 cycles. During the PCR reaction, the libraries
were indexed with Illumina indexing primers to allow for multiplexing on the
sequencing flow cell. Indexing primers used are summarised in Table 2.2
Table 2.2 Illumina Indexing Barcodes (i7)
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Following the PCR reactions, cDNA libraries were purified using the Agen-
court AMPure XP Kit (Beckman Coulter). The completed libraries were analysed
for size, quantity, and purity on an Agilent Bioanalyzer, using the High Sensitivity
DNA kit. If needed, contaminations were removed by running the libraries on a
8% native TBE Polyacrylamide gel (Novex, ThermoFisher) and fragments of
the desired size were cut and purified from the gel.
2.2.2 NEXTflex™ Small RNA Sequencing Kit v3 for Illumina
Platforms (Bioo Scientific)
Because the Illumina Ribo Profile kit became obsolete, we changed over
to the NEXTflex™ kit for library generation from fragmented RNA. After the
end-repair, samples were quantified using the Agilent Small RNA Kit. Input was
balanced between samples to ensure similar output. The manufacturer’s proto-
col was followed, using the lowest input option, due to total sample quantities
below 1 ng.
In brief, an adenylated 3’ adapter was ligated, followed by an adenylated
5’ adapter ligation. The RNA fragments were then reverse transcribed into cDNA
and amplified using PCR (18 cycles). During the PCR, individual samples were
barcoded for multiplex sequencing using the barcoding primers compatible with
Illumina sequencing, included in the kit.
Indexing primers used are summarised in Table 2.3. The PCR products
were size selected on an 8% native TBE-PAGE gel (Novex, ThermoFisher) and
purified from the gel according to the manufacturer’s instructions. The cDNA
libraries were then analysed for size, quantity and quality using the Agilent High
Sensitivity DNA kit.
Samples were balanced and pooled for sequencing with Edinburgh Ge-
nomics on NovaSeq S1/2 flow cells yielding 50 bp paired-end reads.
2.2.3 Next generation sequencing
Libraries of sufficient quality and quantity (according to the sequencing facil-
ity’s requirements) were pooled and submitted for sequencing with Edinburgh
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Table 2.3 NEXTflex™ Indexing Primers
NEXTflex™ Index Sequence Reverse Complement
PCR Primer 1 CGTGAT ATCACG
PCR Primer 2 ACATCG CGATGT
PCR Primer 3 GCCTAA TTAGGC
PCR Primer 4 TGGTCA TGACCA
PCR Primer 5 CACTGT ACAGTG
PCR Primer 6 ATTGGC GCCAAT
PCR Primer 7 GATCTG CAGATC
PCR Primer 8 TCAAGT ACTTGA
PCR Primer 9 CTGATC GATCAG
PCR Primer 10 AAGCTA TAGCTT
PCR Primer 11 GTAGCC GGCTAC
PCR Primer 12 TACAAG CTTGTA
PCR Primer 13 TTGACT AGTCAA
PCR Primer 14 GGAACT AGTTCC
PCR Primer 15 TGACAT ATGTCA
PCR Primer 16 GGACGG CCGTCC
PCR Primer 17 CTCTAC GTAGAG
PCR Primer 18 GCGGAC GTCCGC
PCR Primer 19 TTTCAC GTGAAA
PCR Primer 20 GGCCAC GTGGCC
PCR Primer 21 CGAAAC GTTTCG
PCR Primer 22 CGTACG CGTACG
PCR Primer 23 CCACTC GAGTGG
PCR Primer 24 GCTACC GGTAGC
PCR Primer 25 ATCAGT ACTGAT
PCR Primer 26 GCTCAT ATGAGC
PCR Primer 27 AGGAAT ATTCCT
PCR Primer 28 CTTTTG CAAAAG
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Genomics on either a HiSeq2500 v4 50 bp single-end reader, or more recently
on NovaSeq S1 flow cells yielding 50 bp paired-end reads.
2.2.4 Bioinformatics analysis
Bioinformatic/statistical consulting was provided by omics2view.consulting
GbR, Kiel (Germany). All bioinformatic analysis was performed by omics2view,
using a customised pipeline, adapted for ribosome profiling results. omics2view
was blinded to the genotype and no randomisation was carried out in these
experiments. Pilot experiments in the Gkogkas lab showed that 2 replicates per
library, given the sequencing depth by Edinburgh Genomics, were sufficient for
this type of analysis.
In summary, the FASTX Toolkit v0.0.14 (Gordon and Hannon, 2010) was
used to trim adapter sequences from raw reads of both RPF and total RNA
samples and RPF reads below 18 bp removed from the data. Next, undesired
sequences (ribosomal RNAs and tRNAs) were removed from the datasets using
Bowtie v1.1.2 (Langmead et al., 2009).
The Filtered RPF and total reads were then aligned to an indexed reference
genome (built from GRCm38 primary genome assembly and the corresponding
gene structure information, retrieved from GENCODE), using STAR v2.5.2b
(Dobin et al., 2013). Only uniquely mapped reads were considered for the
output. Data, including counts was summarised in a table including several
columns:





• Non-coding (a binary value indicating whether or not the gene is coding
or non-coding)
• Pseudogene (binary value, compare to non-coding)
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Figure 2.1 Schematic depiction of the bioinformatics pipeline workflow.
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• Entrez gene ID
• Official gene ID (gene description)
Further, the table contained reads per kilobase of transcript per million mapped
reads (RPKM) and translational efficiency (TE) values for each gene/condition












the sum of read counts for the given sample over all k genes in the reference
genome. Results were rounded to 4 decimal places.







RPFi and total mRNAi is the respective number of reads mapped to gene






ni total mRNAi are the sums of the read counts, respectively, over all
k genes in the reference genome. Again, results were rounded to four decimal
places.
Both of these values were added to the summarised results table.
Further, the pipeline produced graphical outputs summarising the data.
Reproducibility Plots are pairwise plots between biological replicates, show-
ing the reproducibility between replicates. The squared Pearson prod-
uct-moment correlation coefficient r2 is calculated as a coefficient of
determination. These plots are generated from log2-transformed RPKM
and TE values.
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Per-sample size distribution Plots show the length (in nucleotides) of 100,000
randomly sub-sampled RPF and total mRNA, respectively, for each sample
in the same plot, for comparison.
Cumulative footprint 5’ end positions relative to all start and stop codons
plots are generated by mapping 5’ end positions to positions in a window of
±30 nt around the starting nucleotide of any start and stop codon, respec-
tively. These mapped positions are then transformed into offset positions
(relative to the start codon of the respective gene). These offset positions
are combined for all genes and RPF positions are displayed as peaks,
while total mRNA positions are visualised as a line in the background.
Cumulative reading frame usage plots show the relative abundance of re-
spective reading frames within a sample. The reading frames are calcu-
lated as follows:
ops mod 3
ops stands for the offset 5’ end position of a read, relative to the start
codon (as determined for the cumulative footprint 5’ end positions relative
to all start and stop codons plots). mod 3 is the modulo, also called the
remainder, after Euclidean division by 3. 5’ end positions are added up for
each reading frame and converted to relative abundances.
Histogram of translational efficiencies The translational efficiencies across
all replicates are averaged for each protein coding gene. 0 values are
excluded and all remaining values are log2-transformed and plotted as
superimposed histograms.
Violin plots of translational efficiencies the same values as for the histogram
plots are plotted in violin plots.
Changes in TE and transcription were analysed for pairwise comparisons,
based on experimental design, using microarray normalisation methods, as
reviewed by Quackenbush (2002). For each treatment, an average across
replicates was calculated for TE/RPKM values, using the geometric mean on a
per-gene basis. Two statistics were then derived from these averages, for each
gene:
Ratio which is calculated by dividing the value for the alternative treatment/knock-
out/transgenic by the value for the base-level treatment/WT.
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Intensity which is calculated by multiplying the afore-mentioned values
Data was ordered by increasing log10(Intensity). Along this ordered set
of values, mean log10(Intensity), as well as mean and standard deviation of
log2(Ratio) were calculated within a sliding window of 100 genes at steps of 50
genes. Each gene was assigned to the window with a mean log10(Intensity)
closest to the gene’s log10(Intensity).
A z-score was calculated for each gene i using the respective window’s




p-values were derived for each gene i from the z-score by treating it as a
quantile of the standard normal distribution:
pi = 2⇥ (1   (|zi|))
The sliding window was used to adequately represent the inherent structure
of the data. Similar to microarray data, TE ratios and – particularly – transcrip-
tion ratios are more variable at low intensities. With z-scores simply calculated
from the overall mean and standard deviation of the data, one might misidentify
extreme log2(Ratio) values as significant at low intensities. At higher intensi-
ties, on the other hand, genes with significant log2(Ratio) values might not be
identified. The intensity-dependent z-score is calculated with a subset of data
from genes with similar intensity. This takes local data structure into account,
allowing a more accurate determination of differential TE and transcription.
For TE values, we further used the R package Xtail v1.1.5 (Xiao et al., 2016),
a tool that has been specifically developed for analysing ribosome profiling data.
For both the z-score-based p-values and the p-values derived with Xtail,
false-discovery-rates (FDR) were calculated sensu Benjamini and Hochberg
(1995), according to three (adjustable) parameters:
• Low TE/RPKM ratio threshold (generally pre-set to 0.666)
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• High TE/RPKM ratio threshold (generally pre-set to 1.5)
• Minimum across all samples (generally pre-set to 40)
2.2.5 UTR analysis
Analysis of untranslated regions (UTR) of differentially translated genes
(DTG) was performed using a custom-scripted pipeline implemented in R. The
pipeline analyses a list of genes provided as ensembl gene IDs in a .txt file and
consists of several modules:
Reference Preparation the pipeline downloads the latest reference data and
compiles a UTR database from them
Input check the gene IDs provided as an input are matched against the UTR
database and filtered according to user commands (3’/5’, all/longest UTR
sequences)
Basic statistics this module extracts information such as UTR sequence
length and GC content for each sequence
Clustering an optional module that aligns UTR sequences using MAFFT
v7.407 (Katoh and Standley, 2013). Pairwise dissimilarities are calculated
from the multiple sequence alignment and used to construct a dendrogram
with the complete-linkage hierarchical clustering method. The optimal
number of clusters is determined according to the C-Index (Hubert and
Levin, 1976)
Gibbs free energy mfold v3.6 (Zuker, 2003) is used to calculate Gibbs free
energy for each sequence and results are represented as values and in
image form
Motifs all sequences are scanned for known motifs using a stand-alone version
of Utrscan (Pesole and Liuni, 1999)
Output the results of individual modules are combined in a tab-separated file
for the user to interpret
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2.2.6 Gene ontology analysis
Gene ontology (GO) analysis was performed on DEGs and DTGs using
the Database for Annotation, Visualization and Integrated Discovery (DAVID)
version 6.8 (Huang et al., 2009a,b). GO annotations were gathered for the
following categories:
Molecular function (MF) tests for molecular function GO terms enriched in
the analysed data.
Biological process (BP) tests for biological process GO terms enriched in the
analysed data.
Cellular component (CC) tests for cellular component GO terms enriched in
the analysed data.
KEGG pathways maps the dataset to Pathways in the KEGG (Kyoto Encyclo-
pedia of Genes and Genomes) database and tests for any enrichment.
BIOCARTA pathways maps the dataset to Pathways in the BioCarta database
and tests for any enrichment.
Only GO terms with associated p-values <0.05 were considered.
2.2.7 Ingenuity Pathway Analysis (IPA)
DEG and DTG datasets were uploaded on IPA (IPA; QIAGEN Inc.) and
submitted to Core Analysis. Analysis settings were set to include direct and
indirect relationships, and experimentally observed nervous system data. In
more detail, the gene sets were analysed for enrichment, based on p-value, in
the following categories:
Canonical Pathways determines most significantly affected, established sig-
nalling and metabolic pathways. Can predict activation/inhibition of path-
ways and identify overlapping pathways in the dataset.
Upstream Regulators predicts which molecules (including microRNA and tran-
scription factors) may be causing the observed changes in the data being
analysed.
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Diseases and Functions predicts changes downstream of the observed ex-
pression changes, in the tissue or cells studied.
Mechanistic networks (incl. molecule activity prediction) generates plau-
sible signalling cascades, based on the data, that may describe the
potential mechanism leading to gene expression changes in the data.
Molecule activity prediction (MAP) can be used to overlay the generated
networks, predicting activity of the nodes, based on expression changes
observed in the data.
Sub-cellular localisation genes get assigned to one category (cytoplasm,
extracellular space, nucleus, plasma membrane, other). This information
can be used to determine whether there was an enrichment/depletion in
any of the locations.
Type categorises genes based on their function in the cell (including cytokine,
enzyme, G-protein coupled receptor, growth factor, ion channel, kinase,
ligand-dependent nuclear receptor, peptidase, phosphatase, transcrip-
tion regulator, translation regulator, transmembrane receptor, transporter,
other)
2.3 Western blotting
Samples for Western blotting were homogenised in an appropriate volume
of RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS), containing protease and phosphatase inhibitors
(Roche). Homogenates were incubated on ice for 15 min with occasional vor-
texing and were cleared by centrifugation at 16,000 RCF at 4°C for 20 min. The
supernatant was used for Western blotting, after each sample was quantified
using the DC Protein Assay (Bio-Rad).
20-50 µg of protein per lane were prepared in SDS Sample Buffer (50 mM
Tris pH 6.8, 100 mM DTT, 2% SDS, 10% Glycerol, 0.1% bromophenol blue),
heat-denatured at 98°C for 5 min and resolved on 10-16% home-made poly-
acrylamide gels (Bio-Rad gel-pouring system). The resolved proteins were
transferred to 0.2 µm nitrocellulose membranes (Bio-Rad), blocked with 5%
BSA in TBS-T (10 mM Tris pH 7.6, 150 mM NaCl, 0.1% Tween-20) for 1 h
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Table 2.4 Primary antibodies
Target Species Supplier Cat No WB
4E-BP1 rabbit New England Biolabs 9644 1:1000
4E-BP1 phospho Thr37/46 rabbit Cell Signalling 2855 1:1000
4E-BP2 rabbit New England Biolabs 2845 1:1000
Akt rabbit Cell Signalling 9272 1:1000
Akt phospho Ser473 rabbit Cell Signalling 9271 1:1000
Akt phospho Thr308 rabbit Cell Signalling 9275 1:1000
eIF4E mouse BD Biosciences 610270 1:1000
eIF4E phospho Ser209 rabbit abcam ab76256 1:1000
FAK rabbit Millipore 06-543 1:1000
FAK phospho Tyr397 rabbit Thermo Scientific 44-624G 1:1000
GAPDH rabbit Cell Signalling 2118S 1:5000
HDAC3 7G6C5 mouse GeneTex GTX83173 1:1000
HSC-70 mouse Santa Cruz sc-7298 1:1000
MAPK (ERK1/2, p44/42) rabbit Cell Signalling 4695 1:1000
MAPK (ERK1/2, p44/42) phospho Thr202/Tyr204 rabbit Cell Signalling 9101 1:1000
Myelin Basic Protein mouse abcam ab62631 1:1000
PSD95 rabbit Cell Signalling 3450 1:1000
Puromycin mouse Millipore MABE343 1:1000
Ribosomal Protein L10a rabbit abcam ab174318 1:1000
Ribosomal Protein L11 rabbit Cell Signalling 18163 1:1000
Ribosomal Protein L13 rabbit Cell Signalling 2765 1:500
Ribosomal Protein S6 mouse Santa Cruz sc-74459 1:1000
Ribosomal Protein S6 phospho Ser235/236 rabbit Cell Signalling 2211S 1:1000
Ribosomal Protein S6 phospho Ser240/244 rabbit Cell Signalling 2215S 1:1000
Ribosomal Protein S6 phospho Ser240/244 XP rabbit Cell Signalling 5364 1:1000
Ribosomal Protein S15 rabbit abcam ab157193 1:1000
SV2A mouse DSHB University of Iowa AB_2315387 1:1000
Synaptophysin 1 rabbit Synaptic Systems 101 002 1:1000
Table 2.5 Secondary antibodies
Description Species Supplier Cat No WB
IRDye® 680RD Donkey anti-Mouse IgG (H + L) Donkey LiCOR Biosciences 926-68072 1:5000
IRDye® 680RD Donkey anti-Rabbit IgG (H + L) Donkey LiCOR Biosciences 926-68073 1:5000
IRDye® 800CW Donkey anti-Mouse IgG (H + L) Donkey LiCOR Biosciences 926-32212 1:5000
IRDye® 800CW Donkey anti-Rabbit IgG (H + L) Donkey LiCOR Biosciences 926-32213 1:5000
at RT, incubated with primary antibodies (summarised in Table 2.4) at 4°C
overnight, and with secondary antibodies (summarised in Table 2.5) at RT for
1 h. Membranes were washed extensively in TBS-T between the incubations.
The membranes were imaged using an Odyssey Imaging System (Li-COR
Biosciences) at a resolution of 169 µm and quantified using the Image Studio™
Software Version 5.x (Li-COR Biosciences). The intensity of each protein band
was measured in triplicate and averaged to minimize measuring variability.
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2.4 Statistical analysis
Quantitative data were collected and organised in Microsoft Excel®. Data
was visualised and statistical analysis was carried out using GraphPad Prism®
6 software. Details of statistical tests used are outlined in the results sections or
within the associated figure legends. Statistical significance was set to 0.05 a
priori.
Chapter 3
The role of overexpression of
MMP-9 in fragile X syndrome
3.1 Introduction
3.1.1 Autism and Fragile X Syndrome
Autism spectrum disorders (ASDs) are a heterogeneous group of neurodevel-
opmental disorders, in which patients exhibit impairments in three core domains:
communication, social behaviour, and repetitive/stereotypic behaviours (Ameri-
can Psychiatric Association, 2000). The global burden of ASDs has increased
drastically over the last few decades, with a prevalence of 1 in 132 people on the
spectrum (Baxter et al., 2014). ASDs exhibit a strong genetic component and
several single-gene neurodevelopmental disorders are frequently co-diagnosed
with ASD. For instance, tuberous sclerosis complex (TSC) accounts for 1-4% of
ASD patients (Kelleher III and Bear, 2008), whereas fragile X syndrome (FXS),
currently the most prevalent known inherited cause of autism, accounts for
approximately 5% of the ASD population (Budimirovic and Kaufmann, 2011).
Patients with FXS clinically present with a variety of symptoms, including
intellectual disability, hyper-excitability, anxiety, repetitive behaviours and mor-
phological abnormalities (Zoghbi and Bear, 2012). In addition, 50-60% of
patients are co-diagnosed with ASDs (Budimirovic and Kaufmann, 2011).
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FXS results from expanded CGG repeats in the FMR1 gene, leading to
hypermethylation (silencing) of the locus and, subsequently, loss of fragile X
mental retardation protein (FMRP) expression (Budimirovic and Kaufmann,
2011). FMRP is an mRNA binding protein that plays an important role in
regulating synaptic translation (Darnell et al., 2011) and has been linked to
aberrant translation of subpopulations of mRNAs (Gkogkas et al., 2013; Jung
et al., 2014; Santini et al., 2013). Both Fmr1 knock-out (Fmr1KO) mice and
patients exhibit abnormal dendritic spine morphology (Comery et al., 1997;
Janusz et al., 2013; Rudelli et al., 1985), suggesting that synaptic connections
might not be established correctly. Synaptic plasticity is altered in Fmr1KO mice,
further supporting this hypothesis (Gkogkas et al., 2014; Huber et al., 2001;
Osterweil et al., 2013).
According to the mGluR theory of FXS, loss of FMRP leads to an upregula-
tion in translation of mRNAs through two major signalling axes: PI3K/Akt/mTOR
(mechanistic target of rapamycin) (Sharma et al., 2010) and Ras/ERK (extracel-
lular signal-regulated kinase)/Mnk (mitogen-activated protein kinase interact-
ing kinases) (Osterweil et al., 2010). Upregulation of these pathways results
in exaggerated global translation, altered synaptic plasticity (e.g. enhanced
mGluR-dependent late long-term depression), and ASD-like behaviours in mice
(Gkogkas et al., 2014; Osterweil et al., 2013).
3.1.2 FXS and MMP-9
Expression of matrix metalloproteinase 9 (MMP-9) is regulated through cap-
dependent translation (Furic et al., 2010; Gkogkas et al., 2014) and its mRNA
is translationally regulated by FMRP (Janusz et al., 2013). MMP-9 levels are
elevated in tissues from Fmr1KO mice, and post-mortem tissue and plasma
from FXS patients (Dziembowska et al., 2013; Gkogkas et al., 2014; Sidhu
et al., 2014). Abdallah et al. (2012) et al reported elevated levels of MMP-9
in amniotic fluid from mothers of ASD patients. In addition, a mouse model
overexpressing MMP-9 in the brain recapitulates some of the key phenotypes
of FXS, such as abnormal dendritic spine morphology, repetitive/stereotypic
behaviours, and social deficits (Gkogkas et al., 2014).
MMP-9 is a well-studied effector in neuroinflammation that has also been
implicated in the regulation of synaptic plasticity and dendritic spine remodelling
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(Nagy et al., 2006; Szepesi et al., 2013; Wiera et al., 2013). Correction of high
levels of MMP-9 using inhibitors of the Ras/ERK/Mnk pathway (e.g. Lovastatin,
Cercosporamide), inhibitors of MMP-9 (e.g. minocycline) or genetic deletion
of upstream activators (Figure 3.1) has been shown to ameliorate several
of the FXS phenotypes in Fmr1KO mice (Bilousova et al., 2008; Gkogkas
et al., 2014; Janusz et al., 2013; Lovelace et al., 2016; Sidhu et al., 2014).
Furthermore, treatment of Fmr1KO mice with metformin, a commonly used drug
for diabetes that suppresses translation through inhibition of AMP-activated
kinase upstream of both mTORC1 and ERK pathways, rescued several of the
key FXS phenotypes, including elevated levels of MMP-9 (Gantois et al., 2017).
Minocycline has also proven effective in treating FXS patients (Dziembowska
et al., 2013).
Figure 3.1 Regulation of Mmp-9 translation through mGluR5 and the
Ras/ERK/Mnk pathway. In response to mGluR activation eIF4E is phosphorylated
by Mnk1/2 and upregulates cap-dependent translation of Mmp-9. Right panel shows
currently available and tested inhibitors of the pathway and at which stage they inhibit
signalling.
MMP-9 cleaves several substrates within the extracellular matrix (ECM)
that have the ability to influence intracellular signalling (Huntley, 2012). For
instance, MMP-9 has been shown to cleave b1-integrins, cell surface receptors
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that interact with the ECM and activate the PI3K/Akt/mTOR pathway (Sidhu
et al., 2014; Yong, 2005), an important regulator of cell growth and translation
in particular (Hay and Sonenberg, 2004). MMP-9 and other matrix metallopro-
teinases appear to play an important role in ASDs by proteolysing molecules
such as neuroligins (Peixoto et al., 2012), cadherins, integrins and growth
factors (Figure 3.2), some of which have previously been implicated in autism
(Abdallah and Michel, 2013).
Figure 3.2 Cleavage substrates of MMP-9 at the synapse Previously established
substrates of MMP-9 and how they may influence cell signalling. MMP-9 has been
shown to cleave neuroligins in an activity-dependent fashion, altering synaptic trans-
mission. Furthermore, MMP-9 has been shown to cleave growth factors such as
pro-BDNF into its active form (BDNF), activating TrkB and downstream mTORC1
signalling. MMP-9 cleaves various components of the ECM, resulting in short RGD
(arginylglycylaspartic acid) peptides, which can activate integrin signalling, which is
upstream of the PI3K/Akt/mTORC1 cascade.
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3.1.3 Aims
With the experiments presented in this chapter, we aimed to elucidate the
role of upregulated MMP-9 in FXS. It has been extensively shown that upreg-
ulation of MMP-9 plays a significant role in the aetiology of FXS and several
studies lowering MMP-9 levels either pharmacologically or genetically have
been shown to treat key phenotypes of FXS in rodent models and patients. We
hypothesised that MMP-9 contributes to FXS phenotypes through regulating
a secondary wave of upregulated translation. Specifically, we wanted to un-
derstand the effects of upregulating MMP-9 in the brain outwith the context of
FXS on several levels of translation regulation: global translation, regulation of
signalling pathways impinging on translation, and transcript-specific changes in
translation. Lastly, we also aimed to compare these results to a commonly used
model of FXS, a Fmr1 knock-out mouse.
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3.2 Materials and methods
3.2.1 TgMMP9 mice
TgMMP9 mice overexpress full-length human proMMP-9 under the PDGF-B
(platelet-derived growth factor B-chain) promoter, which provides brain-specific
expression of MMP-9 (Fragkouli et al., 2012). A genetic construct containing
the PDGF-B promoter and the MMP-9 cDNA, was injected into fertilised mouse
oocytes, where it randomly inserted into the genome, to generate transgenic
founders (Figure 3.3). All animal experiments were carried out in agreement with
the ethical recommendation of the European Communities Council Directive of
22 September 2010 (2010/63/EU). Tissue was obtained from transgenic mice
and wildtype controls directly from Dr. Tzinia’s lab at the National Center for
Scientific Research Demokritos.
Figure 3.3 TgMMP9 genetic design. Schematic depicting the cloned cDNA construct
that was injected into fertilised mouse oocytes to generate transgenic founder mice.
The cloning procedure was described in Fragkouli et al. (2012), the construct contains
full length human pro-MMP-9 cDNA under the control of the human PDGF-B promoter.
3.2.2 Fmr1KO mice
All procedures were in accordance with United Kingdom Home Office and
were approved by the University of Edinburgh. Animals were kept under stan-
dard husbandry conditions, with ad libitum access to food and water, unless
otherwise specified. The animal facility was operated on a 12 h light/dark cycle.
Fmr1Y/- mice were obtained from Jackson Laboratories (003025) and were
originally generated trough a targeted mutation at Dr Ben Oostra’s labora-
tory at Erasmus University in the Netherlands (The Dutch-Belgian Fragile X
Consortium, 1994) (Figure 3.4).
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Figure 3.4 Fmr1KO genetic design. A scheme showing how the Fmr1 targeted
mutation was designed. Exon 5 of the gene was disrupted by inserting a neomycin
resistance cassette (neo). Further, thymidine kinase (tk ) was inserted 3’ of the genomic
sequence as a negative selection marker gene. Adapted from The Dutch-Belgian
Fragile X Consortium (1994).
3.2.3 Puromycin release assay
The Puromycin release assay was carried out in the Gkogkas lab by Dr. Inês
S. Amorim.
This method was adapted from Eacker et al. (2017), which uses a variation
of the SUnSET method (Schmidt et al., 2009) and was previously described in
Biever et al. (2015). Frozen forebrain tissue was homogenised in 1 ml puromycin
release buffer (10 mM HEPES pH 7.4, 5 mM MgCl2, 150 mM KCl, 200 µM
emetine, 0.5 mM DTT, EDTA-free protease inhibitors, 200 µM ATP, 100 µM
GTP), using a motorised pestle. The homogenate was incubated on ice for
15 min, with occasional vortexing. The lysate was cleared by centrifugation at
12,000 RCF for 10 min at 4°C and the supernatant transferred to a fresh tube.
The protein concentration was determined by A280 absorbance measurements
on a NanoDrop™ 2000 (ThermoFisher, ND-2000) and all samples adjusted to
5 mg/ml protein concentration with puromycin release buffer (PRB).
Puromycin (Merck, P7255-100MG) was added to 100 µl sample aliquots to
a final concentration of 1.25 mM. The samples were incubated for 10, 30, or
60 min at 37°C. Once the incubation was finished, reactions were stopped by
adding EDTA at a final concentration of 25 mM. To prepare samples for Western
blotting, 50 µl of the Puromycin incorporation reactions were diluted with 20 µl
ddH2O and mixed with 30 µl of 4X SDS-PAGE Loading Buffer (200 mM Tris-HCl
pH 6.8, 400 mM DTT, 8% (w/v) SDS, 40% (v/v) Glycerol, 0.4% Bromophenol
Blue).
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3.2.4 Other methods
Ribosome profiling (including GO analysis and UTR analysis) and Western
blotting methods are outlined in Chapter 2 "General materials and methods".
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3.3 Results
3.3.1 Global protein synthesis is unaffected in animals con-
ditionally overexpressing human MMP-9 in the brain
Since loss of FMRP has been shown to result in global upregulation of
translation (Gkogkas et al., 2014; Osterweil et al., 2013; Sharma et al., 2010),
we wanted to see whether a transgenic mouse model overexpressing human pro-
MMP-9 under the control of a brain specific promoter (from here on referred to
as TgMMP9), would result in a similar molecular phenotype. TgMMP9 animals
have previously been shown to mimic the social deficits, repetitive/stereotypic
behaviours, and abnormal dendritic spine morphology observed in models
of FXS. To test our hypothesis, we used an in vitro Puromycin incorporation
assay, which functions in a pulse-chase fashion and labels all proteins newly
synthesised during the duration of the experiment.
We tested whole forebrain lysates from TgMMP9 animals and wildtype (WT)
littermates at three different timepoints (10, 30, and 60 min) of Puromycin
incorporation. Although we found a trend towards decreased Puromycin incor-
poration at the 60 min timepoint in the TgMMP9 animals (Figure 3.5 E, F), we
did not observe any statistically significant differences in protein synthesis rates
between TgMMP9 and WT animals at any of the timepoints (Figure 3.5).
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Figure 3.5 Global translation activity levels are unchanged in TgMMP9 brains.
A, C, E Representative images of Western blots for samples run through Puromycin
release assay (10, 30, 60 min). The blots were probed with an anti-Puromycin antibody
and anti-GAPDH, as a loading control. B, D, F Quantification of Western blots for
Puromycin, values were normalised to the loading control (n = 8 for each genotype)
and are represented relative to WT average. Shown are mean and standard error of
the mean (SEM), including individual data points. Student’s t-test was used to evaluate
changes. A, B Experimental timepoint 10 min. C, D Experimental timepoint 30 min. E,
F Experimental timepoint 60 min.
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3.3.2 Signalling pathways upstream of translation are un-
changed in animals conditionally overexpressing hu-
man MMP-9 in the brain
To evaluate the role of MMP-9 upregulation in the brain, specifically, in
regulation of translation, we probed for phosphorylation of major hubs in the
PI3K/Akt/mTOR and Ras/ERK/Mnk pathways using Western blotting. We did
not observe any significant changes in phosphorylation of PI3K/Akt/mTOR
components AKT (Ser473, p = 0.7435) (Figure 3.6 C, F), ribosomal protein S6
(Ser235/236 p = 0.6832)(Figure 3.6 A, D), and 4E-BP1/2 (Thr34/46, p = 0.8048
and 0.2652, for isoforms 1 and 2, respectively) (Figure 3.6 A, D). Equivalently,
we were not able to detect any differences in phosphorylation of components of
the Ras/ERK/Mnk pathway, namely ERK (p = 0.2385) and eIF4E (p = 0.8194)
(Figure 3.6 B, E).
Further, we probed for phosphorylated and total focal adhesion kinase (FAK)
which had previously been shown to be upregulated in response to treatment
with recombinant MMP-9 in hippocampal cultures (Sidhu et al., 2014). We did
not observe any changes in phosphorylation of FAK in TgMMP9 animals (p =
0.6680) (Figure 3.6 C, F).
Taken together, we did not detect any significant changes in signalling
pathways upstream of translation in forebrain tissue overexpressing MMP-9,
compared to WT controls.
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Figure 3.6 Phosphorylation levels of signalling pathways upstream of transla-
tion are unchanged in TgMMP9 brains. A-C Representative images of Western blots
probed with phospho and total antibodies against the indicated signalling molecules, to
assess activation levels. HSC-70 was used as a loading control. A Blots against key
components of the mTOR pathway, ribosomal protein S6 (RPS6, two distinct phospho
sites) and 4E-BP1/2. B Blots against key components of the ERK/Mnk pathway, ex-
tracellular signal-regulated kinase (ERK) and eukaryotic initiation factor 4E. C Blots
against Protein kinase B (AKT, upstream signal of mTORC1) and focal adhesion kinase
(FAK, important regulator of cell migration). D-F Quantification of the Western blots,
n = 8 for each genotype. Values shown are phospho signal intensity normalised to total
protein expression and relative to WT average. Shown are mean and standard error of
the mean (SEM), including individual data points. No significant differences between
WT and TgMMP9 were found in a Student’s t-test.
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3.3.3 Conditional overexpression of human MMP-9 in the
brain does not significantly alter mRNA expression or
translation
Faced with the apparent diversion of the global translation and signalling
pathways phenotypes between TgMMP9 and Fmr1KO animals, we set out to
explore translation in the TgMMP9 animals in a less biased and more global
fashion. To study changes in translation of individual mRNAs in detail, we
prepared ribosome profiling libraries from TgMMP9 whole forebrain samples.
Ribosome profiling is an unbiased method that employs nuclease footprinting of
translating ribosomes followed by next generation sequencing to quantitatively
assess the translation status (i.e. ribosome occupancy) of each transcript
present in the sample. The sequencing libraries we prepared showed great
reproducibility between replicates for both footprint and total mRNA transcript
abundance (Figure 3.7 A, r2 > 0.95 for all replicate comparisons). Furthermore,
as expected for ribosome profiling libraries, the ribosomal footprints showed a
high read abundance between 28 and 30 nt, whereas total RNA, which was
randomly fragmented to yield similar sized fragments, showed a more random
size distribution and slightly larger fragments (Figure 3.7 B).
Reads from footprint samples aligned preferentially with the first open read-
ing frame of their respective transcripts, while total mRNA reads aligned equally
with all three reading frames (Figure 3.7 C). As demonstrated in Figure 3.7 D,
footprint samples show a clear three nucleotide periodicity, when compared
to total RNA reads, which align randomly along transcripts. Moreover, we ob-
served a peak in footprint abundance around both the start and stop codons of
messages, indicating that captured footprints originated indeed from translating
ribosomes (Figure 3.7 D).
The overexpression of MMP-9 does not appear to have strong effects on
the transcription and translation of specific mRNAs, which is in accordance
with our Puromycin incorporation data. In the TgMMP9 animals, we observed
8 transcriptionally significantly upregulated mRNAs and 10 downregulated
transcripts (Figure 3.8 A, Table A.1). We saw slightly more significant changes in
translation with 22 translationally upregulated transcripts and 22 downregulated
transcripts (Figure 3.8 B, Table A.2).
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Figure 3.7 Ribosome profiling data for TgMMP9 is of high quality and repro-
ducibility. A Replicates were plotted against each other and show a very high correla-
tion between each other, confirming the reproducibility of our data. B Sequenced cDNA
library fragments show the expected length distributions, a sharp peak between 28 and
30 nt for the footprints and a flat, random distribution for total RNA samples. C The
majority of the footprints align with the first open reading frame of a transcript, whereas
the randomly fragmented total RNA aligns equally to all reading frames. D Ribosomal
footprints cluster around Start and Stop codons and show a 3 nt periodicity. Plots of
representative samples, visualising how reads align relative to start and stop codons of
their respective mRNA. Overall, footprints show peaks around start and stop codons,
as well as a 3 nt periodicity, while total mRNA aligns randomly along the message.
3.3 Results 45
Figure 3.8 Read counts and TE of TgMMP9 show little differences compared to
WT. Scatter plots (WT vs TgMMP9) of the log2 mean read count and mean TE values
for each set of sequencing replicates (n = 3). Blue indicates significantly downregulated
genes, red significantly upregulated genes in the dataset. A Mean read count of WT vs
TgMMP9. R2 = 0.99518785 B Mean TE of WT vs TgMMP9. R2 = 0.996749746
3.3.3.1 Gene ontology analysis of TgMMP9 DEGs and DTGs
To determine any functional relationships within the DEGs and DTGs, we per-
formed DAVID (Database for Annotation, Visualization and Integrated Discovery,
v6.8) analysis (Huang et al., 2009a,b) and IPA (Qiagen). We identified signifi-
cantly enriched GO terms in the biological process, cellular component, and
molecular function categories in the DEG list using DAVID. Notable categories
include glycinergic synaptic transmission, extracellular matrix organisation, and
proteinaceous extracellular matrix (Figure 3.9 A). In the DTGs identified for
TgMMP9 brains, only few terms were significantly enriched (Figure 3.9 B).
Similarly, we identified some interesting enriched Ingenuity Canonical Path-
ways and Diseases/Function Annotations, as well as networks in our data with
the help of IPA, using a neuronal tissue specific analysis. In the DEGs, IPA
identified Calcium signalling, FAK signalling, VEGF signalling, eIF2 signalling,
and Integrin signalling. Moreover, molecules relating to familial Alzheimer dis-
ease, Alzheimer disease, and function of the blood-brain barrier were enriched
in the data (Figure 3.10 A). We further identified a network (Figure 3.11 A), that
includes interesting nervous system regulators (APP, neuropeptide Y, sodium-
and chloride-dependent glycine transporter). Few terms were identified for the
TgMMP9 DTGs but included synaptic long term depression and several nervous
system development annotations, (Figure 3.10 B). Network analysis identified a
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Figure 3.9 Significantly enriched GO categories in TgMMP9 DEGs and DTGs.
Plots summarising the identified categories for DEGs and DTGs and associated p-
values, retrieved from DAVID. A Functional categories identified in TgMMP9 DEGs. B
Functional categories identified in TgMMP9 DTGs.
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regulatory network including Fus (RNA binding protein), APP, and Presenilin-1
(Figure 3.11 B).
Taken together, GO analysis identified some interesting terms and annota-
tions that may be relevant to the aetiology of the FXS. However, regulation of
mRNA translation through overexpression of MMP-9 does not appear to explain
the phenotypes observed in Fmr1KO animals. On the other hand, our data
supports the previously studied involvement of MMP-9 in Alzheimer’s disease
(Fragkouli et al., 2012).
3.3 Results 48
Figure 3.10 Significantly enriched Ingenuity Canonical Pathway and Diseases
and Function annotations in TgMMP9 DEGs and DTGs. Plots summarising the
identified categories for DEGs and DTGs and associated p-values, retrieved from IPA.
A Functional categories identified in TgMMP9 DEGs. B Functional categories identified
in TgMMP9 DTGs.
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Figure 3.11 Significant networks including molecule activity prediction in
TgMMP9 DEGs and DTGs. Networks identified in the DEG/DTG lists from the
TgMMP9 data using IPA, including a molecule activity prediction (MAP) A Network
identified in TgMMP9 DEGs. B Network identified in TgMMP9 DTGs.
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3.3.3.2 UTR analysis of TgMMP9 DTGs
Untranslated regions (UTR) of transcripts can have a considerable effect
on their stability and/or translation. Therefore, we carried out UTR analysis
of the DTGs in our data, looking for common, known motifs and examining
basic UTR statistics, namely guanine-cytosine (GC) content, length, and Gibbs
free (folding) energy. We did not detect significant occurrence of any motifs in
neither the 5’ UTR nor the 3’ UTR, comparing the up- and downregulated gene
groups. However, there was a trend towards an increased number of upstream
open reading frames (uORF) in the 5’ UTRs downregulated genes (Figure 3.12
A, B). 3’ UTRs of upregulated genes were significantly longer than 3’ UTRs of
downregulated genes. We did not find significant changes between any other
UTR parameters (Figure 3.12 C, D).
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Figure 3.12 UTR motif and basic statistics analysis of TgMMP9 DTGs. A Motifs
identified in the 5’ UTR of up- and downregulated DTGs. The bars represent the
percentage of genes (UTRs) containing one or more of the indicated motifs. B RNA
motifs identified in the 3’ UTR of up- and downregulated DTGs. The bars represent the
percentage of genes (UTRs) containing one or more of the indicated motifs. B-C Bar
graphs for the indicated values, represented as mean ± standard error of the mean,
including the individual data points. Shown are percentage of GC nucleotides in the
UTR, length of UTR, and Gibbs free (folding) energy of UTR sequence. C GC content,
length and Gibbs free energy calculated for 5’ UTRs of the DTGs. D GC content, length
and Gibbs free energy calculated for 3’ UTRs of the DTGs. *** p  0.0001 Student’s
t-test.
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3.3.4 Ribosome profiling of Fmr1KO brain tissue reveals mi-
nor changes in transcription and TE
To gain a better understanding of the translational profile of Fmr1KO brains
and how it compares to the data collected on TgMMP9 animals, we proceeded
to generate ribosome profiling libraries from adult Fmr1KO forebrains and WT
controls. Fmr1KO libraries were of comparable quality to TgMMP9 libraries
(Figure 3.13 A-D) and did not show gross changes in global translation (Fig-
ure 3.15). In Fmr1KO animals, 25 mRNAs were transcriptionally downregulated
and only 3 transcripts upregulated, in our dataset (Figure 3.14 A, Table A.3).
TE was also lightly affected by the mutation with 16 upregulated genes and 19
downregulated genes (Figure 3.14 B, Table A.3).
Same as for the TgMMP9 data, we carried out GO analysis using DAVID
and IPA. Relevant GO terms enriched in the DAVID analysis of Fmr1KO animals
were regulation of neuronal synaptic plasticity, extracellular region, extracellular
space, and calcium ion (Figure 3.16 A). For the DTGs, we identified signifi-
cantly enriched functional terms in the biological process, cellular component,
molecular function, and Biocarta Pathway categories in DAVID. Some of the key
categories enriched in the DTGs include positive regulation of MAP kinase ac-
tivity, cytosolic small ribosomal subunit, intracellular ribonucleoprotein complex,
and p38 MAPK Signalling Pathway (Figure 3.16 B).
In the IPA analysis for Fmr1KO DEGs, the categories include HIPPO Sig-
nalling, PI3K Signalling in B Lymphocytes, Calcium Signalling, Hyperpolarisation
of neurons, Plasticity of neuronal synapse, and several transcriptional regula-
tors, as well as cytoplasmic FMRP interacting protein 1 (CYFIP1) and amyloid
precursor protein (APP) as upstream regulators of the genes in our data set
(Figure 3.17 A). Interestingly enough, IPA also identified a network in the data
(Figure 3.18 A) that relates to behaviour and nervous system development
and function terms and predicts changes in activity in several genes related to
disease and essential to normal function of the brain (APP, huntingtin, glutamate
receptor 1 precursor).
For the DTGs in the Fmr1KO data, IPA found canonical pathways related to
translation, namely STAT3 Pathway, p38 MAPK signalling, HIPPO Signalling,
TGF-b Signalling, mTOR signalling, and eIF2 signalling. Furthermore, APP
and apolipoprotein E were in the list of upstream regulators (Figure 3.17 B). A
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Figure 3.13 Ribosome profiling data for Fmr1KO is of high quality and repro-
ducibility. A Replicates were plotted against each other and show a very high correla-
tion between each other, confirming the reproducibility of our data. B Sequenced cDNA
library fragments show the expected length distributions, a sharp peak between 28 and
30 nt for the footprints and a flat, random distribution for total RNA samples. C The
majority of the footprints align with the first open reading frame of a transcript, whereas
the randomly fragmented total RNA aligns equally to all reading frames. D Ribosomal
footprints cluster around Start and Stop codons and show a 3 nt periodicity. Plots of
representative samples, visualising how reads align relative to start and stop codons of
their respective mRNA. Overall, footprints show peaks around start and stop codons,
as well as a 3 nt periodicity, while total mRNA aligns randomly along the message.
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Figure 3.14 Read counts and TE of Fmr1KO show little differences compared to
WT. Scatter plots (WT vs Fmr1KO) of the log2 mean read count and mean TE values
for each set of sequencing replicates (n = 3). Blue indicates significantly downregulated
genes, red significantly upregulated genes in the dataset. A Mean read count of WT vs
Fmr1KO. R2 = 0.99548689 B Mean TE of WT vs Fmr1KO. R2 = 0.704016563
Figure 3.15 Ribosome profiling reveals no global changes in TE between WT,
TgMMP9, and Fmr1KO. Violin plots of the translational efficiency by genotype, showing
that there are no significant changes in global translation.
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Figure 3.16 Significantly enriched GO categories in Fmr1KO DEGs and DTGs.
Plots summarising the identified categories for DEGs and DTGs and associated p-
values, retrieved from DAVID. A Functional categories identified in Fmr1KO DEGs. B
Functional categories identified in Fmr1KO DTGs.
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Figure 3.17 Significantly enriched Ingenuity Canonical Pathway and Diseases
and Function annotation in Fmr1KO DEGs and DTGs. Plots summarising the
identified categories for DEGs and DTGs and associated p-values, retrieved from IPA.
A Functional categories identified in Fmr1KO DEGs. B Functional categories identified
in Fmr1KO DTGs.
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functional network centring around APP and TGF-b was also identified in the
data and shows some interesting predicted changes (Figure 3.18 B).
Figure 3.18 Significant networks including molecule activity prediction in
Fmr1KO DEGs and DTGs. Networks identified in the DEG/DTG lists from the Fmr1KO
data using IPA, including a molecule activity prediction (MAP) A Network identified in
Fmr1KO DEGs. B Network identified in Fmr1KO DTGs.
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Lastly, we also carried out UTR analysis for the Fmr1KO DTGs. Interestingly
enough, three 5’ UTR motifs, uORF, terminal oligopyrimidine (TOP) tracts, and
internal ribosome entry sites, all of which have previously been associated with
mTOR dependent regulation of translation, showed a trend towards enrich-
ment in the upregulated genes (Figure 3.19 A, B). Furthermore, 3’ UTRs of
upregulated genes were longer and predicted to show more stable secondary
structures compared to downregulated genes (Figure 3.19 C, D).
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Figure 3.19 UTR motif and basic statistics analysis of Fmr1KO DTGs. A Motifs
identified in the 5’ UTR of up- and downregulated DTGs. The bars represent the
percentage of genes (UTRs) containing one or more of the indicated motifs. B RNA
motifs identified in the 3’ UTR of up- and downregulated DTGs. The bars represent the
percentage of genes (UTRs) containing one or more of the indicated motifs. C-D Bar
graphs for the indicated values, represented as mean ± standard error of the mean,
including the individual data points. Shown are percentage of GC nucleotides in the
UTR, length of UTR, and Gibbs free (folding) energy of UTR sequence. C GC content,
length and Gibbs free energy calculated for 5’ UTRs of the DTGs. C GC content, length
and Gibbs free energy calculated for 5’ UTRs of the DTGs. D GC content, length and
Gibbs free energy calculated for 3’ UTRs of the DTGs. * p  0.05, ** p  0.01 Student’s
t-test.
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3.3.5 No significant overlap in the translational and tran-
scriptional landscapes of brain tissue overexpressing
MMP9 and Fmr1 knockout brain tissue
Of the DEGs and DTGs in Fmr1KO brains and in TgMMP9 brains, very
few genes were shared. Only one DEG overlapped in our data, Foxe3, a
transcription factor important to eye development. No genes overlapped in the
DTG datasets. In the DAVID analysis, none of the terms that were significantly
enriched in the data overlapped between the two genotypes. When carrying out
a comparison analysis between the two data sets with IPA, in the transcription
datasets ILK signalling and calcium signalling were enriched in both, although
less significantly enriched in Fmr1KO (Table 3.1). The TE data overlapped on
"abnormal morphology of stereocilia bundles" (part of the inner ear) (Table 3.4).
Notably, none of these common terms were statistically significant (p < 0.05).
No other significant terms overlapped in the DEGs (Table 3.1, 3.2) or DTGs
(Table 3.3, 3.4).
Table 3.1 DEG Canonical Pathways comparison between Fmr1KO and TgMMP9.
Pathway name and associated  log2(p  value) are reported. All Pathways listed by
IPA are included.
Canonical Pathway Fmr1KO TgMMP9
Hepatic Fibrosis/Hepatic Stellate Cell Activation not detected 3.535347
ILK Signaling 0.767938 2.108334
Calcium Signaling 0.716509 1.999368
Cellular Effects of Sildenafil (Viagra) not detected 2.482812
Agranulocyte Adhesion and Diapedesis not detected 2.35298
Embryonic Stem Cell Differentiation into Cardiac Lineages not detected 2.346318
Epithelial Adherens Junction Signaling not detected 2.323488
Tight Junction Signaling not detected 2.190149
Actin Cytoskeleton Signaling not detected 1.947722
Fatty Acid a-oxidation not detected 1.870978
Coagulation System not detected 1.686765
Mechanisms of Viral Exit from Host Cells not detected 1.506558
Role of JAK2 in Hormone-like Cytokine Signaling 1.469443 not detected
Cell Cycle: G2/M DNA Damage Checkpoint Regulation not detected 1.449454
Cell Cycle Control of Chromosomal Replication not detected 1.449454
Circadian Rhythm Signaling 1.412445 not detected
Eicosanoid Signaling not detected 1.35432
Crosstalk between Dendritic Cells and Natural Killer Cells not detected 1.345897
Caveolar-mediated Endocytosis Signaling not detected 1.321606
Thus, we conclude that the overexpression of MMP-9 in FXS does not play
a significant role in the dysregulation of translation observed in the disorder, but
probably through a yet to be discovered mechanism.
3.3 Results 61
Table 3.2 DEG Diseases and Biological Functions comparison between Fmr1KO
and TgMMP9. Term name and associated  log2(p  value) are reported. All Diseases
and Biological Functions listed by IPA are included.
Diseases and Bio Functions Fmr1KO TgMMP9
Cadasil not detected 3.044575
Firing of nucleus accumbens shell 2.909877 not detected
Cerebrovascular dysfunction not detected 2.909448
Uptake of chloride not detected 2.743724
Familial Alzheimer disease not detected 2.567811
Lack of trigeminal ganglion 2.433255 not detected
Length of primary neurites 2.433255 not detected
Clearance of amyloid-beta plaques 2.308565 not detected
Deposition of senile plaques 2.308565 not detected
Cerebral amyloid angiopathy not detected 2.046179
Abnormal morphology of somatic nervous system not detected 1.967354
Lack of forebrain 1.957629 not detected
Concentration of D-glucose 1.912121 not detected
Alzheimer disease not detected 1.8066
Hyperphagia 1.737275 not detected
Hyperpolarization of neurons 1.683416 not detected
Function of blood-brain barrier not detected 1.668459
Ingestion by rats 1.635609 not detected
Plasticity of neuronal synapse 1.592641 not detected
Ischemic injury of brain not detected 1.544943
Weight gain 1.517915 not detected
Feeding 1.350636 not detected
Cell viability of cortical neurons 1.307046 not detected
Table 3.3 DTG Canonical Pathways comparison between Fmr1KO and TgMMP9.
Pathway name and associated  log2(p  value) are reported. All Pathways listed by
IPA are included.
Canonical Pathway Fmr1KO TgMMP9
T Helper Cell Differentiation 2.24876 not detected
Eumelanin Biosynthesis 2.194765 not detected
STAT3 Pathway 1.834282 not detected
p38 MAPK Signaling 1.744908 not detected
Aryl Hydrocarbon Receptor Signaling 1.627874 not detected
Fatty Acid a-oxidation not detected 1.613582
Th1 and Th2 Activation Pathway 1.477928 not detected
IL-22 Signaling 1.423281 not detected
Coagulation System 1.319041 not detected
Role of Cytokines in Mediating Communication between Immune Cells 1.301001 not detected
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Table 3.4 DTG Diseases and Biological Functions comparison between Fmr1KO
and TgMMP9. Term name and associated  log2(p  value) are reported. All Diseases
and Biological Functions listed by IPA are included.
Diseases and Bio Functions Fmr1KO TgMMP9
Abnormal morphology of stereocilia bundles 1.423281 1.535413
Abnormal morphology of lobule I not detected 2.784938
Binding of endoplasmic reticulum membrane 2.670995 not detected
Outgrowth of vestibulocochlear cranial nerve ganglion 2.670995 not detected
Spontaneous hypertension 2.670995 not detected
Binding of mitochondrial membrane 2.670995 not detected
Exit from cell cycle progression of oligodendrocyte precursor cells 2.670995 not detected
Multiple Sclerosis 2.488532 not detected
Abnormal morphology of lobule III not detected 2.484247
Abnormal morphology of lobule II not detected 2.484247
Differentiation of Th17 cells 2.37041 not detected
Relaxation of middle cerebral artery 2.37041 not detected
Quantity of West Nile virus 2.37041 not detected
Clinical dementia rating score 3 Alzheimer disease 2.37041 not detected
Bioavailability of nitric oxide 2.37041 not detected
Proliferation of folliculo-stellate cells 2.37041 not detected
Myelination of white matter 2.37041 not detected
Contraction of cerebral artery 2.37041 not detected
Progressive motor neuropathy 2.357981 not detected
Abnormal morphology of cerebellum fissure not detected 2.308494
Edema of white matter 2.194765 not detected
Vasoconstriction of middle cerebral artery 2.194765 not detected
Development of infarct 2.194765 not detected
Formation of cerebellar lobule not detected 2.183894
Size of inferior colliculus not detected 2.087322
Compound action potential of cochlear nerve not detected 2.087322
Number of stereocilia not detected 2.087322
Re-entry into cell cycle progression of Schwann cells 2.070271 not detected
Mitogenesis of anterior pituitary cells 2.070271 not detected
Demyelination of fiber tract 2.070271 not detected
Development of midbrain-hindbrain boundary not detected 2.008479
Neuromuscular disease 1.982944 not detected
Function of brain 1.968389 not detected
Function of vestibular system not detected 1.941871
Activation of sensory neurons 1.89507 not detected
Abnormal morphology of midbrain-hindbrain boundary not detected 1.833403
Myelination of corpus callosum 1.771022 not detected
Abnormal auditory evoked potential not detected 1.709478
Encephalitis 1.635136 not detected
Long term depression of Purkinje cells 1.596708 not detected
Apoptosis of cerebral cortex cells 1.59259 not detected
Abnormal morphology of tectum mesencephali not detected 1.58589
Proliferation of neuroglia 1.565521 not detected
Inflammation of spinal cord 1.473546 not detected
Deposition of amyloid-beta plaques 1.473546 not detected
Fragmentation of DNA 1.447661 not detected
Quantity of outer hair cells 1.423281 not detected
Abnormal morphology of spiral ganglion 1.357664 not detected
Neuroinflammation 1.357664 not detected
Quantity of macrophages 1.319041 not detected
Abnormal morphology of granule neuron progenitor cells not detected 1.303705
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3.4 Discussion
In this chapter, we present an analysis of global translation and signalling
pathways upstream of translation in murine forebrain overexpressing human
MMP-9 (TgMMP9 animals). We further show ribosome profiling data comparing
translation of specific transcripts in a mouse model of FXS (Fmr1KO), and
TgMMP9 animals. TgMMP9 mice have previously been shown to resemble FXS
phenotypes, specifically social deficits, repetitive and stereotypic behaviours,
and abnormalities in dendritic spine morphology (Gkogkas et al., 2014). With
this research we attempted to dissect the potential contribution of MMP-9 to
dysregulated translation phenotypes in FXS.
Our observations of global translation in TgMMP9 forebrain tissue, using a
Puromycin incorporation assay marking all newly synthesised proteins within the
time frame of the experiment, do not resemble the global upregulation of protein
production that has been shown in FXS before (Bear et al., 2004; Gkogkas et al.,
2014). On the contrary, our data appears to show a trend towards decreased
translation in TgMMP9 forebrain lysates, with increasing time of incorporation
(Figure 3.5). This is interesting, since genetic or pharmacological restoration of
MMP-9 levels to baseline in models of FXS has been shown to correct several
of the key phenotypes, including exaggerated translation (Gkogkas et al., 2014;
Sidhu et al., 2014).
When probing for phosphorylation of important components of the mTOR
(RPS6 and 4E-BP1/2) and Mnk (ERK and eIF4E) signalling pathways in
TgMMP9 forebrain lysates, we did not observe any significant changes in
phosphorylation levels, compared to WT controls. We also did not detect any
changes in phosphorylation of AKT, an upstream regulator of mTOR, or FAK, a
molecule that had previously been shown to be hyperphosphorylated in DIV14
hippocampal neurons after treatment with recombinant MMP-9 (Sidhu et al.,
2014). These results are fairly divergent from phenotypes commonly observed
in models of FXS. A role for MMP-9 in FXS has been fairly well established
(Abdallah and Michel, 2013; Gantois et al., 2017; Gkogkas et al., 2014; Sidhu
et al., 2014). Nevertheless, we do not know about the molecular effects of
solely upregulating MMP-9 expression in vivo in much detail. Previous research
had strongly indicated that MMP-9 would contribute to the key FXS phenotypes
through differentially regulating translation (Gantois et al., 2017; Gkogkas et al.,
2014; Sidhu et al., 2014). Our data, however, does not support this hypothesis.
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To illuminate whether overexpression of MMP-9 had an effect on translation
and/or transcription of specific genes, we carried out ribosome profiling. Ribo-
some profiling in adult TgMMP9 whole brain identified few significant changes
in both the internal transcription control (18 DEGs) and TE (44 DTGs). We per-
formed GO analysis on these data sets, using DAVID and IPA. DAVID analysis
for biological process, molecular function, and cellular component GO terms
identified terms related to ECM and glycinergic synaptic transmission. ECM
involvement may be an interesting avenue to further explore because it has
previously been shown (Osterweil et al., 2010; Sharma et al., 2010; Wen et al.,
2018), and it may present the missing link between MMP-9 and FXS.
IPA showed very interesting terms relating both to general function of the
nervous system, as well as Alzheimer’s disease. Fragkouli et al. (2012) have
previously studied TgMMP9 animals with relation to Alzheimer’s disease. In
their study, TgMMP9 animals showed enhanced performance in the watermaze
and novel object tasks, along with increased hippocampal late long-term poten-
tiation. Overexpression of MMP-9 further resulted in increased soluble APPa
secretion. TgMMP9 animals also exhibit a decreased preference for the social
stimulus and social novelty in the three chamber task (Gkogkas et al., 2014).
Furthermore, TgMMP9 animals present with increased dendritic spine density
in the hippocampus (Fragkouli et al., 2012; Gkogkas et al., 2014).
UTR analysis of the TgMMP9 DTGs, consistent with the fairly small changes
in translation and transcription, showed no gross differences in specific motifs
between up- and downregulated genes. The length of 3’ UTRs was significantly
longer, on average, in upregulated than in downregulated genes, which may
influence protein abundance (Mayr, 2017). Additionally, differential 3’ UTR
length has recently been associated with neuronal activity (Tushev et al., 2018).
Since our ribosome profiling data from TgMMP9 forebrain alone did not
yield a clear answer as to whether MMP-9 was a regulator of transcript-specific
translation in the context of FXS, we decided to prepare ribosome profiling li-
braries from adult Fmr1KO forebrain and compare the results with the TgMMP9
data. Fmr1KO ribosome profiling data was of high quality and reproducibility.
Nevertheless, we identified only few significantly up- and downregulated genes.
This is consistent with previous translational profiling of Fmr1KO animals (Thom-
son et al., 2017). Thomson et al. (2017) identified 121 differentially expressed
genes, which may be due to their cell and region specific profiling approach
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compared to our unbiased whole brain profiling, as well as the age groups used
(P25-32 vs 6-8 weeks in our experiments).
GO analysis of the Fmr1KO DEGs and DTGs revealed ECM, synaptic
transmission, and protein synthesis related terms, which agrees with recently
published work that carried out ribosome profiling of P24 Fmr1KO mice (Sharma
et al., 2019). Analysis of UTR motifs exposed a clear trend towards uORF,
TOP, and IRES enrichment in the 5’ UTR of upregulated genes, although not
statistically significant. These motifs have been associated with regulation
of cap-dependent translation (Hinnebusch et al., 2016; Sharma et al., 2019;
Thoreen et al., 2012), which in turn is considered to be altered in FXS (Napoli
et al., 2008). Comparing the TgMMP9 and Fmr1KO data sets showed minimal
overlaps in DEGs and DTGs, as well as the GO analysis.
Taken together, our data highlight the differences between TgMMP9 mice
and Fmr1KO mice. In spite of the similar behavioural phenotypes, we were
unable to confirm similarities in the translation phenotypes of the two models.
Global translation in TgMMP9 whole brain lysates was not significantly different
from WT brain lysates, whereas Fmr1KO brain tissue has previously been
shown to have increased Puromycin and 35S incorporation (Bhattacharya et al.,
2012; Dölen et al., 2007). Phosphorylation of important signalling molecules
upstream of translation was unchanged in TgMMP9 brain lysates compared to
WT controls. Several of these molecules have been shown to exhibit an altered
phosphorylation pattern in Fmr1KO mice before (Sharma et al., 2010). Ribo-
some profiling identified only very few significantly regulated genes. However,
they grouped under relevant terms in GO analysis.
Lastly, in spite of the established causal relationship between FXS and the
upregulation of MMP-9, we only observed one overlap in the DEGs between
our two models, namely Foxe3, which is downregulated in both Fmr1KO and
TgMMP9. Foxe3 encodes for a transcription factor that is essential for correct
lens development (Blixt et al., 2000; Brownell et al., 2000). Lack of Foxe3
leads to severe abnormalities during the formation of the eye, through reduced
proliferation of the anterior lens epithelium and early differentiation of cells,
resulting in smaller eyes that may never open in KO mice (Medina-Martinez
et al., 2005). How it might be related to FXS and the upregulation of MMP-9 is
currently unclear, however, it may be expressed in other tissues than the lens
and play different roles at varying developmental timepoints.
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A lot of work remains to be done to dissect the contribution of MMP-9 to
the generation of psychiatric disorders. Possible targets to study are the ECM,
as terms related to it were enriched in both mouse models. Another important
factor to consider is the age of the animals that are being used, as some of
the changes may be more prevalent at an earlier and more plastic period. Due
to the use of whole forebrain, we may also have observed a diluted effect in
specific regions and/or cell types. As indicated by behavioural phenotypes in
TgMMP9 animals, described by Fragkouli et al. (2012); Gkogkas et al. (2014),
the changes may be more pronounced in the hippocampus or regions of the
cortex such as the entorhinal or perirhinal cortices, so investigating more defined
brain regions may prove worthy.
3.5 Conclusions
In this study, we aimed to better define the contributions of MMP-9 to the
phenotypes observed in FXS at a molecular level. Increased MMP-9 levels had
previously been shown to substantially contribute to FXS pathophysiology. In
our analysis of translation in mouse brains that overexpress human MMP-9,
we found that TgMMP9 brain lysates do not resemble the increased global
translation and upregulation of the mTOR pathway that has been observed
in Fmr1KO animals. Furthermore, ribosome profiling of both Fmr1KO and
TgMMP9 whole brain lysates showed only few genes that were differentially
regulated overall and almost no overlaps between the results of the two genetic
lines. Given the similarity of the mouse lines at a behavioural level, we conclude
that what we may have been unable to detect bigger changes due to homeostatic
effects in our genetic models or dilution of effects due to our use of whole brain
as starting material rather than a smaller brain region or specific cell types.
Moreover, pathways and structures other than translation regulation, e.g. ECM,
may be responsible for the similarities observed between the two models.
Chapter 4
The role of Mnk/eIF4E translational
control in depression-like
behaviours
The work presented in this chapter has been reported in part in the following
publication:
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Gantois, Seyed Mehdi Jafarnejad, Yupeng Li, Agniete Kampaite, Tine Pooters,
Nicola Romanò, and Christos G. Gkogkas Loss of eIF4E phosphorylation en-
genders depression-like behaviors via selective mRNA translation, Jour-
nal of Neuroscience, 24 January 2018, 2673-17;
DOI: 10.1523/JNEUROSCI.2673-17.2018
*These authors contributed equally
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4.1 Introduction
4.1.1 The socio-economic impact of major depression dis-
orders
According to the World Health Organisation (WHO), the prevalence of major
depressive disorders (MDD) is at 2.21% globally and continues to rise. In the
UK alone, the prevalence in the population is 1.8 million (2.88%), in Scotland
153,000 (2.9%) (Global Burden of Disease Collaborative Network, 2018). MDD
is a great contributor to disability, with as much as 50% of chronic sick leaves
being accounted to MDD/anxiety in the EU. The associated cost to the health
care system is a great challenge (Global Burden of Disease Collaborative
Network, 2018; World Health Organization, 2017a). Current medications are
limited and ineffective in about one third of patients, which further complicates
treatment (Rush et al., 2006). This present situation highlights the need to
better understand the pathophysiology of MDD and develop novel therapeutic
targets.
4.1.2 The MAPK/ERK signalling axis and mRNA translation
regulation in MDD
The MAPK/ERK (mitogen-activated protein kinases/extracellular signal-
regulated kinases) signalling pathway (Figure 4.1) is highly conserved between
species and responds to many different signals, both intra- and extracellu-
larly (e.g. cytokines, mitogens, growth factors, hormones, neurotransmitters),
adjusting gene expression to the cell’s needs (Kelleher et al., 2004; Thomas
and Huganir, 2004). Regulation of MAPK/ERK has been linked to long-term
potentiation in excitatory signal transmission, learning and memory, and fear
conditioning (Atkins et al., 1998; English and Sweatt, 1997; Kanterewicz et al.,
2000; Kelleher et al., 2004; Schafe et al., 2000; Thomas and Huganir, 2004;
Zhu et al., 2002). Moreover, the involvement of ERK1/2, mainly through re-
duced activation, in the pathophysiology of MDD is well accepted. In subjects
suffering from MDD that committed suicide, the activity, protein, and mRNA
levels of ERK1/2, an important hub of the MAPK/ERK pathway, were decreased
in prefrontal and hippocampal areas, post-mortem (Dwivedi et al., 2001; García-
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Fuster et al., 2014). Reduced activation (phosphorylation) of ERK1/2 promotes
depression-like behaviours and blocks the antidepressant action of tricyclic
compounds as well as selective serotonin reuptake inhibitors (SSRIs) and mood
stabilisers (Chen and Manji, 2006; Duman et al., 2007; Gourley et al., 2008).
Furthermore, in an animal model of depression and agressive behaviour, in-
duced through dietary deprivation of n-3 polyunsaturated fatty acids, reduced
p38 MAPK phosphorylation was reported (Rao et al., 2007). Additionally,
depression-like behaviour elicited by chronic stress and immune mediators,
presented with p38 MAPK hyperphosphorylation (Bruchas et al., 2011; Miller
and Raison, 2016).
4.1.3 eIF4E phosphorylation in the brain
Figure 4.1 eIF4E phosphorylation in translational control. Diagram of the major
signalling pathways upstream of eIF4E. External stimuli, e.g. Insulin, growth factors,
activate the Ras/Raf/MEK/ERK Mnk1/2 pathway, which phosphorylates eIF4E on
Ser209 to stimulate translation (left), or the PI3K/Akt/TSC/mTORC1 pathways, which
in turn phosporylates 4E-BPs and thereby relieves 4E-BP’s inhibitory sequestering of
eIF4E. Figure taken from Amorim et al. (2018a)
ERK1/2 and p38 kinases phosphorylate MAPK-interacting serine/threonine
protein kinase 1 and 2 (MNK1/2) (Joshi and Platanias, 2014; Waskiewicz et al.,
1997), which in turn regulate translation through phosphorylating eukaryotic
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initiation factor 4E (eIF4E) on serine residue 209 (Flynn and Proud, 1995; Joshi
et al., 1995; Ueda et al., 2004). eIF4E binds to the 5’ cap of mRNAs and forms
the eIF4F complex together with eIF4G (scaffolding protein) and eIF4A (mRNA
helicase), to recruit the preinitiation complex (PIC) and promote translation
initiation (Figure 4.1) (Hinnebusch et al., 2016). Phosphorylation of eIF4E
stimulates the translation of a specific subset of mRNAs ("eIF4E-sensitive"),
rather than upregulating translation globally and some of these mRNAs have
been shown to be key regulators in memory formation and regulation of circadian
rhythms (Bramham et al., 2016; Cao et al., 2015; Furic et al., 2010). eIF4E
phosphorylation has also been shown to play a role in depression-like behaviour
(Aguilar-Valles et al., 2018; Amorim et al., 2018a) and ASD (Gkogkas et al.,
2014). Since eIF4E promotes eIF4A helicase activity, it facilitates translation of
mRNAs containing long and highly structured 5’ untranslated regions (UTRs,
e.g. proto-oncogenes and growth factors) (Feoktistova et al., 2013; Sonenberg
and Hinnebusch, 2009).
Overall, the literature postulates an activating role for phospho-eIF4E in
translation (Bramham et al., 2008; Lachance et al., 2002; Panja et al., 2014;
Pyronnet et al., 1999), however, it was also suggested that it decreases cap-
dependent translation (Knauf et al., 2001) or that phosphorylation is not required
for translation initiation (McKendrick et al., 2001). Little is known about the
subset of mRNAs that are regulated by phospho-eIF4E in the brain. In the
hippocampus, phospho-eIF4E regulates the translation of Mmp9 (Gantois et al.,
2017; Gkogkas et al., 2014), whereas in the suprachiasmatic nucleus, it has
been shown to regulate expression of Per1/2 mRNAs (Cao et al., 2015). Several
cancer studies identified phospho-eIF4E-sensitive mRNAs (Furic et al., 2010;
Konicek et al., 2011; Robichaud et al., 2015). Interestingly, phospho-eIF4E
controls Type I IFN production trough regulating translation of NFKBIA mRNA
(coding for IkBa protein; nuclear factor of k polypeptide gene enhancer in B-cells
inhibitor, a), a key inhibitor of NFkB function. Antiviral responses and cytokine
production are regulated through activation of the transcription factor NF-kB,
which in turn is activated after IkBa downregulation through hypophosphorylated
eIF4E (Herdy et al., 2012).
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4.1.4 Behavioural effects of ablating eIF4E phosphorylation
in a mouse
Phospho-eIF4E is widely expressed throughout the hippocampal forma-
tion (Figure 4.2), however, no effect on hippocampal learning and memory
was detected in animals expressing a non-phosphorylatable form of eIF4E
(termed 4EKi from here on), specifically the Morris water maze and contextual
fear conditioning (Table 4.1). Furthermore, late long-term potentiation was
unchanged in hippocampal CA1 neurons of 4EKi animals. Contrarily, 4EKi
mice performed poorly in behavioural tests for depression and anxiety, including
a forced swim test (FST), a tail suspension test (TST), novelty suppressed
feeding behaviour (NSF), open field test (OF), and the elevated plus maze
(EPM, Table 4.1) (Amorim et al., 2018a). These observations support a role for
phospho-eIF4E in depression and anxiety. Interestingly enough, Amorim et al.
(2018a) also reported that chronic fluoxetine (an SSRI) treatment had no effect
on depression-like behaviours (FST, TST) in 4EKi mice. Fluoxetine treatment
has previously been shown to induce phosphorylation of eIF4E (Dagestad et al.,
2006) and alleviate depression-like phenotypes in mice (Dulawa and Hen, 2005).
Figure 4.2 eIF4E phosphorylation in the dorsal hippocampus. Representative
confocal images of immunofluorescent staining of WT dorsal hippocampi with antibodies
against total and phospho-eIF4E (Ser209). Scale bar, 100 µm Figure from (Amorim
et al., 2018a).
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Table 4.1 Results summary of the behavioural data collected by Amorim et al.
(2018a). Test and connected measures, as well as outcome (compared to WT) is
reported. — no change compared to WT, ↑ elevated compared to WT, ↓ reduced
compared to WT
Learning and memory 4EKi
Morris water maze (all measured parameters) —
Contextual fear conditioning (freezing) —
Depression- and anxiety-like behaviour 4EKi
Forced swim test (immobility time) ↑
Tail suspension test (immobility time) ↑
Novelty suppressed feeding (latency to feed) ↑
Open field test (time in center) ↓
Open field test (time spent close to walls) ↑
Elevated plus maze (time spent in open arms) ↓
Another recent publication examining the role of phospho-eIF4E in depres-
sion (Aguilar-Valles et al., 2018) found similar results in two different genetic
mouse models of ablated eIF4E phosphorylation at Ser209, namely 4EKi mice
and Mnk1/2 double knock-out mice (Mnk1/2-/-). Furthermore, they tested both
males and females, revealing some gender differences (results summarised
in Table 4.2). Both models exhibited increased immobility time in the FST
(compared to WT littermates), in both sexes, although the difference was more
pronounced in Mnk1/2-/- females than in males (Table 4.2). The authors were
unable to accurately evaluate females in the TST, due to them climbing on their
own tails, but males of both genetic models exhibited increased immobility. NSF
latency was increased in Mnk1/2-/- and 4EKi males and 4EKi females, but not in
Mnk1/2-/- females. On the other hand, Mnk1/2-/- females exhibited a latency to
feed in the home cage after fasting, but not males of either line or 4EKi females
(Table 4.2). Males and females of both genetic lines spent significantly less
time in the centre of the arena during an OF test. The total distance travelled
during the OF test was unchanged in 4EKi mice of both sexes, and decreased
in Mnk1/2-/- animals of both sexes, suggesting decreased locomotion behaviour
(Table 4.2).
Taken together, animals deficient in phosphorylation of eIF4E Ser209 (4EKi
and Mnk1/2-/- mice) show depression-like and anxiety-related behaviours. More-
over, 4EKi behaviours were resistant to chronic fluoxetine treatment.
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Table 4.2 Results summary of the behavioural data collected by Aguilar-Valles
et al. (2018). Test and connected measures, as well as outcome (compared to WT) is
reported for each genetic model and gender. — no change compared to WT, ↑ elevated
compared to WT, ↓ reduced compared to WT, n.a. test inconclusive
Test Mnk1/2
-/- 4EKi
male female male female
Forced swim test (immobility time) ↑ ↑↑ ↑ ↑
Tail suspension test (immobility time) ↑ n.a. ↑ n.a.
Novelty suppressed feeding (latency to feed) ↑ — ↑ ↑
Homecage feeding (latency to feed) — ↓ — —
Open field test (time in center) ↓ ↓ ↓ ↓
Open field test (distance travelled) ↓ ↓ ↓ ↓
4.1.5 Aims
In this chapter, we aimed to better understand how the phosphorylation of
eIF4E at serine residue 209 regulates translation of specific mRNAs in the brain
and how it affects depression-like behaviour in mice. Furthermore, we wanted
to understand how absence of the phosphorylation signal on eIF4E changes
the regulation of other pathways impinging on translation.
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4.2 Materials and methods
4.2.1 4EKi mice
The eIF4ES209A/S209A mice (referred to as 4EKi mice in the text) were obtained
from the Sonenberg lab at McGill University, Montréal and were first described
by Furic et al. (2010). The genetic construct to generate p-eIF4E-KI S209A
contained the serine to alanine mutation in exon 8 and a Neo-TK selection
cassette flanked by flippase recognition target sites within exon 7 (Figure 4.3).
Figure 4.3 4EKi design of the genetic targeting strategy. A The eIF4E gene was
targeted with a vector encompassing exons 7 and 8, the serine to alanine mutation in
exon 8, as well as a Neo-TK cassette after exon 7 as a selection marker. Primers 3 and
4 are used for genotyping. S, SacI restriction site B The introduction of the Ser209Ala
point mutation generated a new restriction site for Nar I (underlined) in exon 8, which
was used to confirm the correct insertion.
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4.2.2 Other methods
Ribosome profiling (including GO analysis and UTR analysis) and Western
blotting methods are described in Chapter 2 "General materials and methods".
DAVID analysis was carried out by Dr. Inês S. Amorim, results analysed and
summarised by Konstanze Simbriger.
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4.3 Results
4.3.1 Ribosome profiling of 4EKi mouse whole brain
To gain a better insight into the role of phospho-eIF4E in the brain, we per-
formed genome-wide analysis of translation using the novel method of ribosome
profiling adapted from (Ingolia et al., 2012, 2009). We prepared sequencing
libraries from forebrain tissue (olfactory bulb and cerebellum removed), from WT
and 4EKi animals (Figure 4.5 A). All sequenced libraries, both total mRNA and
ribosomal footprints, were of high quality and reproducibility (Figure 4.4). This is
demonstrated by the following: (1) the r2 between the normalised read counts
is > 0.99 for all comparisons (Figure 4.4 A); (2) the canonical distributions of
footprint (28-32 nt) and total mRNA fragment (30-45 nt) sizes (Figure 4.4 B); (3)
read distributions within the 3 main open reading frames (ORFs)(Figure 4.4 B).
We did not observe any significant changes in global transcription or transla-
tion in the brain of 4EKi mice, compared to WT littermates (R2 = 0.9187), which
was in accordance with previous reports (Gkogkas et al., 2014). However, we
did find that hypophosphorylation at Ser209 regulates the translational efficiency
(TE) of a specific subset of mRNAs (Figure 4.5 B). The TE of 52 transcripts was
significantly upregulated (displayed in red), while the TE of 651 mRNAs was
significantly downregulated (displayed in blue) in the 4EKi (Figure 4.5 B, Ta-
ble B.1). Thus, phospho-eIF4E does not significantly regulate global translation,
but preferentially regulates the translation of a subset of mRNAs in the brain.
To gain a better understanding of the groups of genes differentially translated
in 4EKi brain tissue, we carried out gene ontology (GO) analysis using the
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8
(Huang et al., 2009a,b). We identified several biological process and molecular
function terms (p < 0.05; Figure 4.6 A) in the downregulated genes. Notable
categories included response to stress, extracellular organisation and ECM,
biological adhesion, and defence response. We further identified some key
pathways (in the KEGG database) in our data, e.g. PI3K-Akt signalling pathway,
ECM-receptor interaction, and focal adhesion, that were related to translation
regulation and ECM (Figure 4.6 B). Some of the top genes that were identified
to be translationally downregulated included genes encoding pituitary hormones
(prolactin, growth hormon, and pro-opiomelanocortin-alpha) and extracellular
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Figure 4.4 Ribosome profiling of 4EKi forebrain is of high quality and repro-
ducibility. A Scatter plots of the two replicates of each genotype, for footprints and
total reads. The correlation coefficient r2 for each set is noted on the graph. All
replicates were highly reproducible, showing an r2 > 0.99. B Length distributions of
total mRNA (grey) and ribosomal footprint reads (black), for WT and 4EKi. Footprints
show a distinct peak between 28 and 34 nt length, whereas total mRNA samples are
more broadly distributed due to the random fragmentation. Alignment of sequencing
reads with the distinct codon windows (1-3). Footprints align preferentially with the
first (coding) reading frame, while total mRNA reads align equally with all three frames
(Amorim et al., 2018a).
4.3 Results 78
Figure 4.5 Ribosome profiling of 4EKi forebrain reveals a great number of down-
regulated genes. A Cartoon of the ribosome profiling strategy as described in the
method chapter. In brief, tissue was lysed and polysomes digested with an RNase
(footprints), while part of the lysate was kept as an internal transcription control (total
mRNA). All samples were prepared into cDNA sequencing libraries and sequenced
on an Illumina system. To obtain translational efficiencies, normalised read counts
(RPKM) for each gene for footprints were divided by total mRNA RPKMs. B Statistical
comparison of WT and 4EKi TE (R2 = 0.9187) identified 651 downregulated genes
(blue) and 52 upregulated genes (red). Scatter blot of the TE values for each gene of
WT versus 4EKi with the differentially translated genes marked in red and blue (p < 0.05
and 0.75   TEratio  1.5). Gray represents unchanged mRNAs; n = 2 for footprints
and mRNA (Amorim et al., 2018a).
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matrix (ECM) genes (e.g. proteoglycan 2, aggrecan, tenascin C)(Figure 4.6 C).
One of the identified genes was Mmp9, which had previously been shown to be
regulated by phospho-eIF4E (Furic et al., 2010) and is a crucial player in the
development of some of the key phenotypes in Fmr1y/- (Gantois et al., 2017;
Gkogkas et al., 2014; Sidhu et al., 2014). Due to the smaller number of genes,
the upregulated gene group showed less, but nevertheless significantly enriched
GO categories and pathways. The most abundant category was cytosolic
ribosome and the most significant pathway ribosome (Figure 4.6 D). Amongst
the most significantly changed genes, we identified several ribosomal protein
coding genes, but also genes related to the serotonin pathway (Figure 4.6 E).
Taken together, this data points towards a role of phospho-eIF4E in regulating
the ECM, pituitary hormones, the serotonin pathway, and ribosomal proteins.
Since untranslated regions (UTRs), flanking the coding sequence of tran-
scripts at both ends, can harbour sequence motifs and basic features that can
influence translation and stability of mRNAs, we continued to analyse the 5’
and 3’ UTRs of phospho-eIF4E-sensitive mRNAs, along with 325 mRNAs that
were picked from the sequencing data, because they were unchanged (TE ratio
of 4EKi /WT of 1). Using a custom programmed pipeline that takes advantage
of several available tools (mfold v3.6 and UTRscan) (Pesole and Liuni, 1999;
Zuker, 2003), we analysed the UTR sequences for known UTR motifs, as well
as length and guanine-cytosine (GC) content. Upstream open reading frames
(uORFs), internal ribosomal entry sites (IRESs), and terminal oligopyrimidine
tracts (TOP) were underrepresented in the downregulated DTGs, compared with
the control and upregulated groups (Figure 4.7 A). Both up- and downregulated
mRNAs contain significantly less cytoplasmic polyadenylation elements (CPEs)
in their 3’ UTRs, compared to control genes. 3’ UTRs of downregulated genes
further contain significantly less gamma interferon inhibitor of translation (GAIT)
elements than control or upregulated genes (Figure 4.7 A). These data suggest
that these identified regulatory elements that are significantly smaller in num-
bers in the downregulated group, may reveal yet to be described mechanisms
of phospho-eIF4E regulation of translation in the brain. Lastly, we observed
a significant increase in length of 5’ UTRs of downregulated genes compared
to control and upregulated genes, but not in GC content. We did not detect
any changes in 3’ UTR length or GC content (Figure 4.7 B). Taken together,
these data indicate that the mechanism regulating translation downstream of
phospho-eIF4E may be dependent on certain UTR elements (e.g. GAIT, TOP).
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Figure 4.6 Gene ontology analysis of 4EKi ribosome profiling data. Summary of
GO terms identified in 4EKi ribosome profiling data. A Gene ontology terms identified
in downregulated genes, plots for biological process and molecular function categories
with number of genes associated to them. The numbers displayed next to the bars are
the p-values for the respective terms. B KEGG pathways identified for downregulated
genes. C Main genes that were downregulated in 4EKi, split into two categories, pituitary
hormone genes and ECM genes, with the associated p-value and false discovery rate.
D Gene ontology terms identified in upregulated genes, plots for cellular components
and KEGG pathways. E Major genes that were upregulated in 4EKi, split into two
categories, serotonin pathway genes and ribosomal proteins, with the associated
p-value and false discovery rate (Amorim et al., 2018a).
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Figure 4.7 UTR analysis of 4EKi ribosome profiling data. A Analysis for known 5’
and 3’ UTR motifs. Up- and downregulated genes were analysed along with control
group of unchanged genes selected based on their TE from the ribosome profiling data.
# Categories in downregulated or upregulated mRNAs, which are underrepresented
compared with control mRNA. B Length and GC content of 5’ and 3’ UTRs of differen-
tially translated genes, as well as the unchanged genes and the total transcriptome as
controls. Values are represented as mean ± standard deviation, including the individual
data points. # p < 0.05 difference from all other categories (one-way ANOVA with
Tukey’s post hoc); all other multiple comparisons between groups are not significant
(Amorim et al., 2018a).
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4.3.2 Regulation of signalling pathways impinging on trans-
lation in 4EKi whole brain
Because the PI3K-Akt pathway was among the top categories in the KEGG
pathway classification of downregulated mRNAs in 4EKi forebrain, we exam-
ined signalling in 4EKi mice, as compared to wild-type (Figure 4.8). Using
Western blotting, we examined changes in phosphorylation of major hubs in the
PI3K-Akt-mTOR and MAPK pathways. As expected, no changes were observed
in ERK phosphorylation (Figure 4.8 A, D), upstream of eIF4E. However, we
detected decreased phosphorylation of ribosomal protein S6 (both Ser240/244
and Ser235/236 phosphorylation sites)(Figure 4.8 B, E) and increased phos-
phorylation of 4E-BP2 Thr37/46 downstream of mTORC1 (Figure 4.8 A, D).
Furthermore, we detected increased Akt Thr308 and Akt Ser473 phospho-
rylation (upstream of mTORC1), in 4EKi forebrain lysates (Figure 4.8 C, F).
Thus, ablation of the single phosphorylation site on eIF4E engenders selective
translation of a subset of mRNAs possibly mediated by mRNA UTR elements
(such as GAIT, Figure 4.7 A), and/or altered Akt/mTORC1 signalling.
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Figure 4.8 Increased mTOR signalling in 4EKi mice. A-C Representative Western
blots for phospho-proteins in the ERK and Akt/mTORC1 pathway in forebrain lysates
from wild-type and 4EKi mice. D-F Quantification of protein expression for proteins
shown. Phospho-protein expression (arbitrary units) is shown, normalised to total
protein. n = 8 for each genotype. Values are shown as mean and standard error with
individual data points plotted in the same graph. Student’s t-test; * p < 0.05
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4.4 Discussion
In this chapter, we presented translational profiling data from brain tissue of
a mouse model of ablated eIF4E phosphorylation that displays depression and
anxiety related behaviour. In the ribosome profiling data, we saw no significant
changes in global transcription or translation in 4EKi brains, but significantly
decreased translation of 651 genes and increased translation of 52 genes
(Figure 4.5), in accordance with previous reports of eIF4E-sensitive mRNAs.
Further analysis of the up- and downregulated groups revealed genes related
to/involved in ECM and pituitary hormones in downregulated, and serotonin
pathway and ribosomal proteins in upregulated genes (Figure 4.6). Analysis of
the UTR sequences of DTGs highlighted several regulatory motifs that may be
involved in their translational regulation, namely uORFs, IRES, and TOP motifs
that were less abundant in 5’ UTRs of downregulated genes and GAIT elements
that were significantly reduced in number in the 3’ UTRs of downregulated
genes, as well as CPEs that were reduced in both up- and downregulated
genes compared to control genes (Figure 4.7 A). Furthermore, we found that
the average length of 5’ UTRs of downregulated genes was significantly longer
than 5’ UTRs of control and upregulated genes, while GC contents of both 5’
and 3’ UTRs and length of 3’ UTRs was unchanged (Figure 4.7 B). We probed
for changes in phosphorylation of key signalling molecules impinging on transla-
tion in the brain and found that ERK1/2 (Thr202/Tyr204) phosphorylation was
unchanged, while Akt (Thr308 and Ser473), an upstream regulator of mTOR,
was mildly hyperphosphorylated and ribosomal protein S6 (Ser235/236 and
Ser242/244), a downstream target of mTORC1 was slightly hypophosphory-
lated. Lastly, phosphorylation of mTORC1 target protein eIF4E binding protein
2 (4E-BP2, Thr37/46) was slightly increased compared to WT (Figure 4.8).
The selective translation of eIF4E-sensitive mRNAs has previously been
reported in cancer models (Furic et al., 2010; Konicek et al., 2011; Robichaud
et al., 2015), as well as in the brain (Cao et al., 2015; Gantois et al., 2017;
Gkogkas et al., 2014) but all of these previous studies were limited to a small
number of genes. Our ribosome profiling approach, however, allowed us to
obtain translational efficiencies for all annotated genes in our samples and
provided us with an unbiased view of the translational landscape in 4EKi brain.
We identified several significantly downregulated genes that code for pituitary
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hormones and ECM constituents and upregulated genes that code for ribosomal
proteins and serotonin pathway genes.
Interestingly, several ECM molecules have been linked to MDD (Dityatev,
2014; Pantazopoulos and Berretta, 2016) and antidepressant treatment efficacy
(Alaiyed and Conant, 2019; Donegan and Lodge, 2017; Ohira et al., 2013).
Given the link between antidepressant treatment and ERK/MAPK activation
(Chen and Manji, 2006; Duman et al., 2007; Gourley et al., 2008) and the role
that phospho-eIF4E appears to play in regulating the translation of ECM genes
(Figure 4.6 A, C), as well as the role it plays in the control of cancer metastasis
through the ECM (Furic et al., 2010; Robichaud et al., 2015), this is a highly
interesting direction to take for further research. Furthermore, antidepressant
efficacy has been linked to to perineuronal nets and matrix metalloproteinases
(Alaiyed and Conant, 2019; Donegan and Lodge, 2017). The ECM as a func-
tional component of the brain has been highly underestimated in the past and
may prove a very interesting and promising line of investigation to pursue with
respect to neuropsychiatric disorders and discovery of novel treatments.
The upregulation of serotonin uptake receptor (Slc6a4) and the enzyme
tryptophan hydroxylase (Tph2) that we observed in our data (Figure 4.6 E)
provides a strong link between phospho-eIF4E and depression/anxiety and has
been further supported through decreased serotonin levels in the brain (Amorim
et al., 2018a) and impaired serotonin transmission in the prefrontal cortex of
4EKi mice (Aguilar-Valles et al., 2018). Furthermore, there is an interplay
between the hypothalamic-pituitary-adrenal axis, serotonin, and dopamine
(Hamon and Blier, 2013; Hoogendoorn et al., 2017), which may be further
explained through the translational regulation exerted by phospho-eIF4E.
A link between phospho-eIF4E, eIF4E, and innate immunity has previously
been reported (Colina et al., 2008; Herdy et al., 2012). As a UTR regulatory
motif, GAIT elements serve as a "gatekeeper" of gene expression in response
to inflammatory signals (Mukhopadhyay et al., 2008). It functions through
interacting with both the GAIT element in the 3’ UTR and the cap-bound eIF4F
complex (Figure 4.9). Both clinical and preclinical data has been published
in support of a strong link between mood disorders and inflammation and
many pre-inflammatory mRNAs contain GAIT elements in their 3’ UTRs, similar
to our upregulated mRNAs. Some MDD patients show increased levels of
cytokines, including TNFa and IL-6 (Dowlati et al., 2010; Goldsmith et al.,
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2016). Furthermore, a well-understood risk factor of MDD and other mental
disorders (Nanni et al., 2012), childhood trauma and abuse, can lead to elevated
cytokine levels as well (Baumeister et al., 2016). In rodent models of depression,
induced by chronic stress, these observations too have been replicated (Hodes
et al., 2014; Kreisel et al., 2014). Moreover, sickness behaviours triggered by
infections, which are reminiscent of the symptoms of depression, are treatable
with classical antidepressants (Aguliar-Valles et al., 2014; O’Connor et al.,
2009). Lastly, clinical trials have shown the efficacy of non-steroidal anti-
inflammatory drugs in treating depression (Köhler et al., 2014), as well as
successful treatment by blocking cytokine function using antibodies targeting
TNFa (Kappelmann et al., 2018). On the other hand, antidepressants can also
decrease inflammatory responses in MDD subjects (Więdłocha et al., 2018).
Brain wide blocking of TNFa in 4EKi mice resulted in diminished depressive-
like behaviours and corrected serotonergic neurotransmission to WT levels
(Aguilar-Valles et al., 2018).
Our group showed that in 4EKi mice, a novel mouse model of depression,
not only a bigger number of GAIT element containing mRNAs is present in the
upregulated group than in the downregulated, but also that out of six major
cytokines (IL-6, IL-10, IL-1B, IL-2, TNFa, IFNg), two showed increased pro-
tein levels in the 4EKi mice both at baseline and after immune challenge with
lipopolysaccharide (LPS) (IL-2, TNFa), IFNg was increased after LPS injection
only, and all other cytokines showed no differences between WT and 4EKi
(Amorim et al., 2018a). Notably, IL-6, IL-10, and IL-1B are expressed by Th2-
type T helper cells, while IL-2, TNFa, and IFNg are expressed by Th1-type
T helper cells (Romagnani, 2000). The role of the GAIT mechanism in the
phenotypes observed in 4EKi mice is further supported by reduced binding
of rpL13a, a key component of the GAIT complex, to the eIF4F complex, as
shown by cap-column (m7GDP) pulldown from brain lysates (Amorim et al.,
2018a). Since the GAIT complex suppresses the translation of GAIT sequence
elements containing mRNAs and rpL13a binding is a key event in this process
(Fox, 2015), the decreased cap binding of rpL13a may explain the increased
expression of inflammatory genes in 4EKi mice. Additionally, microglia showed
significant activation in 4EKi mice both at baseline and after LPS injection
(Amorim et al., 2018a). Taken together, these data strongly support the role of
eIF4E-dependent translation of specific mRNAs in the context of inflammation,
serotonergic function (Figure 4.10), and depression and may open up new
avenues for treatments when symptoms prove resistant to classic antidepres-
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sants. To gain further understanding of the processes involved, cell type specific
translational profiling such as TRAP (Heiman et al., 2008), of microglia or sero-
tonergic cells, may prove valuable in the discovery of unknown mechanisms.
Figure 4.9 Diagram of the GAIT complex closed loop model. The GAIT complex,
consisting of rpL13a, EPRS, and GAPDH, binds the 3’ UTR GAIT element as well as
the eIF4F complex through contact with the scaffolding protein eIF4G and consequently
inhibits translation (Amorim et al., 2018a).
Apart from the inflammation-related GAIT elements, we also discovered
an under-representation of uORFs, IRES, and TOP regulatory motifs in the 5’
UTRs of downregulated genes, as well as an under-representation of CPEs
in the 3’ UTRs of both up- and downregulated genes. CPEs may exert a
function through activity changes of poly(A)-binding protein, which initiate mRNA
circularisation by bridging eIF4G, bound to the 5’ complex, to the 3’ poly(A) tail,
that subsequently regulate translation of specific mRNAs (Smith et al., 2014).
The eIF2a pathway may regulate translation of uORF-containing mRNAs in
the brain (Costa-Mattioli et al., 2007), but also mTORC1 (Schepetilnikov et al.,
2013). Considering the changes in phosphorylation of key Akt/mTOR pathway
components, translation regulation of uORF-containing mRNAs through an
mTORC1 dependent mechanism is more conceivable. Significant evidence
supports mTORC1-sensitivity of TOP-containing mRNAs (e.g. ribosomal protein
coding genes) (Avni et al., 1997; Thoreen et al., 2012), which is further backed
by our data (Figure 4.6, 4.8). Long 5’ UTRs require activity of the helicase
eIF4A1 to allow the the eIF4G complex to scan for the start codon and initiate
translation (Feoktistova et al., 2013). 5’ UTRs of downregulated genes in the
4EKi showed an increased length, compared to control and downregulated
genes, which may point to a mechanism requiring phosphorylated eIF4E to bind
and stimulate eIF4A1 activity. This is further supported by reduced cap-binding
of eIF4A1 in 4EKi brain lysates (Amorim et al., 2018a).
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Finally, the signalling changes we observed in the Akt/mTORC pathway (Fig-
ure 4.8), may be a result of the downregulation of several mRNAs downstream
of phospho-eIF4E (Figure 4.6 B) or could reflect homeostatic signalling changes,
with other pathways trying to compensate for the ablation of the Ser209 site
on eIF4E. These signalling changes could further be associated with the 4EKi
depression and inflammatory phenotype, as Akt activation (phospho-Thr308)
can stimulate NFkB and TNFa, and mTORC1 by inhibiting phosphatase and
tensin homologue on on chromosome ten (PTEN) (Carracedo and Pandolfi,
2008).
4.5 Conclusion
Altogether, we show that depression-like behaviour in 4EKi animals, as
reported by Amorim et al. (2018a), may stem from the differential regulation
of a subset of phospho-eIF4E-sensitive mRNAs. We propose a mechanism
(Figure 4.10), in which disinhibition of the GAIT complex translational repression
downstream of phospho-eIF4E and reduced binding of the helicase eIF4A1
increases inflammation and depression-like behaviour through translationally
downregulating pituitary hormones and ECM genes and upregulating serotonin
pathway genes (Amorim et al., 2018a). Changes in the regulation of the
Akt/mTORC1 signalling pathway may further contribute to these phenotypes
and detailed experiments are needed to dissect the individual contributions of
the discussed regulatory pathways.
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Figure 4.10 Ablation of eIF4E phosphorylation engenders depression-like be-
haviour through altered translational mechanisms. Cartoons of the proposed
mechanism of phospho-eIF4E action in depression and inflammation in the brain. A
Ablation of the key phosphorylation site on eIF4E through a point mutation (Ser209Ala)
has no effects on global protein synthesis, but rather on the translational regulation
of a subset of mRNAs harbouring GAIT elements. This differential regulation leads
to a depression-like phenotype in 4EKi animals, as well as increased expression of
inflammatory cytokines. Disinhibition of GAIT translational repression, may be the
cause of this increased expression in conjunction with the depression-like behaviours.
Since altered cap-binding of both the helicase eIF4A1 and the GAIT complex protein
rpL13a have been shown in 4EKi mice, we propose that this could be the underlying
mechanism behind translation regulation in this mouse model. B eIF4E phosphorylation
stimulates anti-inflammatory and anti-depressant pathways in the brain (Amorim et al.,
2018a).
Chapter 5




Memory formation is a well-orchestrated mechanism of neurons and circuits
of the brain to store relevant information for a short or long time. Storing
information about past experiences allows the organism to retrieve it at a
later time and alter future behaviour accordingly. This process and its correct
functioning is key to the survival of the organism. At the cellular level, memories
are stored through synaptic plasticity, a strengthening (long-term potentiation,
LTP) or weakening (long-term depression, LTD) of specific neuronal connections.
Synaptic plasticity is a complex process that has been shown to be reliant on
several factors including transcription, translation, protein degradation pathways,
and extracellular matrix components (Bourtchouladze et al., 1998; Costa-Mattioli
et al., 2009; Dityatev et al., 2010; Mayford et al., 2012; Poo et al., 2016; Richter
and Klann, 2009).
The hippocampus has been shown to be essential for both short and long-
term memory formation, in particular spatial memory. It has been studied
extensively at the behavioural, electrophysiological, and molecular levels, with
regard to its role in memory formation. The dorsal hippocamus especially, has
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been shown to be key in the formation of contextual fear memories (Pothuizen
et al., 2004).
5.1.2 Pavlovian fear conditioning
Contextual fear conditioning (CFC) is a frequently used form of Pavlovian
conditioning, in which animals are exposed to a novel environment/context, the
fear conditioning apparatus (conditioned stimulus, CS), and receive a series
of non-harmful electrical footshocks (unconditioned stimulus, US) via a metal
grid at the bottom of the apparatus. Through the pairing of the originally
neutral stimulus that is the novel context and a biologically relevant or aversive
stimulus (i.e. pain), a memory is formed to represent the potential danger
of the novel context. When returned to the apparatus 24 h later and up to
several weeks, conditioned animals show quantifiable fearful behaviour, most
commonly freezing, defined as the complete absence of somatic movements,
except breathing (Curzon et al., 2009; Izquierdo et al., 2016). Since CFC is
rapidly acquired, the outcome easy to measure, and the cortical and subcortical
networks involved are fairly well described, the CFC paradigm is commonly
used in studying memory. Furthermore, it is used in several adapted forms to
study fear- and anxiety-related behaviours and the extinction of these, which is
of high relevance for anxiety-related disorders (Chaaya et al., 2018).
5.1.3 Gene expression in memory formation
Storing information about potentially harmful environments is essential to
an organism’s survival and requires a well-coordinated spatio-temporal molec-
ular response in the brain. Synaptic plasticity and memory formation, are
dependent on gene expression, both at the level of transcription and transla-
tion (Bourtchouladze et al., 1998; Davis and Squire, 1984). Although there is
plenty of evidence for the necessity of gene expression for memory formation,
as well as some information about the dynamics of a defined set of immedi-
ate early genes (IEGs), only little is known about how the transcriptional and
translational landscape changes at the gene level to encode a memory (Gallo
et al., 2018; Peter et al., 2012). Despite the fact that the CFC paradigm is
well established and often used in the field of learning and memory, as well as
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anxiety-related research, a comprehensive view of gene expression, required
to form these memories remains elusive. A few studies focussed on the expres-
sion of a small number of genes, in particular IEGs (Cho et al., 2017; Rosen
et al., 1998; Tischmeyer and Grimm, 1999). Since the advent of quantitative
genome-wide gene expression analysis tools (e.g. microarrays, RNA-Seq), a
more generalised picture of gene expression during memory formation has
been obtained (Barnes et al., 2012; Keeley et al., 2006; Poplawski et al., 2016;
Rao-Ruiz et al., 2019), including translational profiling approaches (Cho et al.,
2015; Eacker et al., 2017). In particular, changes in translation of genes re-
main understudied, simply because of the availability of suitable techniques.
The recent establishment of ribosome profiling as a method to study genome
wide regulation of translation in an unbiased manner (Ingolia et al., 2012) has
opened up new avenues to elucidate gene expression in memory formation
(Cho et al., 2015; Eacker et al., 2017). However, independent of type of analysis
and the timepoint or -frame of gene expression that was analysed with respect
to the generation of fear memories, one factor has been largely neglected: The
contribution of the electrical footshock to gene expression observed post-CFC.
Only a few published studies investigated the effects of delivering an electrical
shock to an animal on gene expression in the brain and all of them focussed
on specific genes rather than taking a genome-wide approach (Federighi et al.,
2013; Rosen et al., 1998). Experiencing an electrical shock that can elicit the
formation of a fear memory, we hypothesise, can also have a significant impact
on gene expression in the brain, potentially confounding the discovery of true
memory genes.
5.1.4 Aims
The aim of the work presented in this chapter was to dissect the contribution
of the footshock only and training conditions, to the changes in mRNA expres-
sion and translation in dorsal hippocampus of animals trained with a commonly
used CFC protocol. A molecular response to the footshock only can be an
underestimated confounding factor, in particular for omics based studies. While
improving the general understanding of the molecular happenings in response
to an electrical shock and the actual CFC paradigm, we also wanted to define
marker genes that change their expression specifically in response to the CFC
protocol and not in the shock only control group.
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5.2 Materials and methods
5.2.1 Contextual fear conditioning
All behavioural training and part of the tissue dissection was carried out by
Dr. Gilliard Lach.
To generate material for ribosome profiling, WT mice were trained using a
contextual fear conditioning protocol. All animals were handled for three days
prior to behavioural experiments. Animals in the training group were allowed to
explore the fear-conditioning context for two minutes and given two consecutive
footshocks of 0.5 mA, duration 4 s, with a 30 s interval in between. After the
footshocks, the animals were allowed to explore the context for another minute,
before being removed to their homecage. Animals in the shock only group
were transferred to the fear conditioning apparatus from their homecage and
immediately received one 4 s long 0.5 mA footshock and were removed to their
homecage immediately after. Control animals (homecage) remained in their
homecage until sacrificing. All animals were sacrificed 20 min after administer-
ing the stimulus (training/shock only/homecage) and their dorsal hippocampi
dissected. Tissue from 5-6 animals was pooled to obtain sufficient material for
ribosome profiling. We used 10-week old animals for all experiments.
For the groups tested for long-term memory (n = 12 per experimental group,
training/shock only/homecage), 24 h after the training session, mice were tested
for contextual fear memory expression by being placed in the conditioning
context and % freezing being scored for a 5 minute period, in 5 s intervals,
either "freezing" or "not freezing". The value for % freezing represents the
number of 5 s intervals where freezing was observed divided by the total
number of intervals scored.
5.2.2 Object location task
All behavioural training and part of the tissue dissection was carried out by
Dr Gilliard Lach.
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WT animals were trained in an adapted version of an object location memory
task from the lab. In brief, there were three experimental groups, homecage,
sham and object. Homecage animals received handling only and remained in
their homecage for the duration of the behavioural trainings. The sham and the
object groups received two habituation sessions in the empty object arena on
two consecutive days, followed by 20 min in a dark box to consolidate memories.
On day 3, the sham group was allowed to explore the empty arena three times
for 5 min with a 20 min inter training interval (ITI). The Object group was allowed
to do the same, however, not in the empty arena, but the arena with two objects.
All animals were culled and dissected 20 min after the training session on day
three. Only dorsal hippocampi were analysed.
Figure 5.1 Experimental design of the object location task. Animals were trained
on three consecutive days after handling, in one of three groups (homecage, sham,
Object) as indicated. On day three, animals were sacrificed 20 min after the last session
and dorsal hippocampi were dissected and snap-frozen in liquid nitrogen.
5.2.3 Quantitative real-time polymerase chain reaction (qRT-
PCR)
Extracted total RNA from the Ribosome Profiling samples and total RNA
extracted with the RNeasy Mini Kit (Qiagen, 74104) was used for qRT-PCR.
1 µg of each sample was reverse transcribed into cDNA using SuperScript™ IV
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Table 5.1 qPCR Primers, all designed for this project, except GAPDH primers which
were previously published by Huang et al. (2011)
Gene Name Forward Primer (sense) Reverse Primer (anti-sense)
Egr2 CACCTAGAAACCAGACCTTCAC GATGCCCGCACTCACAATA












Table 5.2 qPCR cycling conditions and melting curve
Step Temperature Duration Cycles
UDG activation 50°C 2 min hold
Dual-Lock™DNA polymerase 95°C 2 min hold
Denature 95°C 15 s
 
⇥ 40Anneal/extend 60°C 1 min
Step Ramp rate Temperature Time
1 1.6°C/s 95°C 15 s
2 1.6°C/s 60°C 1 min
3 0.15°C/s 95°C 15 s
VILO™ Master Mix (ThermoFisher Scientific). Appropriate dilutions of the cDNA
were used in the qPCR reaction, using PowerUp™ SYBR™ Green Master Mix
(Thermofisher). Relevant primer sequences can be found in Table 5.1, primers
were used at 5 µM and cycling conditions were according to the manufacturers
specifications (summarised in Table 5.2). Reactions were run in an AriaMx
Real-time PCR System (Agilent).
Raw data was analysed using the AriaMx software. Expression fold change
was calculated using the DDCt method, normalising to loading control (GAPDH
expression within the same sample) and homecage.
FC = 2((Ct,GIE Ct,LC) (Ct,GIC Ct,LC))
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Ct is the cycle threshold (number of cycles at which the signal exceeds back-
ground). Ct,GIE is the value for the gene of interest in the experimental condition,
Ct,GIE the value for the gene of interest in the experimental condition, and Ct,LC
the value for the loading control.
5.2.4 Other methods
Ribosome profiling (including GO analysis and UTR analysis) and Western
blotting methods are described in Chapter 2 "General materials and methods".
DAVID analysis and IPA were carried out by Dr Inês S. Amorim, results analysed




We generated ribosome profiling libraries from dorsal hippocampi that were
dissected 20 min after treatment (homecage/shock only/CFC) and snap-frozen
(Figure 5.2). The 20 min time point was chosen, because we were interested in
early changes in gene expression elicited by the behavioural paradigm. Tissue
was pooled across several animals to obtain sufficient material and two technical
sequencing replicates were generated from the pooled tissue for each treatment
group (Figure 5.3). After the sequencing, we confirmed that our data was indeed
originating from ribosomal footprints, of good quality and that the replicates
were reliable. To this end, we analysed the read length distributions, as they
are expected to be between 28 and 32 nt for canonical footprints, while the
randomly fragmented total RNA samples show bigger fragments and a more
random distribution (Figure 5.4 A). Ribosomal footprint reads will preferentially
align with the first reading frame (RF) of a gene, since they are expected to
originate from translating ribosomes. As shown in Figure 5.4 B, this is indeed
the case, while the total RNA fragments align with all RFs equally. Furthermore,
when focussing on the regions around the start and stop codons of each gene,
we see that footprints preferentially align with the coding sequence and show
a strong three-nucleotide periodicity. Beginnings of footprint reads also show
a strong peak at -12 nt from the start codon, which implies that the captured
ribosomes were initiating translation, as 12 nt is the distance from the side of the
ribosome to the A-site of the ribosome (Figure 5.4 C). Furthermore, replicates
were highly reproducible between each other, as exemplified by the r2 > 0.98
for all replicate pairs (Figure 5.5).
Using Xtail, we identified 168 differentially translated genes (DTGs) in the
shock only condition compared to homecage. 69 of these genes were upregu-
lated and 99 downregulated (Table C.1). For the CFC condition compared to
homecage, we identified 84 DTGs, of which 42 were up- and 42 were downreg-
ulated (Figure 5.6 A, B; Table C.2). Of these DTGs, some overlapped between
the different groups: shock and CFC upregulated shared 4 genes, shock and
CFC downregulated shared 8 genes, and one DTG was upregulated in shock
and downreglated in CFC (Figure 5.6 B).
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Figure 5.2 Diagram of the experimental design, describing the three experimen-
tal groups, homecage, shock only and CFC. Top: Animals in the homecage group
remained in their homecage for the full duration of the experiment. Shock only animals
received one 4 s footshock of 0.5 mA, immediately after being put into the context and
were immediately removed to their homecage after. Animals of the CFC group were al-
lowed to explore the context for two minutes, followed by two 4 s 0.5 mA footshocks with
a 30 s interval and remained in the context for another minute before being removed to
their homecage. Bottom left: Fear-conditioned animals (CFC group) show significant
freezing behaviour when re-exposed to the fear-conditioning apparatus (context, CS)
24 h after training, whereas the other two groups show insignificant freezing behaviour
in response to the context. Values are represented as mean ± standard deviation,
including the individual data points. Bottom right: We were interested in transcriptional
and translational changes after shock only (US) and in early fear memory formation
(CS + US), so we picked a dissection timepoint of 20 min after the training to collect
samples for ribosome profiling.
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Figure 5.3 Flow diagram of the ribosome profiling strategy. Dorsal hippocampi
were dissected 20 min after the experiment and snap-frozen. Polysomes were isolated
and part of the lysate digested with RNase I and ribosomal footprints isolated, while
from the remainder of the lysate total mRNA was extracted and heat-fragmented to yield
similarly sized fragments to the footprints. cDNA sequencing libraries were generated
from all fragments (footprints and total RNA) for each sample and sequenced. TE was
calculated by dividing the RPKMs of footprints with total RNA.
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Figure 5.4 Ribosome profiling data is of good quality and reproducibility. A RPF
samples show a distinct frequency peak between 28 and 30 nt, whereas total RNA sam-
ples show a broader distribution at a slightly larger size. B Footprints align preferentially
with the first RF of their respective message, while total RNA samples align randomly
with all three reading frames. C Around the region of the start and stop codons of
each gene, footprints exhibit an increased density, compared to the rest of the coding
sequence. Furthermore, footprints show a distinct three-nucleotide periodicity, whereas
randomly fragmented total RNA distributes equally along the message. Notably, a small
peak is visible in the footprint samples 12 nt before the start codon. This is due to the
offset of the start of the footprint and the ribosomal P-site.
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Figure 5.5 Ribosome profiling data shows high reproducibility. Scatterplots of
replicate 1 vs replicate 2 of the data, confirming high reproducibility of replicates for
both total RNA and footprints within the different conditions. Correlation coefficients for
each comparison are noted on the respective plot.
Similarly, we identified changes in transcription through differential expres-
sion analysis. A total of 86 genes showed significant changes in transcription
between shock only and homecage groups. Of these 86 differentially expressed
genes (DEGs), 63 were upregulated and 23 downregulated (Table C.3). In the
CFC group, a total of 155 DEGs was identified, of which 99 were upregulated
and 56 downregulated compared to homecage (Figure 5.7 A, B; Table C.4).
The CFC and shock upregulated gene groups shared 15 genes, and CFC and
shock downregulated groups shared 2 genes. Genes that were upregulated in
CFC and downregulated in shock were 3 and genes downregulated in CFC, but
upregulated in shock 8 (Figure 5.7 B). The genes that were regulated by shock
are summarised in Figure 5.8, genes that were common between the shock
and CFC conditions in Figure 5.9, and genes that were uniquely regulated in
CFC in Figure 5.10.
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Figure 5.6 Differentially translated genes. A Changes in TE in response to shock or
CFC, normalised to homecage. log2 fold change values are plotted, coloured points
represent significantly changed genes in each group as summarised in the legend. B
The number of DTGs in each group and overlaps are summarised.
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Figure 5.7 Differentially expressed genes. A Changes in mRNA abundance in
response to shock or CFC, normalised to homecage. log2 fold change values are plotted,
coloured points represent significantly changed genes in each group as summarised in
the legend. B The number of DEGs in each group and overlaps are summarised.
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Figure 5.8 DEGs and DTGs that are regulated in response to shock only. Genes
that were either up- or downregulated transcriptionally or translationally in response to
a single footshock (unconditioned stimulus, US), compared to homecage.
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Figure 5.9 DEGs and DTGs that are regulated in both the shock control and the
CFC groups. Overlap of the genes that were either up- or downregulated transcription-
ally or translationally in response to CFC (CS + US) and shock only (US), compared to
the homecage condition
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Figure 5.10 DEGs and DTGs that are regulated uniquely in the CFC group. Genes
that were either up- or downregulated transcriptionally or translationally in response




To gather a better understanding of the genes being regulated by shock only
and CFC, we conducted gene ontology (GO) analysis, using DAVID (Huang
et al., 2009a,b) and IPA (Qiagen). To this end, we analysed only two groups
of DEGs and DTGs each: genes that were regulated by shock (Figure 5.8)
and genes that were uniquely regulated in CFC (CFC genes with the overlap
of CFC and shock genes removed)(Figure 5.10). Genes were analysed in
different categories, including cellular component (CC), molecular function
(MF), biological process (BP), and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways.
For the DEGs identified in the shock only group, several groups related to
energy metabolism at the mitochondrion and terms related to DNA binding and
transcription factors were enriched in all four categories (Figure 5.11). This may
point towards the need to alter cellular states in response to a fearful stimulus
and start a wave of transcription and translation to form a memory.
Figure 5.11 DAVID analysis of DEGs in shock only. Terms identified as significantly
enriched in the categories biological process, cellular component, molecular function,
and KEGG pathway. The name of the terms are shown with their respective log10(p-
value) represented as a bar graph.
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In the DTGs of the shock only group, we identified several terms in three of
the categories, that are related to the ribosome (Ribosome pathways, ribosome
and large ribosomal subunit CC, and structural constituent of ribosome MF).
Some CC terms were related to the ECM, extracellular exosome and lysosomes.
Genes related to the regulation of translation appeared to be involved as well,
as translation is the most significant term in BP and the MAPK pathway was
identified in KEGG pathways. Lastly, several genes related to the nucleosome
and chromosomes were identified, indicating the need of the cell to alter the
DNA packaging status to respond to a stimulus, such as an electrical shock
(Figure 5.12).
Figure 5.12 DAVID analysis of DTGs in shock only. Terms identified as significantly
enriched in the categories biological process, cellular component, molecular function,
and KEGG pathway. The name of the terms are shown with their respective log10(p-
value) represented as a bar graph.
Using IPA, we identified enriched canonical pathways relating to the mi-
tochondrion and oxidative phosphorylation in shock only DEGs and DTGs
(Figure 5.13).
Several terms, in more than one category, relating to the ECM (proteinaceous
extracelllular matrix, extracellular matrix, extracellular space, extracellular region.
extracellular matrix organisation, and ECM-receptor interaction) were identified
in the DEGs unique to the CFC group. The ECM has been shown to play an
important role in synaptic plasticity, including fear memory formation (Dityatev,
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Figure 5.13 IPA analysis of DTGs and DEGs shock only. Top 5 Ingenuity Canonical
Pathways (by p-value) identified by IPA in the A DTGs and B DEGs. The highlighted
(red) pathways are related to mitochondrial function.
5.3 Results 110
2014; Hylin et al., 2013). Additionally, several terms relating to mRNA translation
regulation were enriched in the DEGs (Figure 5.14).
Figure 5.14 DAVID analysis of unique DEGs in CFC. Terms identified as significantly
enriched in the categories biological process, cellular component, molecular function,
and KEGG pathway. The name of the terms are shown with their respective log10(p-
value) represented as a bar graph.
Similarly to the shock only DTGs, the CFC DTGs were enriched in ribosome
related terms (ribosome CC, structural constituent of ribosome, Ribosome
KEGG, rRNA methylation). Furthermore, they were enriched for terms relating
to transcription and translation (including transcription factor complex, nucleus,
transcriptional activator activity, DNA binding, transcription, translation, and
more; Figure 5.15). This is evidence for the importance of transcription and
translation in the process of forming fear-related memories.
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Figure 5.15 DAVID analysis of unique DTGs in CFC. Terms identified as significantly
enriched in the categories biological process, cellular component, molecular function,
and KEGG pathway. The name of the terms are shown with their respective log10(p-
value) represented as a bar graph.
Notable pathways identified with IPA in the DTGs included eIF2 signalling
and role of PKR in interferon induction response, as well as axonal guidance
signalling in the DEGs (Figure 5.16).
Cho et al. (2015) had previously reported a translational suppression of
genes related to the translational machinery in hippocampus and cultured
hippocampal neurons, but not in other cell types. Since by now there is more
ribosome profiling data (across different tissues) available from publications
and our DAVID analysis identified several terms related to ribosomes and
translation in our DTGs, we decided to carry out further analysis of our data,
with expression of ribosomal genes in mind. Nevertheless, our analysis shows
results in disagreement with Cho et al. (2015)’s findings. We clearly detected
polyribosomes in both dorsal hippocampal tissue and DIV25 hippocampal
neurons, at comparable levels to HEK293 cells (Figure 5.17A), indicating normal
levels of proteins of the translational machinery. Using Western blotting in
different tissue lysates (hippocampus, kidney, liver muscle, and spleen), we
were were able to detect comparable levels of two proteins of the small ribosomal
subunit (rpS6 and rpS15) at equal levels in all tested tissues (Figure 5.17 B).
Three proteins of the large ribosomal subunit (rpL13, rpL10a, and rpL11) were
detectable in hippocampus but expressed at a lower level compared to other
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Figure 5.16 IPA analysis of unique DTGs and DEGs CFC. Top 5 Ingenuity Canonical
Pathways (by p-value) identified by IPA in the A DTGs and B DEGs. The shaded
pathways are relevant gene expression pathways.
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tissues (Figure 5.17 B). When looking at overall TE of the whole translatome
compared to the ribosomal and mitochondrial ribosomal translatome in several
different tissues and cell types, we saw a general trend for lower TE values
in the ribosomal translatome across all datasets (Figure 5.17 C). Collectively,
our data does not support a translational repression of genes of the ribosomal
machinery, specifically in brain, but does not exclude any specific ways of
regulating translation and perhaps making it more efficient in neurons.
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Figure 5.17 Ribosomal genes do not show a particular pattern of expression. A
Polysome profiles of HEK293 cells, dorsal hippocampus, and DIV25 primary hippocam-
pal neurons. The HEK293 profile shows a stronger 80S monosome peak, but all three
samples show comparable levels of polysome associated mRNAs. B Immunoblots
against ribosomal proteins in different murine tissues. HSC-70 is shown as a loading
control. As evidenced by these blots, not all ribosomal proteins are expressed at equal
levels across all tissues (rpL13, rpL10a, and rpL11), however, some of the ribosomal
proteins are expressed at comparable levels in all tissues tested (rpS6 and rpS15).
B Box plots of TEs of mRNAs encoding ribosomal proteins, mitochondrial ribosomal
proteins, or all other proteins. Overall, ribosomal protein genes show a trend towards
reduced TE in comparison to the two other groups, across different tissues and cell
types. HEK Illumina is a test data set from the Truseq Ribosome Profiling Kit, Diss.
Neurons Primary dissociated cortical neurons (data from our lab), mESC Ingolia 2011
a published dataset from murine embryonic stem cells (Ingolia et al., 2011), Kidney
published data (Castelo-Szekely et al., 2017), Liver published data (Janich et al., 2015),
Muscle published data (Drummond et al., 2017), published data from Cho et al. (2015).
5.3.1.2 UTR analysis
Untranslated regions (UTRs) of mRNAs can contain sequence elements,
which may regulate the translation of the associated transcript and thereby
explain changes in translational efficiency in response to a specific signal.
Therefore, we analysed the UTRs of DTGs from the CFC group, along with a
control group of unchanged genes, that were randomly selected from our data
set, for known UTR motifs using a stand-alone version of Utrscan (Pesole and
Liuni, 1999), which scans input sequences for all known UTR motifs. The results
are summarised in Figure 5.18, shown are only motifs that were identified in
the gene groups more than once. Several trends were observed, as described
below, however, none of these trends reached statistical significance. The
5’ UTR of genes downregulated by CFC showed an increased abundance of
upstream open reading frames (uORFs), compared to control and upregulated
genes. Both groups of DTGs also appeared to contain less internal ribosome
entry sites (IRES) in their 5’ UTR, compared to the control gene group. Within
the 3’ UTR, UNR binding sites appear more frequently in both up- and down-
regulated DTGs, compared to the control group, whereas SXL binding sites
(SXL BS) and GY-boxes are less abundant compared to the control genes.
Cytosolic polyadenylation elements (CPE) appear more abundant in 3’ UTRs
of upregulated genes compared to downregulated and control DTGs. Alcohol
dehydrogenase 3’ UTR downregulation control element (ADHDRE), G-quadru-
plex structure (PG4), and K-box are less abundant in the downregulated group
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compared to the other two groups. Brd box and GU-rich destabilization element
(GRE) are motifs that are less abundant in the DTG down group and more
abundant in the DTG up group compared to control genes. The polyadenyla-
tion signal (PAS) was less frequently identified in the CFC upregulated group
compared to control and downregulated genes. Very little is known about UTR
motifs and their relation to synaptic plasticity and memory, however, we know
some motifs respond specifically to defined signals from pathways regulating
translation that are essential to memory formation. For example, mTORC1
has been shown to regulate translation of mRNAs containing TOP elements
(Thoreen et al., 2012) and translation of uORF-containing mRNAs may be
regulated by eIF2a(Costa-Mattioli et al., 2007; Eacker et al., 2017) and impinge
on memory translation.
Figure 5.18 UTR motifs identified in DTGs. Known UTR motifs identified in 3’ and 5’
UTR, respectively, in DTGs specific to CFC. The data is presented as percentage of
genes, in each indicated group, that contain the motif at least once in their UTR.
We also extracted and calculated some basic UTR characteristics, such as
length, GC content and Gibbs free energy (a value that can be used to describe
the complexity of secondary structures that an RNA molecule is most likely
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to adopt in order to increase its stability). We did not observe any significant
differences in the length of the 3’ UTRs, but upregulated DTGs contained longer
5’ UTRs than downregulated DTGs (one-way ANOVA). Genes downregulated
by CFC had higher GC content in their 3’ UTR compared to upregulated genes.
The GC content in the 5’ UTR was only different, when comparing the control
gene group with the upregulated genes. The Gibbs free energy calculated for
the UTRs only showed a significant difference in the 5’ UTR, when comparing
downregulated genes with upregulated genes. Downregulated genes exhibited
lower Gibbs free energy, which indicates a higher complexity in the secondary
structure.
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Figure 5.19 Summary of the basic UTR statistics for DTGs in CFC. Summary of
length, GC content and Gibbs free energy of UTRs retrieved for DTGs in CFC. Bar
graphs for the indicated values representing the means and standard error of the
mean, as well as individual data points for each gene. Shown are percentage of
GC nucleotides in the UTR, length of UTR, and Gibbs free (folding) energy of UTR
sequence. Significance in multiple comparisons one-way ANOVA is indicated on the
graphs (* p  0.05, ** p  0.01.)
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5.3.2 qPCR of targets
To validate the specificity of our sequencing data and see if we could use
any of our targets as marker genes of memory formation, we picked two to
three DEGs from each of the following groups: CFC/shock only common upreg-
ulated (c-fos, Arc, Egr2), CFC/shock only common downregulated (Ankrd60,
Asmt), CFC unique upregulated (Col11a1, Robo3, Leng8), and CFC unique
downregulated (Hs3st2, Camk2d, Klhdc8a).
c-fos (Fos proto-oncogene), a transcription factor, is a commonly used marker
of recent neuronal activity and important in cancer and cell growth.
Egr2 (early growth response protein 2), a transcription factor, is involved in cell
growth and migration.
Arc (activity-regulated cytoskeleton-associated protein) is a master regulator
of synaptic plasticity.
Col11a1 (Collagen, type XI, alpha-1) is a collagen coding gene associated with
genetic disorders and is differentially expressed in the superficial-deep
CA1 hippocampal axis, linked to hippocampal place cells and spatial
memory (Cembrowski et al., 2016; Mallory and Giocomo, 2018)
Robo3 (roundabout guidance receptor 3) is a member of the roundabout family
and codes for a gene of key function in axonal navigation during neurode-
velopment (Friocourt and Chédotal, 2017).
Leng8 (leucocyte receptor cluster gene 8) is highly expressed in brain and
predicted to be involved in RNA transport and was previously shown to be
upregulated in mouse hippocampus 1 h after CFC (Peleg et al., 2010).
Akrd60 (ankyrin repeat domain 60) is a gene of unknown function.
Asmt (acetylserotonin O-methyltransferase) is an enzyme that catylyzes the
final step in melatonin biosynthesis. It has previously been associated
with psychiatric disorders.
Hs3st2 (heparan sulfate-glucosamine 3-sulfotransferase 2) is an enzyme that
generates distinct heparan sulfate fine structures and is expressed pre-
dominantly in the brain and may thus play a role in the nervous system.
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Camk2d (Calcium/Calmodulin dependent protein kinase II delta) is a calcium
dependent kinase important for several aspects of glutamatergic plasticity,
this gene encodes the delta chain of the protein.
Klhdc8a (kelch domain-containing protein 8a) is a a gene commonly found to
be upregulated in glioma and commonly expressed in nervous tissue.
c-fos, Egr2, and Arc are in the group of IEGs commonly used to show recent
neuronal activity. We ran qPCRs targeting the listed genes and with the excep-
tion of Ankrd60 and Asmt confirmed the differential expression of our targets.
Upon further investigation into the ribosome profiling raw data, Ankrd60 and
Asmt appeared to be false positives identified by the differential expression
analysis (Table 5.3) and were excluded from the target validation.
Table 5.3 Raw RPKM values for Asmt and Ankrd60, showing that the differential
expression between conditions is inconsistent within the replicates and most likely a
false positive.
Gene Symbol homecage 1 homecage 2 shock only 1 shock only 2 CFC 1 CFC 2
Asmt 0.8201 1.2447 0.2112 0.5534 0.5165 0.4519
Ankrd60 4.405 0.5085 0.5325 0.1077 1.8356 0.3115
Notably, c-fos and Arc, which are commonly used as markers for memory
formation, are not specifically associated with the fear memory, but also with the
shock only condition, in which no memory forms. Therefore, some of the genes
we identified that are uniquely up- or downregulated in the CFC group, e.g.
Col11a1, Robo3 or Leng8 may be more suitable markers of memory formation.
To test this hypothesis, on a more "softer" type of memory task, we trained WT
animals in a modified object location (OL) task, mimicking the controls we used
in the CFC protocol. OL memory is also hippocampus and location-dependent,
but does not contain a fear component. We trained animals as detailed in
Figure 5.1, dissected their dorsal hippocampi 20 min after the training or mock
training session and extracted RNA for qPCR. When quantifying expression of
the genes identified in the CFC tissue, we saw some similarities in expression.
C-fos, Arc and Egr2 followed the same expression pattern in OL as in CFC, as
they were upregulated in both sham and training groups. The genes identified
as uniquely down- or upregulated in CFC, compared to homecage and shock
did not follow the same expression pattern in OL trained animals. Camk2d was
downregulated in both sham and training and Hs3st2 showed great variability
between replicates that made it difficult to draw any conclusions. Our targets
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Figure 5.20 Quantification of qPCRs of potential marker genes of memory forma-
tion. DDCt quantification of qPCRs of indicated mRNAs in each sample. A mRNAs that
were upregulated in both shock only and CFC groups in the total mRNA sequencing
data. B mRNAs that were downregulated in both shock only and CFC groups in the
total sequencing mRNA data. C mRNAs that were upregulated in the CFC group,
but not in the shock only group, in the total sequencing mRNA data. D mRNAs that
were downregulated uniquely in the CFC group, but not in the shock only group, in the
total sequencing mRNA data. Values are represented as mean ± standard deviation,
including the individual data points (n = 2, except for the training group for Klhdc8a n
=1).
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from the genes uniquely upregulated in CFC, Col11a1, Robo3, and Leng8, were
downregulated in both sham and training groups. Taken together, this implies
Figure 5.21 Quantification of qPCR in animals trained in the OL task. qPCRs of
indicated mRNAs in each sample. A mRNAs that were upregulated in both shock only
and CFC groups. B mRNAs that were upregulated in the CFC group, but not in the
shock only group. C mRNAs that were downregulated in the CFC group, but not in the
shock only group. Values are represented as mean ± standard deviation, including the
individual data points.
that our newly identified markers for early memory, are suitable for fear-related
memories but not other memory tasks such as OL tasks.
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5.4 Discussion
With this project we set out to dissect the contribution of the electrical shock
as a potentially confounding factor in experiments studying gene expression
in a contextual fear conditioning paradigm. We showed that a single electrical
shock, as it is commonly used to fear condition rodents (which is insufficient
to produce a context-dependent memory, Figure 5.2), is sufficient to elicit
significant gene expression, within both transcription and translation, in the
mouse dorsal hippocampus only 20 min after behavioural training. Furthermore,
using GO analysis, we showed that differentially expressed and translated
genes in the shock only group were involved in several functions/pathways
related to gene expression. In the CFC group, DEGs and DTGs produced GO
terms related to synaptic plasticity, gene expression, and signalling pathways
were identified. We analysed UTRs of DTGs for enrichment in motifs and/or
some basic statistics such as length, GC content, and Gibbs free energy, finding
no significant differences, but some interesting trends towards differential usage
in some of the categories. qPCR of targets identified with ribosome profiling
confirmed several candidate genes as potential markers for memory formation
(in the fashion of immediate early genes, e.g. cfos, Arc, Egr2), namely Col11a1,
Robo3, Leng8, Hs3st2, Camk2d, and Klhdc8a. When tested in a less invasive
memory task (object location), however, these marker genes were suboptimal.
We have shown convincingly that the contribution of the electrical shock in
fear conditioning paradigms is non-negligible when conducting gene/protein
expression studies. A considerable number of genes that changed expression
in the dorsal hippocampus of conditioned animals overlapped with genes differ-
entially regulated in the group that received only a foot shock (approx. 18% of
DEGs and 15.5% of DTGs of the CFC group). Thus, when studying fear-related
gene-expression it is of great importance to carefully design experiments and
use appropriate controls.
GO analysis revealed interesting categories for all data sets examined.
Shock only genes, both DEGs and DTGs, were enriched for terms relating to
the mitochondrion and energy metabolism. This could relate to a heightened
state of readiness to synthesise new mRNAs and proteins. As shown by our
data, a single footshock elicited considerable changes in both transcription (68
genes) and translation (168 genes) in the dorsal hippocampus within just 20
min. Memory formation in the brain requires both transcription and translation
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(Alberini and Kandel, 2015; Costa-Mattioli et al., 2009), which are both energy
dependent processes. Furthermore, several GO terms were related to DNA
transcription, supporting our hypothesis. Importantly, quite a few IEGs, which
we have shown to be regulated by shock, function as transcription factors, which
may explain the enrichment in transcription related GO terms.
In the CFC unique group, we found enrichment in different terms relating to
the ECM as well as intracellular signalling pathways impinging on translation.
Both of these are key to synaptic plasticity and memory formation (Costa-Mattioli
et al., 2009; Dityatev, 2014; Hylin et al., 2013). Furthermore, terms related
to both transcription and translation were enriched, again highlighting their
importance in the formation of new memories.
A published study using ribosome profiling of the brain (Cho et al., 2015) had
suggested that translation of ribosomal genes is suppressed in neuronal cells
compared to all proteins and mitochondrial ribosomal genes. Cho et al. (2015)
did not observe these changes in mouse embryonic stem cells or other tissues
(kidney, testis, liver). We analysed several of our own (dissociated WT cortical
neurons, and homecage data) and some published ribosomal profiling data sets
(murine embryonic stem cells (Ingolia et al., 2011), Kidney (Castelo-Szekely
et al., 2017), Liver (Janich et al., 2015), Muscle (Drummond et al., 2017), Cho
et al. (2015) published data, and a HEK293 sample data set from Illumina)
for TE of ribosomal genes. As shown in Figure 5.17 C, except for HEK293
cells (which are a highly translationally active cell type), all tissues and cell
types analysed showed a pattern of lower TE in ribosomal genes compared to
all other proteins. However, using polysome profiling of HEK293 cells, dorsal
hippocampal tissue, and DIV25 hippocampal neurons, we observed comparable
density of polysomes in all cell types/tissues. Western blots of different tissue
lysates (hippocampus, kidney, liver, muscle, spleen) for several small and large
ribosomal subunit proteins revealed varied expression across all tissues tested,
but no particular pattern of suppression in neurons as shown by Cho et al.
(2015). The collected data point towards a distinct way of ribosomal protein
expression in neuronal cells/tissue, which is not necessarily governed by a
general repression of translation of said proteins. The conducted Western
blots are more suggestive of a different combination of ribosomal proteins in
neuronal cells, compared to other cell types/tissues. Furthermore, there is
ample evidence that expression patterns of ribosomal genes may vary greatly
between tissues (Guimaraes and Zavolan, 2016; Mills et al., 2018; Smagin
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et al., 2018). We therefore conclude that the phenotype described by Cho et al.
(2015) is indeed more complex and awaits further elucidation.
UTR motifs and basic features can be key to translation regulation and many
of them have been reported to specifically regulate the translation of a subset
of mRNAs (Hinnebusch et al., 2016; Mazumder et al., 2003). We analysed 3’
and 5’ UTRs of all DTGs (up- and downregulated) that were unique to CFC, as
well as a control group of unchanged genes for the presence of known UTR
motifs using Utrscan (Pesole and Liuni, 1999). We did find some trends towards
changes in abundance of motifs in the three groups, however, none of the
comparisons reached significance in a two-way ANOVA. The trend towards an
increased number of uORFs in transcripts downregulated by CFC resembles
the phenotypes observed by Eacker et al. (2017) and may be explained through
the role that phospho-eIF2a plays in the regulation of memory-related genes
(Costa-Mattioli et al., 2005, 2007; Eacker et al., 2017)
Additionally, we collected some basic quantifiable measures of the UTRs,
namely length (in nt), GC content, and Gibbs free energy (folding free energy).
In the unique CFC DTGs, 5’ UTRs of upregulated genes were significantly
shorter than 5’ UTRs of downregulated genes. UTR length can be important for
translation regulation, as the longer the sequence, the more regulatory elements
can be contained and the potential for complex secondary structures increases.
Furthermore, long 5’ UTRs may require eIF4A helicase to resolve the sequence
and allow cap-binding by eIF4E and preinitiation complex recruitment. High
GC content and highly negative folding free energy can be used to predict
the presence of secondary structures within the analysed sequence. In the 5’
UTR, upregulated genes showed less negative folding free energy (compared
to downregulated, p  0.05), which may point towards lower complexity 5’ UTRs
in transcripts upregulated by fear conditioning and a potential dependence of
downregulated genes on eIF4A1 helicase activity. The 3’ UTRs followed a
similar trend, where GC content was lower in upregulated genes compared
to downregulated genes. Taken together, our UTR analysis revealed no defi-
nite translational control mechanism, but, nevertheless points towards some
avenues that may prove interesting in further investigation.
When exploring our ribosome profiling data, we found genes that were
upregulated and are commonly used to confirm early memory formation, IEGs
(e.g. cfos, Arc, Egr2). We find that these IEGs should be used with caution in
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combination with memory tasks containing a potential confounding factor such
as the foot shock in CFC (compare Figure 5.20). A single footshock, that is
insufficient to establish significant long-term fear memories associated to the
context it was delivered in (Figure 5.2), is sufficient to induce IEG transcription.
Following on from this discovery, we chose several genes (Col11a1, Robo3,
Leng8, Hs3st2, Camk2d, Klhdc8a) that showed specific expression patterns
in the different behavioural groups in the profiling data and quantified their
expression using qPCR (Figure 5.20). Some of the genes we tested as marker
genes, may be suitable alternatives to conventional IEGs (Figure 5.20 C),
however, in a brief experiment testing the validity of our selected genes, using a
different memory task (object location memory), the only genes showing the
same trends in expression as in CFC were the canonical IEGs. This points
strongly towards a role of the IEGs encoding novelty rather than a specific
memory. Thus, examining more genes and characterising them carefully is
necessary to eventually establish marker genes that are suitable for different
forms of memories.
5.4.1 Conclusions
In this chapter, we showed that omics studies in the brain to better under-
stand genes relevant to memory formation need to be carefully planned and
relevant controls need to be carried out. Our basic version of the contextual fear
conditioning task showed significant regulation of transcription and translation
after both presentation with only the unconditioned stimulus (shock only) as
well as after the full training protocol that included exposure to the conditioned
stimulus (context, training group). Furthermore, the shock only and training
groups showed significant overlaps in the genes that were expressed. This
fact highlights the importance of using suitable genes as markers of memory
formation. For example, commonly used IEGs, such as c-fos and Arc, were
upregulated in both shock and training groups, so they should be used carefully
as a marker of true memory formation. The novel marker genes we tested
(e.g. Col11a1, Robo3, Leng8), were convincing in the presented CFC task, but
did not yield as clear a result in a less invasive task, namely object location
memory. More of the genes identified in our study should be tested for suitability
as memory genes, that differentiate between the shock and the true memory
response.
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Monitoring translation in synaptic
fractions using a ribosome
profiling strategy
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ing translation in synaptic fractions using a ribosome profiling strategy
6.1 Abstract
Background
The aim of this study was to develop a method to study genome-wide local
translation in biochemically isolated synaptic fractions (synaptoneurosomes).
This methodology is of particular interest for neurons, due to the cardinal role of
local translational control in neuronal sub-compartments, such as dendrites, for
plasticity, learning, memory, and for disorders of the nervous system.
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New method
We combined established methods for purifying synaptoneurosomes, with
translational profiling (ribosome profiling), a method that employs unbiased next
generation sequencing to simultaneously assess transcription and translation in
a single sample.
Results
The two existing methods are compatible to use in combination and yield
high quality sequencing data, which are specific to synaptic compartments.
This new protocol provides an easy to implement workflow, which combines
biochemical isolation of synaptoneurosomes of varying levels of purity (crude or
Percoll gradient purified) with the use of a commercial kit to generate sequencing
libraries.
Comparison with existing method
Compared to previous studies of the synaptic translatome, our method shows
less contamination with non-neuronal cell types or non-synaptic compartments,
increasing the specificity of the data obtained.
Conclusions
Combining the isolation of functional synaptic units with ribosome profiling
offers a powerful tool to study local translation in synaptic compartments both
in health and disease.
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6.2 Introduction
Neurons are highly specialised cells, which require tight spatial and tem-
poral control of protein synthesis, in order to maintain their functionality and
efficiently respond to neuronal activity and external stimuli. Since neuronal
compartments, such as dendrites and pre-synaptic terminals, are often situated
at great distances from the cell soma, neurons have developed mechanisms to
transport mRNAs in a suppressed state to different remote compartments within
the cell and allow initiation of protein synthesis in a local and timely manner
(Rangaraju et al., 2017). Local translation is important for a variety of cellular
mechanisms, including axonal guidance, growth cone development and synap-
tic plasticity, thus influencing neuronal development and crucial processes such
as learning and memory (Holt and Schuman, 2013; Klann and Dever, 2004).
In addition, aberrant local translation is a feature of several neuropsychiatric
and neurodegenerative disorders (Donlin-Asp et al., 2017; Liu-Yesucevitz et al.,
2011). Therefore, it is vital to our understanding of brain function that we clarify
the mechanisms that govern local synaptic translation in health and disease.
Due to the technical challenges of studying local translation, there is no
definitive answer yet regarding the precise composition of the synaptic trans-
latome (transcripts in a cell or tissue, which may be translated at a given point
in time) and how it is regulated (Rangaraju et al., 2017). The translatome differs
from the proteome, since it represents the pool of mRNAs that are associated
with translating ribosomes. Thus, changes in ribosome occupancy may not
precisely reflect changes in the proteome. However, it has been shown on
several instances that measuring ribosome occupancy allows for more confi-
dent estimations of protein expression than transcriptome analysis (RNA-Seq
or microarrays) (Carlyle et al., 2018; Schwanhäusser et al., 2011; Vogel, 2011).
To study local translation several approaches have been employed, including
microdissection of the neuropil layer within the hippocampal CA1 region from
fresh tissue (Tushev et al., 2018), fluorescence activated synaptosome sorting
(FASS) combined with RNA-Seq (Hafner et al., 2019), and the use of tripartite
microfluidic systems that separate the soma, axon, and pre-synapse of cultured
neurons into different compartments (Baleriola et al., 2014). Although useful to
get an insight into the local translatome, these methods have several limitations.
While microdissected tissues contain significant contaminations from glia and
non-neuronal cells, which require extensive bioinformatics analysis to eliminate
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(Tushev et al., 2018), culture systems fail to mimic the complexity of in vivo neu-
ronal networks and are limited to the specific brain regions and developmental
ages from which stable neuronal cultures can be obtained. Furthermore, recent
approaches have employed Translating Ribosome Affinity Purification (TRAP),
but despite the fact that they offer cell-type specificity, they require genetic
manipulation to introduce an exogenous tag (Green Fluorescent Protein) on
ribosomal proteins (Eacker et al., 2017; Ouwenga et al., 2017).
Here, we present the combination of a well-established method for synap-
toneurosome (SN) preparation (adapted from Dunkley et al. (2008)) with the
ribosome profiling methodology (Ingolia et al., 2012, 2009). SN are biochem-
ically isolated pre- and post-synaptic components that are obtained through
gentle homogenisation of nervous tissue under isotonic conditions. These prepa-
rations have the advantage that they can be rapidly isolated from any brain
region, from animals of any age, and have little contamination from non-synaptic
components and non-neuronal cell types. Ribosome profiling is an unbiased
RNA sequencing-based strategy to assess the transcriptional and translational,
i.e. their association with translating ribosomes, state of cells. Therefore, our
method allows the study of the synaptic translatome from whole brain tissue or




C57Bl/6J animals were bred and maintained at facilities at the University of
Edinburgh. Animals were weaned at postnatal day 21 and thereafter housed
in cages of up to 4 animals, in temperature (20-21°C) and humidity ( 55%)
controlled rooms. Animals were kept on a 12 h light/dark cycle and were
provided access to food and water ad libitum. All experimental procedures were
performed in accordance with UK Home Office regulations.
6.3.2 Preparation of synaptoneurosomes (SN)
Synaptoneurosomes were prepared from the forebrain (whole brain dissec-
tion - olfactory bulbs and cerebellum were removed) of 10-week-old C57Bl/6J
male mice. Crude SN and Percoll SN were prepared as described in (Dunkley
et al., 2008), with minor modifications (Fig 6.1A). Briefly, animals were culled
by cervical dislocation followed by decapitation and the brain dissected rapidly.
The freshly dissected forebrain was homogenized (on ice) in ice-cold sucrose
buffer (320 mM sucrose, 5 mM Tris pH 7.4, 1 mM EDTA) and centrifuged for
10 min, at 1,000 x g, 4°C. The pellet (P1) was resuspended in sucrose buffer
and centrifuged as before. The resulting pellet (P1) was kept as the “non-synap-
tic fraction” and the combined supernatant from both spins (S1) was further
centrifuged for 10 min at 21,000 x g, 4°C, to pellet crude SN (P2).
To prepare Percoll SN, the crude pellet (P2) was resuspended in 3% Percoll
(GE Healthcare) in sucrose buffer and centrifuged through a discontinuous
10%-24% Percoll gradient, at 30,750 x g for 9 min at 4°C, with minimum
acceleration and no deceleration on a JA-25.50 fixed angle rotor in a Beckman
Avanti JA-25 centrifuge. The material between layers 24% and 10% was
collected, resuspended in Ionic Media (20 mM HEPES pH 7.4, 10 mM Glucose,
1.2 mM Na2HPO4, 1 mM MgCl2, 5 mM NaHCO3, 5 mM KCl, 140 mM NaCl),
and centrifuged for 15 min at 21,000 x g, 4°C. Cycloheximide (100 µg/ml) was
added to all buffers to stall translating ribosomes and stabilise them in their
position on the mRNA.
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6.3.3 Western Blotting
Protein was extracted from samples by addition of RIPA buffer [50 mM Tris
pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
protease and phosphatase inhibitors (Roche, cOmplete and PhosSTOP mini
tablets)] and homogenisation using a motorized pestle (Kimble, 749540 0000).
Samples were incubated on ice for 15 min, with occasional vortexing, and
centrifuged for 20 min at 16,000 x g at 4°C to clear the lysate from cellular
debris. The protein concentration of each sample was determined by Bradford
assay (Bio-Rad, 5000112).
Samples were prepared in SDS sample buffer (50 mM Tris pH 6.8, 100 mM
DTT, 2% SDS, 10% Glycerol, 0.1% bromophenol blue), heated for 5 min to
95°C and resolved on polyacrylamide gels. Proteins were transferred to 0.2 µm
nitrocellulose membranes (Bio-Rad, 1620112), blocked in 5% BSA in TBS-T
(10 mM Tris pH 7.6, 150 mM NaCl, 0.1% Tween-20) for 1 h at room temperature
(RT), incubated with primary antibodies in 1% BSA in TBS-T overnight at 4°C,
and with secondary antibodies in 1% BSA in TBS-T for 1 h at RT. Between
incubations, membranes were washed extensively in TBS-T. Blots were imaged
using an Odyssey Imaging System (Li-COR Biosciences) at a resolution of
169 µm.
Antibodies used for Western blotting are summarized in Tables 6.1 and 6.2
Table 6.1 Details of primary antibodies used.
Target Species Supplier Cat No Dilution
GAD67 mouse Millipore MAB5406 1:1,000
GAPDH rabbit Cell Signalling 2118 1:5,000
HDAC3 7G6C5 mouse GeneTex GTX83173 1:1,000
Myelin Basic Protein mouse abcam ab62631 1:1,000
PSD95 rabbit Cell Signalling 3450 1:1,000
Ribosomal Protein L11 rabbit Cell Signalling 18163 1:1,000
Ribosomal Protein L13a rabbit Cell Signalling 2765 1:500
Ribosomal Protein S6 mouse Santa Cruz sc-74459 1:5,000
Ribosomal Protein S15 rabbit abcam ab157193 1:1,000
SV2A mouse DSHB University of Iowa AB_2315387 1:1,000
Synaptophysin 1 rabbit Synaptic Systems 101 002 1:1,000
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Table 6.2 Details of secondary antibodies used.
Description Species Supplier Cat No Dilution
IRDye® 680RD Donkey anti-Rabbit IgG (H+L) Donkey Li-COR Biosciences 926-68073 1:5,000
IRDye® 800CW Donkey anti-Mouse IgG (H+L) Donkey Li-COR Biosciences 926-32212 1:5,000
6.3.4 Ribosome Profiling (RPF)
Ribosome profiling was adapted from (Ingolia et al., 2012, 2009) for use
with the TruSeq Ribo Profile (Mammalian) Kit (Illumina, RPMHMR12126) and
the NEXTflex™Small RNA Sequencing Kit v3 (Bioo Scientific, NOVA 5132 06).
The TruSeq Ribo Profile protocol was followed until the end-repair step, after
which the NEXTflex™Small RNA Sequencing Kit v3 was used for generating
sequencing libraries. Polysomes were extracted from SN preparations through
homogenisation in TruSeq Polysome Buffer (Illumina). A fraction of the lysates
was kept as an internal mRNA control (total mRNA), while the remaining frac-
tion was digested with TruSeq Ribo Profile Nuclease (RNase I) (footprints) and
purified through a MicroSpin S-400 column (GE Healthcare) to enrich for small
RNA fragments. From synaptoneurosomes prepared from one full forebrain
(one animal), we extracted between 600 ng and 4 µg of RNA after this step,
depending on the sample type (footprints usually show lower yield than total
RNA). All samples (footprints and total mRNA) went through a ribosomal RNA
depletion protocol using the Ribo-Zero Gold (Human/Mouse/Rat) Kit (Illumina,
MRZG12324). The total mRNA was heat-fragmented according to the TruSeq
Ribo Profile Kit, whereas the footprint samples were further purified on a 15%
TBE-Urea polyacrylamide gel (ThermoFisher Scientific, EC68852BOX) to se-
lect for fragments running between 28 and 30 nucleotides. The quality and
concentration of samples was assessed by running an Agilent Small RNA chip
Bioanalyzer assay (Agilent Technologies, 5067 1548), which allows assessing
the size distribution and concentration of RNA samples sized below 200 nt
using as little as 50 ng of RNA sample. Libraries were generated using the
NEXTflex™Small RNA Sequencing Kit v3, according to the manufacturer’s
instructions. The NEXTflex™Small RNA Sequencing Kit v3 is particularly suit-
able for these applications, as library generation is successful even at very low
input levels (we have used as little as 3 ng of purified, rRNA depleted footprints
as total input). Synaptoneurosomes can also be prepared from specific brain
regions, in which case we would recommend pooling tissue from more than
one animal to achieve comparable quantities of RNA. Bioinformatics analysis
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was performed as previously described (Amorim et al., 2018a). Translational
Efficiency (TE) was calculated as the ratio between reads per kilobase per
million mapped reads (RPKM) of footprints and RPKM of total mRNA for each
gene.
Note:
Since the submission of this manuscript, the two Illumina kits (RPMHMR12126,
MRZG12324) have become obsolete. We recommend following the original
published protocol (Ingolia et al., 2012), but scaling down volumes for the
footprinting step (to 100 µl), replacing the sucrose cushion with MicroSpin S-400
purification (as summarized in the Illumina protocol), and using a commercial
kit for the rRNA depletion (e.g. NEBNext® rRNA Depletion Kit, New England
Biolabs, E6350).
To confirm validity of our data set, we determined the overlap between the
1000 most abundant transcripts in our SN preparations and a published list
of mRNAs identified in SN prepared from adult mouse hippocampi (You et al.,
2015).
6.3.5 Gene Ontology Analysis
Gene Ontology (GO) analysis was performed using the online tool DAVID
(Database for Annotation, Visualization and Integrated Discovery; version 6.8)
(Huang et al., 2009b). Filtered gene lists were submitted to DAVID and GO
annotations gathered for Biological Function, and Cellular Component.
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6.4.1 Isolation of synaptically enriched fractions
We prepared SN from whole mouse forebrain using two different methods,
which yield synaptically enriched fractions of different purity levels. Crude SN
offer a quick and simple way of isolating synaptically enriched fractions from
brain tissue. However, even though this method might be suitable for certain
purposes, crude SN are contaminated with myelin, non-synaptic mitochondria,
and other cellular debris. If a purer sample is required, crude SN can be cen-
trifuged through discontinuous Percoll gradients to remove most contaminants
(Fig. 6.1A).
As demonstrated by immunoblotting (Fig. 6.1C), our protocol reliably pro-
duced synaptic fractions depleted of nuclear components and enriched in both
excitatory and inhibitory synaptic proteins. In the case of the Percoll gradi-
ent purified SN, these were also depleted of further contaminating cellular
components, such as myelin basic protein (MBP, two isoforms (Libich, 2009)).
Furthermore, we probed our samples with antibodies against ribosomal proteins
to show that there are adequate levels of ribosomal proteins present in synaptic
fractions (Fig. 6.1D).
6.4.2 Ribosome profiling in synaptoneurosomes
Having successfully isolated synaptic fractions from brain tissue, we pro-
ceeded with processing them for ribosome profiling (Fig. 6.1B). The crude and
Percoll SN were lysed and separated in two fractions, so total mRNA (a proxy
for transcription) and footprints (a proxy for translation) could be assessed within
each sample. For footprint analysis, the samples were digested with RNase I, to
generate footprints of around 28-30 nucleotides (nt) in length. Total mRNA was
heat-fragmented to yield sequence fragments similar in size to footprints. Both
sets of samples were run through a ribosomal RNA removal kit, to eliminate
highly abundant ribosomal RNA contaminants, and sequencing libraries were
prepared from footprints and total mRNA fragments.
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Figure 6.1 Schematic diagram of the preparation of SN (A) and the ribosome pro-
filing workflow (B). A detailed description can be found in section 2 (Methods). (C)
Immunoblots of the indicated proteins in the different fractions obtained during the
preparation of SN. Note the depletion of nuclear proteins (HDAC) and the enrichment
in both excitatory and inhibitory synaptic proteins (synaptic vesicle glycoprotein 2A
– SV2, synaptophysin, glutamic acid decarboxylase 67 – GAD67, and postsynaptic
density protein 95 – PSD95) in crude and Percoll SN. PSD95 blots show two bands
very close in size, representing aand bisoforms of the protein, respectively (Chetkovich
et al., 2002). In addition, Percoll SN show a major decrease in myelin components
(MBP) of both major isoforms. GAPDH was used as a loading control. H: tissue
homogenate, NS: non-synaptic fraction, CS: crude synaptoneurosomes, PS: Percoll
synaptoneurosomes. (D) Immunoblots confirming the presence of ribosomal proteins
(large ribosomal proteins 11 and 13a, small ribosomal proteins 6 and 15) in the SN
fractions. GAPDH was used as a loading control. (E) Size distribution of the aligned
sequencing reads from the indicated samples. Total mRNA reads show a random size
distribution, whereas ribosomal footprints show a distinct peak between 28 and 30
nt. (F) Reading frame usage in the total mRNA and footprint samples, showing the
preferential alignment within the first reading frame in the footprint samples, compared
to the total mRNA samples which have been randomly fragmented. (G) The total
number of read fragments aligning around the start and stop codons of the coding
sequence of all genes. Footprints show a 3 nt periodicity, compared to total mRNA
reads.
We succeeded in generating high quality ribosome profiling libraries from
both crude and Percoll SN (Fig. 6.1E-G). Quality control graphs confirmed the
restricted size distribution of footprints, as well as the random size of total mRNA
fragments (Fig. 6.1E). Analysis of the usage of reading frames showed that the
majority of footprints aligned with their main reading frame sequence (Fig. 6.1F,
Frame 1), as would be expected for actively translating ribosomes. In addition,
mapping of the footprints along each transcript showed that the 5’-ends of the
RPFs start at 12 to 13 nt upstream of start codons and decrease significantly in
frequency at approximately 15 nt upstream of the stop codon, specific to the size
and shape of initiating and terminating ribosomes, respectively. The footprints
further exhibit a characteristic 3-nt periodicity (Fig. 6.1G), a consequence of
translating in 3-nt codons. In contrast, the equal distribution of total mRNA
fragments between the 3 main reading frames and their lack of 3-nt nucleotide
periodicity highlights the random nature of the heat fragmentation process and
the specificity of the footprint data (Fig. 6.1F-G).
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6.4.3 Gene Ontology Analysis
Sequencing identified transcripts from over 10,000 protein coding genes.
Therefore, to facilitate further analysis and to focus on the most abundant
transcripts in synapses, we selected the 1,000 most abundant (top 1,000)
genes corresponding to the transcripts in our total mRNA and translational
efficiency (TE) datasets with the highest RPKM or TE values, respectively, for
both the crude and Percoll protocols.
First, we compared our data to a published dataset exploring the transcrip-
tome of SN generated from mouse hippocampi (You et al., 2015) (Fig. 6.2A-B).
Even though some regional heterogeneity would be expected when comparing
synaptosomes isolated from hippocampal with those extracted from forebrain
tissue, we found a 3̃0% overlap for the top 1,000 genes (total mRNA) for both
the crude and Percoll SN. This shows that our data is comparable to data
generated from similar experiments by other labs, and that there is a pool of
highly abundant mRNAs enriched in synapses, which may support core synaptic
functions across brain regions. Secondly, we performed Gene Ontology (GO)
analysis of the top 1,000 genes in our samples to define ontological groups
of genes enriched in our SN preparations (Fig. 6.2C-F). Overall, performing
GO analysis using DAVID revealed a highly significant enrichment (p  0.0001)
of Biological Process and Cellular Component GO terms related to synaptic
function in our gene lists (Fig. 6.2C-F). Total mRNA samples showed highly
significant enrichments (p  0.0001) in Cellular Components such as membrane,
synapse, post-synaptic density and dendrites, emphasising the synaptic nature
of the samples (Fig. 6.2C-D). Interestingly, TE datasets were particularly en-
riched (p  0.0001) in transcripts coding for mitochondrial, extracellular matrix
and extracellular exosome proteins (Fig. 6.2E-F). Biological Processes GO
terms followed the same trends, with TE data showing enrichment for metabolic
and oxidation-reduction processes (Fig. 6.2E-F), whereas the total mRNA data
presents an enrichment (p  0.0001) in a broader range of important synap-
tic processes, including nervous system development, ion transport, neuron
migration and long-term synaptic potentiation (Fig. 6.2C-D).
Taken together, these results show that our method reliably identifies tran-
scripts localised to the synapse, as well as the subset of these mRNAs that are
associated to ribosomes and are likely to be locally translated.
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Figure 6.2 (A-B) Comparison of our identified top 1,000 genes with the 1,000 most
abundant genes in hippocampal SN from You et al. (2015). The overlap between the
published data and our crude and Percoll SN are 289 and 300 genes, respectively. (C-F)
Most significant results from the GO analysis of the 1,000 most abundant transcripts
identified in the SN fractions (C-D), and the 1,000 genes with the highest TE in the
SN fractions (E-F). The numbers accompanying each bar on the graphs indicate the
number of genes in the respective group.
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Here we present a new methodology based on two previously established
protocols, allowing us to study simultaneously the synaptic translatome and
transcriptome of neurons. We further demonstrate that our method yields high
quality RNA sequencing data displaying an enrichment in genes related to
synaptic function.
Studying synaptic translation in an unbiased way poses a great challenge,
due to the technical difficulty of isolating pure dendritic or axonal fractions con-
taining mRNA (Rangaraju et al., 2017). Ribosome profiling has been previously
used to study translation in the rodent brain (Amorim et al., 2018a; Cho et al.,
2015) and provides an unbiased, genome-wide assessment of both the total
transcriptome and translatome. Studying the translatome is important because
translation contributes significantly to regulating protein levels, especially at
synapses (Vogel, 2011). By purifying synaptic compartments from live brain
tissue, using a well-established method, we were able to generate ribosome pro-
filing libraries, which allow for gaining a significant insight into the transcriptome
and translatome of SN.
By performing GO analysis of the top 1,000 synaptic transcribed and trans-
lated mRNAs, we showed an enrichment in synaptically relevant transcripts
in both the total mRNAs and the ribosome associated fractions, as well as a
considerable overlap with comparable published data (Fig. 6.2A-B). GO anal-
ysis of our transcriptome targets (Fig. 6.2C-D) showed significant enrichment
in Cellular Component terms relating to the synapse (post synaptic density,
dendrite, synapse, axon, etc) and Biological Process terms such as long-term
synaptic potentiation and ion transport. Interestingly, GO analysis of the most
abundant genes in the ribosome associated fraction (TE dataset) showed an
enrichment in energy metabolism- and mitochondria-related terms (Fig. 6.2E-F).
This is in agreement with the high abundance of mitochondria at the synapse
and the elevated energetic demand required for the maintenance of synaptic
functions (Rangaraju et al., 2019). The contrast between total mRNA and TE
data highlights the fundamental difference between the transcripts present at
synaptic fractions and their level of translation, stressing the importance of
assessing both the transcriptome and translatome of a given sample.
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The choice between using crude or Percoll SN depends on the requirements
of each particular experiment. Both preparations are enriched in synaptic
components and contain good amounts of ribosomal proteins (Fig. 6.1C-D) and
RNA. Total mRNA and footprint libraries can be prepared from either type of
sample, and GO analysis shows similar enrichments in relevant synapse-related
terms (Fig. 6.2). Percoll SN have the advantage of being less contaminated
with myelin and extra-synaptic mitochondria (Fig. 6.1C, Fig. 6.2C), but require
longer preparation times and the use of freshly dissected tissue. Percoll SN
yield lower amounts of mRNA and footprints than crude SN, which may require
pooling of samples from different animals for small brain regions. Ultimately, the
researcher needs to take into consideration the balance between the purity of
samples and technical feasibility of the experiment.
Combining SN isolation with translational profiling has the potential of an-
swering important questions within the field of localised neuronal translation
in an unbiased fashion. SN can be isolated from whole brain, prepared from
specific brain regions or sorted using flow cytometry to yield specific populations
(Biesemann et al., 2014; Hafner et al., 2019). In addition, SN are commonly
used as functional in vitro models of synaptic activity, which can be assessed
at baseline or can easily be stimulated or treated with a variety of agents. The
combination of this powerful tool with ribosome profiling allows researchers
to precisely analyse the local translatome at synapses and to study transla-
tional regulation in response to neuronal activity or in models of neurological
disorders.
6.6 Conclusion
The combination of the unbiased method of ribosome profiling, to study
transcripts that are being actively translated, with well-established protocols of
isolating functional synaptic fractions provides a powerful tool to study localised




Overall, the goal of the work described in this thesis was to gain a better un-
derstanding of mRNA translation in the brain in both health and disease. To this
end, we showed how translation in the brain of a mouse model overexpressing
human MMP-9 brainwide compares to translation in the brain of a mouse model
of FXS and how the phosphorylation of eIF4E Ser209 regulates translation of a
specific subset of mRNAs. We further showed that in a classical Pavlovian fear
conditioning paradigm, a session where only an electrical shock is administered
to the animal, but no connection to the potentially dangerous novel environ-
ment is formed, is sufficient to induce significant gene expression that overlaps
considerably with gene expression after fear conditioning training. Lastly, we
extended the method of ribosome profiling for use in synaptoneurosomes to
study local translation at synaptic terminals.
In Chapter 3, we showed that TgMMP9 animals, which had previously been
shown to display key phenotypes of Fmr1KO mice, showed little to no changes
in global translation, regulation of signalling pathways impinging on translation,
and transcription and translation of specific transcripts. Ribosome profiling of
Fmr1KO mice revealed very small numbers of DEGs and DTGs, comparable
to TgMMP9 profiling. We conclude that in the forebrain of adult TgMMP9 and
Fmr1KO mice translation is not significantly changed. Us not observing bigger
changes in translation, especially in the Fmr1KO mice, where upregulated
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global translation has been postulated as a key phenotype before, may be due
to several factors, including but not limited to the comparably old animals (in
relation to other studies), the use of whole forebrain rather than individual brain
regions or targeting cell types. Furthermore, protein synthesis may be regulated
at a level that is not detectable with ribosome profiling.
In Chapter 4, we applied ribosome profiling to a novel mouse model of de-
pression, harbouring a phospho-dead version of the cap-binding protein eIF4E.
Our data showed that phospho-eIF4E regulates the translation of a specific
subset of mRNAs involved with the serotonin pathway and inflammation. We
further found that 3’ UTRs of upregulated genes in 4EKi contained significantly
less GAIT motifs, while 5’ UTRs of downregulated genes were significantly
shorter. We propose a model in which phospho-eIF4E regulates the translation
of inflammatory genes through the GAIT complex and genes regulated by eIF4E
contain long and structured 5’ UTRs requiring eIF4A1 helicase for translation
initiation.
In Chapter 5, we investigated the effects of a single electrical shock on gene
expression in the dorsal hippocampus, compared to contextual fear conditioning.
The results show a considerable overlap in both transcription and translation
of genes that are expressed after shock only and after CFC. The length and
complexity of the 5’ UTR of genes upregulated by CFC may further present as
an important factor for understanding gene expression in memory, but awaits
further research.
In Chapter 6, we extended the ribosome profiling strategy of monitoring
translation to work in synaptoneurosomes, biochemically isolated synaptic
terminals. Local translation in neuronal cells is of key importance for the cell to
maintain proper function, but presents a challenge when studying tissue. With
our combination of two established methods, we add a new and easy to use
protocol to allow monitoring of translation at synapses. Ribosome profiling of
synaptoneurosomes offers a great basis for studying synaptic translation in
response to diverse stimuli, such as drugs, inhibitors or excitation, in health and
models of disease.
We successfully applied ribosome profiling to several neural tissues, which
at the time, when this study was devised, had not been published. Ribosome
profiling is a great method to gather an omic type overview over ribosomal
occupancy of mRNAs. mRNA expression levels, as assessed using microar-
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rays or conventional RNA-Seq experiments have been shown to not always
accurately resemble protein levels (Schwanhäusser et al., 2011). Ribosome
profiling, on the other hand, showed greater overlaps with mass spectrometry
data (Carlyle et al., 2018). This supports a role for ribosome profiling as a
tool for discovery of differentially translated genes at different conditions, as
well as pathways and ontology terms that may be relevant. However, results
should be carefully validated for their expression and studied in more detail after
profiling experiments, as ribosome profiling offers information on the ribosome
occupancy of mRNAs rather than the protein abundance (Ingolia, 2014).
7.2 Conclusion
Taken together, the work presented in this thesis shows that ribosome pro-
filing is an invaluable tool to gain a better understanding of the translational
regulation of mRNAs in the brain. Specifically, in the context of neuropsychiatric
disorders, such as MDD and ASD, that show dysregulated translation pheno-
types it has proven useful in discovering novel patterns in mRNA translation
regulation. Furthermore, applied to animals trained in a memory task, it iden-
tified key genes involved in early memory formation. We have shown that it
can be applied in various ways and is sensitive enough to pick up on even
small changes in transcription or translation both at a global and a local scale,
therefore supporting its use as a discovery tool.
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Table A.1 DEGs and associated statistics for TgMMP9
Ensembl gene ID Gene symbol avg TgMMP9WT avg TgMMP9OE Ratio log2 ratio z-score p-value FDR
ENSMUSG00000038700 Hoxb5 0.19104383 0.0650875 0.34069406 -1.5534513 -2.3529429 0.01862549 0.02793824
ENSMUSG00000044518 Foxe3 10.8264372 3.81924517 0.35277027 -1.5031991 -6.7423114 1.56E-11 2.10E-10
ENSMUSG00000039728 Slc6a5 18.0335427 6.75019502 0.37431331 -1.4176818 -7.3535941 1.93E-13 5.21E-12
ENSMUSG00000032572 Col6a4 11.5371158 4.95603468 0.42957311 -1.2190244 -6.2766181 3.46E-10 3.11E-09
ENSMUSG00000018830 Myh11 54.2150514 32.1046339 0.59217197 -0.7559119 -4.9477507 7.51E-07 5.07E-06
ENSMUSG00000055333 Fat2 1.81667981 1.09516246 0.60283736 -0.7301593 -2.0713326 0.03832772 0.05174243
ENSMUSG00000027517 Ankrd60 6.75130015 4.16731821 0.61726158 -0.6960461 -3.7602775 0.00016972 0.00035251
ENSMUSG00000001930 Vwf 21.506693 14.041232 0.65287732 -0.6151162 -4.3344897 1.46E-05 5.64E-05
ENSMUSG00000000263 Glra1 15.2639653 9.98721738 0.65430032 -0.6119751 -3.9429449 8.05E-05 0.00019756
ENSMUSG00000035783 Acta2 3.90818207 2.58257516 0.6608124 -0.5976873 -2.933944 0.00334685 0.00602432
ENSMUSG00000032807 Alox12b 23.5542926 15.6416244 0.66406683 -0.5905997 -4.092013 4.28E-05 0.00011546
ENSMUSG00000095041 AC149090.1 12.5554664 19.3783814 1.54342187 0.62613245 4.28470211 1.83E-05 6.18E-05
ENSMUSG00000022831 Hcls1 16.9220369 26.3360933 1.55631933 0.63813811 4.85777572 1.19E-06 6.41E-06
ENSMUSG00000048096 Lmod1 2.81237164 4.44606163 1.58089407 0.6607407 2.47008817 0.01350798 0.02145384
ENSMUSG00000074384 AI429214 1.81677347 2.90256265 1.59764698 0.67594866 2.79705886 0.00515701 0.00870246
ENSMUSG00000054519 Zfp867 30.293658 48.4840852 1.60046981 0.67849547 4.17565259 2.97E-05 8.91E-05
ENSMUSG00000020914 Top2a 3.42683429 5.50255755 1.60572619 0.6832259 3.78440912 0.00015407 0.00034667
ENSMUSG00000028438 Kif24 7.49589942 12.2868328 1.63914056 0.71293957 4.69491406 2.67E-06 1.20E-05
ENSMUSG00000017737 Mmp9 0.67848622 1.22493522 1.8053944 0.85231404 2.21143422 0.02700578 0.03837664
ENSMUSG00000040148 Hmx3 1.71153712 3.33650787 1.94942186 0.96304633 3.6650732 0.00024727 0.00047687
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Table A.2 DTGs and associated statistics for TgMMP9
Ensembl gene ID Gene symbol log2 FC TE p-value TE ratio FDR
ENSMUSG00000060288 Ppih -4.564431125 0.01996982 0.20693609 0.0798793
ENSMUSG00000028188 Spata1 -3.164204193 0.03264199 0.28091842 0.09545801
ENSMUSG00000055523 Gucy2g -2.421900655 0.0302616 0.33517666 0.09545801
ENSMUSG00000038843 Gcnt1 -1.136568901 0.00651624 0.4720283 0.05616479
ENSMUSG00000074384 AI429214 -1.030955796 0.00048576 0.50016423 0.02013618
ENSMUSG00000023336 Wfdc1 -0.85686031 0.00670953 0.54081543 0.05616479
ENSMUSG00000101972 Hist1h3i -0.824865678 0.00640628 0.54947697 0.05616479
ENSMUSG00000032478 Nme6 -0.791423349 0.01810786 0.56685843 0.07860338
ENSMUSG00000020914 Top2a -0.790425982 0.00826101 0.53850065 0.05664695
ENSMUSG00000039552 Rsph4a -0.741482927 0.00145117 0.58819714 0.02968006
ENSMUSG00000029659 Medag -0.734425238 0.03575759 0.58965649 0.09545801
ENSMUSG00000027115 Kif18a -0.713407083 0.03412168 0.64982452 0.09545801
ENSMUSG00000048865 Arhgap30 -0.701483911 0.02516476 0.6213438 0.0902481
ENSMUSG00000046561 Arsj -0.69596296 0.04735762 0.61438456 0.10332572
ENSMUSG00000029499 Pxmp2 -0.659632377 0.01150387 0.62073319 0.05828869
ENSMUSG00000078853 Igtp -0.652149826 0.0110897 0.6425648 0.05828869
ENSMUSG00000052384 Nrros -0.6218521 0.03597676 0.64118497 0.09545801
ENSMUSG00000025504 Eps8l2 -0.620737077 0.01273213 0.64598794 0.05828869
ENSMUSG00000055027 Smyd1 -0.615771187 0.02632236 0.64175703 0.0902481
ENSMUSG00000095041 AC149090.1 -0.614801712 0.0467194 0.60508015 0.10332572
ENSMUSG00000030725 Lipt2 -0.610834812 0.03508937 0.64906739 0.09545801
ENSMUSG00000031382 Asb11 -0.537798974 0.01883206 0.66102068 0.07860338
ENSMUSG00000034164 Emid1 0.5461177 0.04176425 1.51226637 0.10019018
ENSMUSG00000064080 Fbln2 0.561293077 0.03443414 1.52561169 0.09545801
ENSMUSG00000006471 Ndor1 0.564903842 0.04486058 1.58868591 0.10253848
ENSMUSG00000066721 Zfp575 0.588438673 0.02628385 1.57209698 0.0902481
ENSMUSG00000091712 Sec14l5 0.628242419 0.00216417 1.55403737 0.02968006
ENSMUSG00000073565 Prr16 0.633430105 0.03151809 1.60069609 0.09545801
ENSMUSG00000091604 Gm17349 0.640367408 0.03679111 1.50903877 0.09545801
ENSMUSG00000069270 Hist1h2ac 0.655952145 0.04278956 1.52908879 0.10019018
ENSMUSG00000020090 Npffr1 0.660521397 0.04268853 1.58303726 0.10019018
ENSMUSG00000074918 Inafm2 0.668372339 0.00062926 1.55602186 0.02013618
ENSMUSG00000033788 Dysf 0.673860636 0.01275065 1.53204451 0.05828869
ENSMUSG00000049571 Cfap46 0.68569214 0.02325861 1.72292619 0.08931305
ENSMUSG00000040616 Tmem51 0.727488976 0.00793152 1.66377792 0.05664695
ENSMUSG00000030795 Fus 0.759998768 0.00060642 1.70827484 0.02013618
ENSMUSG00000003418 St8sia6 0.779374788 0.00189188 1.76358674 0.02968006
ENSMUSG00000024451 Arap3 0.789752652 0.01008332 1.6798259 0.05828869
ENSMUSG00000032807 Alox12b 0.804363309 0.00657328 1.76823008 0.05616479
ENSMUSG00000090958 Lrrc32 0.836408166 0.01040115 1.72431509 0.05828869
ENSMUSG00000050382 Kif7 0.956948028 0.01238913 1.97915808 0.05828869
ENSMUSG00000035299 Mid1 1.067274176 0.00197746 1.97501717 0.02968006
ENSMUSG00000048174 Tmem81 1.313918659 0.0070206 2.36476446 0.05616479
ENSMUSG00000093806 Asmt 1.534341534 0.0414665 3.26053649 0.10019018
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Table A.3 DEGs and associated statistics for Fmr1KO
Ensembl gene ID Gene symbol avg Fmr1WT avg Fmr1KO Ratio log2 ratio z-score p-value FDR
ENSMUSG00000000838 Fmr1 771.6247368 175.183979 0.22703261 -2.1390286 -9.3397201 9.66E-21 3.67E-19
ENSMUSG00000044518 Foxe3 8.564011577 2.315084857 0.27032715 -1.8872217 -8.0587519 7.71E-16 1.46E-14
ENSMUSG00000035383 Pmch 0.308564612 0.148521547 0.48133046 -1.0549004 -2.1219173 0.03384468 0.05144391
ENSMUSG00000093806 Asmt 20.3600044 11.31369201 0.5556822 -0.8476681 -5.2075379 1.91E-07 1.82E-06
ENSMUSG00000091898 Tnnc1 4.20625246 2.372933029 0.56414422 -0.8258641 -3.3966682 0.00068212 0.00152473
ENSMUSG00000020673 Tpo 5.051014739 2.920863736 0.57827266 -0.7901782 -3.5891208 0.0003318 0.00078801
ENSMUSG00000036198 Arhgap36 2.779074749 1.617817819 0.58214261 -0.7805555 -3.2291731 0.00124149 0.00248297
ENSMUSG00000070564 Ntn5 6.424132937 3.788060789 0.58966102 -0.7620423 -4.5496383 5.37E-06 2.27E-05
ENSMUSG00000056999 Ide 12.04163186 7.216150352 0.59926681 -0.7387296 -4.9048946 9.35E-07 5.79E-06
ENSMUSG00000063681 Crb1 1.25256424 0.750702398 0.59933245 -0.7385716 -2.0704787 0.03840754 0.0561341
ENSMUSG00000002324 Rec8 16.43806247 9.929431204 0.60405119 -0.7272573 -4.6729044 2.97E-06 1.41E-05
ENSMUSG00000038805 Six3 11.19120771 6.845145465 0.61165387 -0.7092126 -4.1337786 3.57E-05 0.0001356
ENSMUSG00000072812 Ahnak2 2.207451869 1.358138766 0.61525181 -0.7007511 -3.0308548 0.00243863 0.00441275
ENSMUSG00000057751 Megf6 2.344761338 1.443185919 0.61549374 -0.7001839 -2.7970609 0.00515698 0.00852023
ENSMUSG00000048772 Tmem53 1.085038961 0.668746933 0.61633449 -0.6982146 -2.1784826 0.02937013 0.0465027
ENSMUSG00000041679 Lrrc29 16.09215714 9.949927507 0.61830912 -0.6935998 -4.0912617 4.29E-05 0.00014821
ENSMUSG00000038550 Ciart 1.569368812 0.982263863 0.6258974 -0.6760019 -2.0177003 0.04362249 0.05931238
ENSMUSG00000020891 Alox8 1.558073232 0.985933521 0.63279023 -0.6602008 -1.9646793 0.04945137 0.06479834
ENSMUSG00000090667 Gm765 17.97394627 11.3865189 0.63350133 -0.6585804 -4.0013584 6.30E-05 0.0001841
ENSMUSG00000022602 Arc 26.94283863 17.11100881 0.6350856 -0.654977 -5.4683157 4.54E-08 5.75E-07
ENSMUSG00000044912 Syt16 11.92611235 7.644160525 0.64095996 -0.6416939 -4.0202863 5.81E-05 0.00018407
ENSMUSG00000054667 Irs4 4.72591783 3.029196552 0.64097529 -0.6416594 -2.8952281 0.00378883 0.00654434
ENSMUSG00000050074 Spink8 9.206852567 5.943052753 0.6455032 -0.6315039 -3.5978433 0.00032087 0.00078801
ENSMUSG00000032511 Scn5a 48.41511417 31.61858019 0.65307251 -0.6146849 -4.8788922 1.07E-06 5.79E-06
ENSMUSG00000036357 Gpr101 9.52534019 6.235435855 0.65461556 -0.6112802 -3.3419324 0.00083197 0.00175639
ENSMUSG00000038775 Vill 9.978626361 6.591400038 0.66055184 -0.5982563 -3.8345168 0.00012581 0.00034149
ENSMUSG00000011171 Vipr2 1.276675227 2.213608861 1.73388565 0.79400876 3.06557067 0.00217255 0.00412785
ENSMUSG00000026579 F5 1.777194489 4.083202393 2.29755517 1.20009951 5.09753253 3.44E-07 2.62E-06
ENSMUSG00000001827 Folr1 0.034934261 0.087895439 2.51602398 1.33114567 2.01692003 0.04370386 0.05931238
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Table A.4 DTGs and associated statistics for Fmr1KO
Ensembl gene ID Gene symbol log2 FC TE p-value TE ratio FDR
ENSMUSG00000000838 Fmr1 -1.1964779 2.35E-14 0.43205818 3.58E-12
ENSMUSG00000069917 Hba-a2 -0.9572793 0.01430241 0.51572763 0.10148363
ENSMUSG00000033307 Mif -0.8539936 0.00298833 0.5424435 0.06055493
ENSMUSG00000041736 Tspo -0.7727913 0.02123128 0.55153324 0.12206254
ENSMUSG00000022969 Il10rb -0.78332 0.01338087 0.56690428 0.10148363
ENSMUSG00000025794 Rpl14 -0.8547736 0.00029657 0.57345138 0.01126957
ENSMUSG00000060708 Bloc1s4 -0.6577806 0.01370417 0.59513522 0.10148363
ENSMUSG00000007877 Tcap -0.7143553 0.02060953 0.60253582 0.12206254
ENSMUSG00000040681 Hmgn1 -0.772124 0.02910577 0.60443114 0.14746922
ENSMUSG00000029994 Anxa4 -0.7200395 0.00651209 0.61355937 0.08495948
ENSMUSG00000030042 Pole4 -0.6503158 0.00726627 0.61697337 0.08495948
ENSMUSG00000063897 CAAA01118383.1 -0.6161239 0.00724439 0.63642828 0.08495948
ENSMUSG00000007833 Aldh16a1 -0.6299192 0.00889073 0.64042334 0.09397368
ENSMUSG00000032959 Pebp1 -0.6062976 7.79E-05 0.6469305 0.00394545
ENSMUSG00000030681 Mvp -0.5811201 0.01602555 0.64717607 0.10149518
ENSMUSG00000056895 Hist3h2ba -0.5280245 0.01532034 0.65228155 0.10148363
ENSMUSG00000024048 Myl12a -0.5843734 0.00414018 0.65378825 0.06293079
ENSMUSG00000025492 Ifitm3 -0.5870171 0.03199838 0.66188033 0.15689527
ENSMUSG00000022559 Fbxl6 -0.6580876 0.0031786 0.6651256 0.06055493
ENSMUSG00000025290 Rps24 0.55333758 0.00348541 1.50168551 0.06055493
ENSMUSG00000089665 Fcor 0.6103239 0.01175737 1.53610428 0.0992845
ENSMUSG00000027230 Creb3l1 0.61816384 0.04940182 1.54479656 0.21454507
ENSMUSG00000060568 Fam78b 0.63791306 0.00927372 1.59386307 0.09397368
ENSMUSG00000079018 Ly6c1 0.62166696 0.03753684 1.59618506 0.17829998
ENSMUSG00000001930 Vwf 0.72776962 0.00280435 1.60781727 0.06055493
ENSMUSG00000034595 Ppp1r18 0.72843563 0.01078101 1.64211941 0.0963949
ENSMUSG00000064363 mt-Nd4 0.85185638 0.046435 1.83583386 0.21388243
ENSMUSG00000044461 Shisa2 0.977416 0.02339739 1.83974133 0.12263461
ENSMUSG00000037725 Ckap2 0.89312292 0.0232463 1.84015102 0.12263461
ENSMUSG00000002603 Tgfb1 0.93726161 0.00358549 1.85361069 0.06055493
ENSMUSG00000063681 Crb1 0.86351473 0.04909519 1.85813354 0.21454507
ENSMUSG00000074802 Gas2l3 0.90634822 0.01046225 1.89052542 0.0963949
ENSMUSG00000003166 Dgcr2 1.22745157 0.01535608 2.23028448 0.10148363
ENSMUSG00000056656 Apol8 1.84358127 0.02168216 2.64474164 0.12206254
ENSMUSG00000044518 Foxe3 3.98721971 1.01E-05 13.0199853 0.00076718
Appendix B
Table B.1 DTGs and associated TE values and fold changes for 4EKi
Ensembl Gene ID Gene symbol log2 FC TE TE ratio
ENSMUSG00000021342 Prl -7.10410239 0.00726862
ENSMUSG00000020713 Gh -7.06399226 0.00747354
ENSMUSG00000027483 Bpifa1 -2.51783099 0.17460527
ENSMUSG00000006574 Slc4a1 -2.06452484 0.23906505
ENSMUSG00000024871 Doc2g -1.95741528 0.25748936
ENSMUSG00000022483 Col2a1 -1.7107256 0.30550638
ENSMUSG00000032496 Ltf -1.67950063 0.31219068
ENSMUSG00000020125 Elane -1.61310061 0.32689504
ENSMUSG00000029306 Ibsp -1.42309735 0.37291084
ENSMUSG00000032484 Ngp -1.41774774 0.37429619
ENSMUSG00000002249 Tead3 -1.40985878 0.37634852
ENSMUSG00000002249 Tead3 -1.40964812 0.37640348
ENSMUSG00000021803 Cdhr1 -1.26807454 0.41521356
ENSMUSG00000027073 Prg2 -1.24868388 0.42083194
ENSMUSG00000056071 S100a9 -1.21232962 0.43157116
ENSMUSG00000001435 Col18a1 -1.17150985 0.44395647
ENSMUSG00000034664 Itga2b -1.15254287 0.44983167
ENSMUSG00000001348 Acp5 -1.13719817 0.45464167
ENSMUSG00000026822 Lcn2 -1.09574874 0.46789323
ENSMUSG00000020660 Pomc -1.09025107 0.46967963
ENSMUSG00000025420 Katnal2 -1.06384532 0.47835536
ENSMUSG00000066842 Hmcn1 -1.0137687 0.49525083
ENSMUSG00000018830 Myh11 -0.97005063 0.51048815
ENSMUSG00000031962 Cdh15 -0.96281133 0.51305617
ENSMUSG00000001473 Tubb6 -0.93314287 0.5237162
ENSMUSG00000024421 Lama3 -0.93111283 0.52445365
ENSMUSG00000027966 Col11a1 -0.92809725 0.52555103
ENSMUSG00000048562 Sp8 -0.92468834 0.52679431
ENSMUSG00000069516 Lyz2 -0.92418963 0.52697644
ENSMUSG00000025504 Eps8l2 -0.92177546 0.52785901
ENSMUSG00000026579 F5 -0.91206064 0.5314255
ENSMUSG00000033257 Ttll4 -0.8842624 0.54176444
ENSMUSG00000028339 Col15a1 -0.87920122 0.54366836
ENSMUSG00000068394 Cep152 -0.87919479 0.54367078
ENSMUSG00000028268 Gbp3 -0.87026398 0.54704674
ENSMUSG00000026043 Col3a1 -0.85972281 0.55105843
ENSMUSG00000064080 Fbln2 -0.8474209 0.55577741
ENSMUSG00000024164 C3 -0.83816551 0.55935438
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Ensembl Gene ID Gene symbol log2 FC TE TE ratio
ENSMUSG00000038058 Nod1 -0.83227552 0.56164268
ENSMUSG00000021069 Pygl -0.82500919 0.56447861
ENSMUSG00000015950 Ncf1 -0.82326552 0.56516126
ENSMUSG00000042997 Nhlrc3 -0.81775675 0.56732339
ENSMUSG00000035021 Baz1a -0.81651575 0.56781161
ENSMUSG00000014773 Dll1 -0.81558598 0.56817766
ENSMUSG00000042540 Acot5 -0.81545012 0.56823117
ENSMUSG00000001506 Col1a1 -0.80965454 0.57051846
ENSMUSG00000028364 Tnc -0.80953613 0.57056528
ENSMUSG00000002055 Spag5 -0.79804384 0.57512847
ENSMUSG00000074818 Pdzd7 -0.79527639 0.57623277
ENSMUSG00000035576 L3mbtl1 -0.79369605 0.57686433
ENSMUSG00000017737 Mmp9 -0.79170596 0.57766062
ENSMUSG00000020527 Myo19 -0.79163751 0.57768802
ENSMUSG00000041741 Pde3a -0.79062226 0.5780947
ENSMUSG00000055541 Lair1 -0.78925777 0.57864171
ENSMUSG00000054404 Slfn5 -0.78811307 0.57910101
ENSMUSG00000009350 Mpo -0.78571753 0.58006339
ENSMUSG00000031328 Flna -0.77956445 0.58254264
ENSMUSG00000052957 Gas1 -0.77102746 0.58599999
ENSMUSG00000030247 Kcnj8 -0.76946893 0.58663338
ENSMUSG00000004127 Trmt10a -0.76945073 0.58664078
ENSMUSG00000000555 Itga5 -0.76720044 0.58755653
ENSMUSG00000031004 Mki67 -0.76719123 0.58756028
ENSMUSG00000023066 Rttn -0.76680459 0.58771776
ENSMUSG00000100254 Trpc2 -0.76602789 0.58803426
ENSMUSG00000005225 Plekha8 -0.76554279 0.58823201
ENSMUSG00000024330 Col11a2 -0.76501505 0.58844723
ENSMUSG00000049538 Adamts16 -0.76430383 0.58873739
ENSMUSG00000037795 N4bp2 -0.76110741 0.59004324
ENSMUSG00000054889 Dsp -0.75548044 0.59234909
ENSMUSG00000030536 Iqgap1 -0.75176464 0.59387671
ENSMUSG00000071984 Fndc1 -0.74525502 0.59656241
ENSMUSG00000057969 Sema3b -0.742488 0.59770769
ENSMUSG00000018143 Mafk -0.73967504 0.59887423
ENSMUSG00000025077 Dclre1a -0.73781862 0.59964534
ENSMUSG00000032175 Tyk2 -0.73513652 0.60076117
ENSMUSG00000068114 Ccdc134 -0.73506893 0.60078932
ENSMUSG00000021260 Hhipl1 -0.73405451 0.60121191
ENSMUSG00000030528 Blm -0.7339676 0.60124813
ENSMUSG00000045903 Npas4 -0.73288448 0.60169969
ENSMUSG00000014039 Prdm15 -0.73144103 0.60230201
ENSMUSG00000030417 Pdcd5 -0.73014683 0.60284256
ENSMUSG00000021754 Map3k1 -0.72626263 0.60446779
ENSMUSG00000004609 Cd33 -0.72497629 0.60500699
ENSMUSG00000030055 Rab43 -0.72102877 0.60666468
ENSMUSG00000026104 Stat1 -0.7181271 0.60788609
ENSMUSG00000090946 Ccdc71l -0.71542143 0.6090272
ENSMUSG00000038506 Dcun1d2 -0.70959958 0.61148983
ENSMUSG00000025993 Slc40a1 -0.70583889 0.61308589
ENSMUSG00000037552 Plekhg2 -0.70582644 0.61309118
ENSMUSG00000021408 Ripk1 -0.70388333 0.61391749
ENSMUSG00000012640 Zfp715 -0.70154118 0.61491496
ENSMUSG00000026017 Carf -0.70117736 0.61507005
ENSMUSG00000036555 Iqce -0.70010042 0.61552936
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Ensembl Gene ID Gene symbol log2 FC TE TE ratio
ENSMUSG00000002814 Top3a -0.69885213 0.61606218
ENSMUSG00000039936 Pik3cd -0.69771252 0.61654901
ENSMUSG00000024186 Rgs11 -0.6957545 0.61738635
ENSMUSG00000027931 Npr1 -0.6943739 0.61797745
ENSMUSG00000039787 Cercam -0.69357056 0.61832166
ENSMUSG00000044906 4930503L19Rik -0.69195396 0.6190149
ENSMUSG00000049287 Iba57 -0.68917926 0.62020658
ENSMUSG00000037846 Rtkn2 -0.68810679 0.6206678
ENSMUSG00000051599 Pcdhb2 -0.68779671 0.62080122
ENSMUSG00000024135 Srbd1 -0.68678366 0.62123729
ENSMUSG00000048424 Ranbp3l -0.68498494 0.62201232
ENSMUSG00000037709 Fam13a -0.68440186 0.62226376
ENSMUSG00000032202 Rab27a -0.68134788 0.6235824
ENSMUSG00000004891 Nes -0.67815137 0.62496557
ENSMUSG00000026349 Ccnt2 -0.67728119 0.62534265
ENSMUSG00000002325 Irf9 -0.67604466 0.62587885
ENSMUSG00000029661 Col1a2 -0.6744137 0.62658681
ENSMUSG00000028776 Tinagl1 -0.66985346 0.62857053
ENSMUSG00000033453 Adamts15 -0.66981824 0.62858588
ENSMUSG00000024098 Twsg1 -0.66962745 0.62866901
ENSMUSG00000026784 Pdss1 -0.66946849 0.62873828
ENSMUSG00000030223 Ptpro -0.66714525 0.62975158
ENSMUSG00000033669 Zfp7 -0.66219606 0.63191567
ENSMUSG00000025815 Dhtkd1 -0.66168708 0.63213865
ENSMUSG00000015879 Fam184b -0.66091683 0.63247623
ENSMUSG00000005682 Pan2 -0.65815712 0.63368724
ENSMUSG00000037016 Frem2 -0.65802298 0.63374617
ENSMUSG00000031628 Casp3 -0.65709807 0.63415259
ENSMUSG00000027750 Postn -0.6496409 0.63743896
ENSMUSG00000033276 Stk36 -0.64924412 0.63761429
ENSMUSG00000022325 Pop1 -0.64910456 0.63767598
ENSMUSG00000046618 Olfml2a -0.64731702 0.63846657
ENSMUSG00000032332 Col12a1 -0.64137758 0.64110049
ENSMUSG00000035493 Tgfbi -0.64064597 0.64142568
ENSMUSG00000061898 Rbak -0.63840788 0.64242152
ENSMUSG00000040711 Sh3pxd2b -0.63774656 0.64271606
ENSMUSG00000028414 Fktn -0.6371243 0.64299334
ENSMUSG00000032511 Scn5a -0.63691239 0.64308779
ENSMUSG00000036036 Zfp57 -0.63428689 0.64425919
ENSMUSG00000031508 Ankrd10 -0.6336724 0.64453366
ENSMUSG00000036036 Zfp57 -0.633531 0.64459683
ENSMUSG00000035914 Cd276 -0.6281648 0.64699891
ENSMUSG00000024610 Cd74 -0.62810237 0.64702691
ENSMUSG00000021224 Numb -0.62464761 0.64857818
ENSMUSG00000035258 Abi3bp -0.62421031 0.6487748
ENSMUSG00000061517 Sox21 -0.6231718 0.64924198
ENSMUSG00000040690 Col16a1 -0.62262804 0.64948673
ENSMUSG00000068959 Zfp619 -0.62219948 0.64967969
ENSMUSG00000020482 Ccdc117 -0.61949102 0.65090052
ENSMUSG00000057722 Lepr -0.61935099 0.6509637
ENSMUSG00000057706 Mex3b -0.6175724 0.65176672
ENSMUSG00000037474 Dtl -0.6170708 0.65199337
ENSMUSG00000058402 Zfp420 -0.61552079 0.65269424
ENSMUSG00000020272 Stk10 -0.61524027 0.65282116
ENSMUSG00000042138 Msantd2 -0.61380747 0.65346983
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Ensembl Gene ID Gene symbol log2 FC TE TE ratio
ENSMUSG00000041911 Dlx1 -0.61013506 0.65513537
ENSMUSG00000032006 Pdgfd -0.61001017 0.65519208
ENSMUSG00000020649 Rrm2 -0.6096446 0.65535813
ENSMUSG00000030786 Itgam -0.60952838 0.65541092
ENSMUSG00000021203 Otub2 -0.60939973 0.65546937
ENSMUSG00000073700 Klhl21 -0.60903866 0.65563344
ENSMUSG00000046351 Zfp322a -0.60844892 0.6559015
ENSMUSG00000030322 Mbd4 -0.60775225 0.65621831
ENSMUSG00000054737 Zfp182 -0.60701094 0.65655558
ENSMUSG00000079038 D130040H23Rik -0.60599597 0.65701765
ENSMUSG00000067942 Zfp160 -0.60108158 0.65925953
ENSMUSG00000028927 Padi2 -0.60001129 0.65974879
ENSMUSG00000029253 Cenpc1 -0.59923284 0.66010488
ENSMUSG00000023088 Abcc1 -0.59912025 0.66015639
ENSMUSG00000056870 Gulp1 -0.59757938 0.66086185
ENSMUSG00000027361 Gabpb1 -0.59625424 0.66146914
ENSMUSG00000034160 Ogt -0.59573765 0.66170604
ENSMUSG00000015522 Arnt -0.5957246 0.66171202
ENSMUSG00000021203 Otub2 -0.59518304 0.66196046
ENSMUSG00000052446 Zfp961 -0.59422627 0.66239961
ENSMUSG00000015659 Serac1 -0.5933912 0.66278314
ENSMUSG00000026176 Ctdsp1 -0.59331431 0.66281846
ENSMUSG00000069135 Fgfr1op -0.59250049 0.66319246
ENSMUSG00000030671 Pde3b -0.59140999 0.66369394
ENSMUSG00000044548 Dact1 -0.59139418 0.66370121
ENSMUSG00000024236 Svil -0.59003328 0.66432758
ENSMUSG00000055065 Ddx17 -0.5875076 0.66549162
ENSMUSG00000071291 Zfp58 -0.58696841 0.66574038
ENSMUSG00000034845 Plvap -0.58676637 0.66583362
ENSMUSG00000022089 Bin3 -0.586497 0.66595795
ENSMUSG00000029701 Rbm28 -0.58644758 0.66598077
ENSMUSG00000009621 Vav2 -0.586264 0.66606552
ENSMUSG00000024968 Rcor2 -0.58449614 0.66688221
ENSMUSG00000031644 Nek1 -0.5843274 0.66696021
ENSMUSG00000016933 Plcg1 -0.58374724 0.66722847
ENSMUSG00000026193 Fn1 -0.583559 0.66731554
ENSMUSG00000035545 Leng8 -0.58331331 0.66742919
ENSMUSG00000041261 Car8 -0.58298056 0.66758315
ENSMUSG00000041353 Tmem29 -0.58274288 0.66769314
ENSMUSG00000028476 Reck -0.58086998 0.6685605
ENSMUSG00000025529 Zfp711 -0.58038289 0.66878626
ENSMUSG00000019846 Lama4 -0.58036571 0.66879422
ENSMUSG00000062116 Zfp954 -0.58033306 0.66880936
ENSMUSG00000058638 Zfp110 -0.57972065 0.66909332
ENSMUSG00000032528 Vipr1 -0.57841219 0.66970043
ENSMUSG00000041238 Rbbp8 -0.57810062 0.66984508
ENSMUSG00000060301 2610008E11Rik -0.57775806 0.67000415
ENSMUSG00000005397 Nid1 -0.57659997 0.6705422
ENSMUSG00000031174 Rpgr -0.57581064 0.67090917
ENSMUSG00000041731 Pgm5 -0.57518964 0.67119802
ENSMUSG00000031583 Wrn -0.57421156 0.67165321
ENSMUSG00000032743 D430042O09Rik -0.57349256 0.67198803
ENSMUSG00000029009 Mthfr -0.57228049 0.67255283
ENSMUSG00000040033 Stat2 -0.57225969 0.67256253
ENSMUSG00000033416 Gucd1 -0.57157704 0.67288085
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ENSMUSG00000044617 Zbtb39 -0.57117177 0.67306989
ENSMUSG00000001123 Lgals9 -0.57030238 0.67347562
ENSMUSG00000044982 Sft2d3 -0.56982515 0.67369843
ENSMUSG00000048939 Atp13a5 -0.56916525 0.67400666
ENSMUSG00000001521 Tulp3 -0.56635224 0.67532214
ENSMUSG00000060063 Alox5ap -0.56442844 0.67622326
ENSMUSG00000079215 Zfp664 -0.56380758 0.67651434
ENSMUSG00000048445 Ccdc57 -0.56373029 0.67655058
ENSMUSG00000027792 Bche -0.56363843 0.67659366
ENSMUSG00000026880 Stom -0.5631007 0.67684589
ENSMUSG00000032267 Usp28 -0.56173513 0.67748686
ENSMUSG00000058145 Adamts17 -0.56111292 0.67777911
ENSMUSG00000031986 Sprtn -0.56061086 0.67801502
ENSMUSG00000015522 Arnt -0.55964451 0.67846932
ENSMUSG00000032303 Chrna3 -0.55940801 0.67858055
ENSMUSG00000003752 Itpkc -0.55880748 0.67886307
ENSMUSG00000020788 Atp2a3 -0.55794628 0.67926844
ENSMUSG00000063564 Col23a1 -0.55464896 0.6808227
ENSMUSG00000039632 Ccdc151 -0.55401985 0.68111965
ENSMUSG00000074483 Bglap -0.55372882 0.68125706
ENSMUSG00000016487 Ppfibp1 -0.55340971 0.68140776
ENSMUSG00000016487 Ppfibp1 -0.55323124 0.68149207
ENSMUSG00000020019 Ntn4 -0.5527281 0.68172977
ENSMUSG00000027676 Ccdc39 -0.55138312 0.68236563
ENSMUSG00000021706 Zfyve16 -0.55113225 0.68248429
ENSMUSG00000027111 Itga6 -0.54978956 0.68311977
ENSMUSG00000017969 Ptgis -0.54868434 0.68364329
ENSMUSG00000050600 Zfp831 -0.54803861 0.68394935
ENSMUSG00000003865 Gys1 -0.54736621 0.68426819
ENSMUSG00000052551 Adarb2 -0.54733221 0.68428432
ENSMUSG00000016087 Fli1 -0.54722961 0.68433298
ENSMUSG00000034009 Rxfp1 -0.54562512 0.68509449
ENSMUSG00000028597 Gpx7 -0.54463408 0.68556527
ENSMUSG00000002617 Zfp40 -0.54456536 0.68559792
ENSMUSG00000026648 Dclre1c -0.5438777 0.68592479
ENSMUSG00000022335 Zfat -0.54241104 0.68662246
ENSMUSG00000038705 Gmeb2 -0.54112217 0.68723615
ENSMUSG00000002835 Chaf1a -0.54069037 0.68744187
ENSMUSG00000027253 Lrp4 -0.54009826 0.68772407
ENSMUSG00000045934 Mtmr11 -0.54008098 0.6877323
ENSMUSG00000030607 Acan -0.53994341 0.68779789
ENSMUSG00000021806 Nid2 -0.53914331 0.68817944
ENSMUSG00000031285 Dcx -0.53773044 0.68885372
ENSMUSG00000031239 Itm2a -0.53731055 0.68905424
ENSMUSG00000056673 Kdm5d -0.53588977 0.68973316
ENSMUSG00000001098 Kctd10 -0.53561527 0.68986441
ENSMUSG00000031502 Col4a1 -0.53480497 0.69025198
ENSMUSG00000020128 Vps54 -0.53467956 0.69031199
ENSMUSG00000017550 Atad5 -0.53414093 0.69056976
ENSMUSG00000020263 Appl2 -0.53412163 0.690579
ENSMUSG00000026655 Fam107b -0.53343704 0.69090677
ENSMUSG00000050973 Gdpgp1 -0.53272638 0.69124719
ENSMUSG00000033083 Tbc1d4 -0.53255473 0.69132944
ENSMUSG00000020674 Pxdn -0.53054707 0.69229217
ENSMUSG00000049232 Tigd2 -0.53033997 0.69239155
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ENSMUSG00000028078 Dclk2 -0.52953225 0.69277931
ENSMUSG00000041180 Hectd2 -0.52845712 0.69329578
ENSMUSG00000042476 Abcb4 -0.52816274 0.69343726
ENSMUSG00000029283 Cdc7 -0.52751748 0.69374748
ENSMUSG00000030243 Recql -0.5274531 0.69377843
ENSMUSG00000042793 Lgr6 -0.52653488 0.69422014
ENSMUSG00000025982 Sf3b1 -0.52610865 0.69442527
ENSMUSG00000002870 Mcm2 -0.52599337 0.69448076
ENSMUSG00000006958 Chrd -0.52592688 0.69451277
ENSMUSG00000024451 Arap3 -0.52544186 0.69474629
ENSMUSG00000040624 Plekhg1 -0.52470056 0.69510337
ENSMUSG00000004105 Angptl2 -0.52400812 0.69543707
ENSMUSG00000036103 Colec12 -0.52356389 0.69565124
ENSMUSG00000020218 Wif1 -0.52312535 0.69586273
ENSMUSG00000030093 Wnt7a -0.52216788 0.69632471
ENSMUSG00000033740 St18 -0.5216239 0.69658731
ENSMUSG00000050846 Zfp623 -0.52160489 0.69659649
ENSMUSG00000028073 Pear1 -0.5204282 0.69716488
ENSMUSG00000044033 Ccdc141 -0.51914131 0.69778703
ENSMUSG00000020140 Lgr5 -0.51872441 0.6979887
ENSMUSG00000027778 Ift80 -0.51690027 0.6988718
ENSMUSG00000027677 Ttc14 -0.51568967 0.69945848
ENSMUSG00000025821 Zfp282 -0.5151204 0.69973453
ENSMUSG00000019986 Ahi1 -0.51509557 0.69974658
ENSMUSG00000038323 1700066M21Rik -0.51482623 0.69987723
ENSMUSG00000001119 Col6a1 -0.51339458 0.70057209
ENSMUSG00000028391 Wdr31 -0.51314551 0.70069305
ENSMUSG00000037108 Zcwpw1 -0.5126305 0.70094322
ENSMUSG00000029122 Evc -0.51123562 0.70162127
ENSMUSG00000040373 Cacng5 -0.5108293 0.7018189
ENSMUSG00000037400 Atp11b -0.51022562 0.70211263
ENSMUSG00000067586 S1pr3 -0.51017253 0.70213847
ENSMUSG00000050315 Synpo2 -0.51013442 0.70215701
ENSMUSG00000047213 Ythdf3 -0.5095822 0.70242583
ENSMUSG00000023990 Tfeb -0.50858292 0.70291253
ENSMUSG00000038718 Pbx3 -0.50832978 0.70303588
ENSMUSG00000001998 Ap4e1 -0.50760622 0.70338856
ENSMUSG00000029290 Zfp326 -0.5067913 0.70378599
ENSMUSG00000064210 Ano6 -0.50580786 0.7042659
ENSMUSG00000025280 Polr3a -0.50561778 0.7043587
ENSMUSG00000024542 Cep192 -0.50541092 0.7044597
ENSMUSG00000013629 Cad -0.50454888 0.70488075
ENSMUSG00000036611 Eepd1 -0.50428159 0.70501136
ENSMUSG00000057367 Birc2 -0.50427966 0.7050123
ENSMUSG00000074282 Zfp94 -0.50340969 0.70543757
ENSMUSG00000045817 Zfp36l2 -0.50311105 0.70558361
ENSMUSG00000049878 Rlf -0.5029468 0.70566394
ENSMUSG00000025323 Sp4 -0.50257883 0.70584395
ENSMUSG00000074282 Zfp94 -0.50244175 0.70591102
ENSMUSG00000026395 Ptprc -0.50228837 0.70598607
ENSMUSG00000026097 Ormdl1 -0.50206971 0.70609308
ENSMUSG00000063550 Nup98 -0.50023146 0.70699334
ENSMUSG00000046572 Zfp518b -0.49925894 0.70747009
ENSMUSG00000051910 Sox6 -0.49881248 0.70768906
ENSMUSG00000027878 Notch2 -0.49881195 0.70768932
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ENSMUSG00000046982 Tshz1 -0.49827699 0.70795178
ENSMUSG00000046311 Zfp62 -0.49761011 0.70827911
ENSMUSG00000024451 Arap3 -0.49754526 0.70831095
ENSMUSG00000091387 Gcnt4 -0.4970758 0.70854147
ENSMUSG00000004626 Stxbp2 -0.49660876 0.70877088
ENSMUSG00000047793 Sned1 -0.49643116 0.70885814
ENSMUSG00000045689 Pcdhb4 -0.49479423 0.70966289
ENSMUSG00000030725 Lipt2 -0.49456569 0.70977531
ENSMUSG00000031337 Mtm1 -0.49407157 0.71001846
ENSMUSG00000052406 Rexo4 -0.49361439 0.71024349
ENSMUSG00000030249 Abcc9 -0.49350551 0.71029709
ENSMUSG00000027947 Il6ra -0.49263626 0.71072519
ENSMUSG00000035351 Nup37 -0.49255705 0.71076422
ENSMUSG00000047036 Zfp445 -0.49232669 0.71087771
ENSMUSG00000039789 Zfp597 -0.49231302 0.71088445
ENSMUSG00000020473 Aebp1 -0.49208398 0.71099732
ENSMUSG00000041215 Yeats2 -0.49180278 0.71113591
ENSMUSG00000028369 Svep1 -0.49134284 0.71136266
ENSMUSG00000044646 Zbtb7c -0.49129653 0.7113855
ENSMUSG00000022443 Myh9 -0.49062322 0.71171758
ENSMUSG00000028228 Cpne3 -0.4895052 0.71226934
ENSMUSG00000028496 Mllt3 -0.4894328 0.71230509
ENSMUSG00000032508 Myd88 -0.48937549 0.71233339
ENSMUSG00000020695 Mrc2 -0.48848264 0.71277437
ENSMUSG00000037010 Apln -0.48795888 0.71303318
ENSMUSG00000025198 Erlin1 -0.48774616 0.71313832
ENSMUSG00000046311 Zfp62 -0.4875746 0.71322313
ENSMUSG00000029913 Prdm5 -0.48752397 0.71324816
ENSMUSG00000021666 Gfm2 -0.4874471 0.71328617
ENSMUSG00000047773 Ankfn1 -0.48730441 0.71335672
ENSMUSG00000030339 Ltbr -0.4872984 0.71335969
ENSMUSG00000024789 Jak2 -0.48727762 0.71336997
ENSMUSG00000033486 Catsper2 -0.48702001 0.71349736
ENSMUSG00000018932 Map2k3 -0.48691532 0.71354914
ENSMUSG00000038836 Agbl3 -0.48633418 0.71383662
ENSMUSG00000038025 Phf2 -0.48608382 0.71396051
ENSMUSG00000071042 Rasgrp3 -0.4858701 0.71406628
ENSMUSG00000028995 Fam126a -0.48560841 0.71419582
ENSMUSG00000039062 Anpep -0.48554855 0.71422545
ENSMUSG00000020914 Top2a -0.48515081 0.71442238
ENSMUSG00000048039 Isg20l2 -0.485056 0.71446934
ENSMUSG00000002265 Peg3 -0.48452521 0.71473225
ENSMUSG00000008090 Fgfrl1 -0.48449396 0.71474773
ENSMUSG00000054237 Fra10ac1 -0.48442125 0.71478375
ENSMUSG00000045466 Zfp956 -0.48441829 0.71478522
ENSMUSG00000054387 Mdm4 -0.48428105 0.71485322
ENSMUSG00000034800 Zfp661 -0.48371596 0.71513327
ENSMUSG00000039286 Fndc3b -0.48320374 0.71538723
ENSMUSG00000025537 Phkg1 -0.48282326 0.71557592
ENSMUSG00000020412 Ascc2 -0.48266246 0.71565568
ENSMUSG00000043257 Pigv -0.48215042 0.71590973
ENSMUSG00000025220 Mgea5 -0.48210274 0.71593339
ENSMUSG00000038990 Cables2 -0.48017024 0.71689303
ENSMUSG00000040693 Slco4c1 -0.48014898 0.71690359
ENSMUSG00000026188 Tmem169 -0.48008459 0.71693559
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ENSMUSG00000060510 Zfp266 -0.47985905 0.71704767
ENSMUSG00000028389 Zfp37 -0.4798425 0.7170559
ENSMUSG00000036446 Lum -0.47837492 0.7177857
ENSMUSG00000102049 Zbed6 -0.47814657 0.71789932
ENSMUSG00000042496 Prdm10 -0.47771038 0.7181164
ENSMUSG00000048546 Tob2 -0.47577707 0.71907937
ENSMUSG00000056174 Col8a2 -0.47576895 0.71908342
ENSMUSG00000027678 Ncoa3 -0.4756526 0.71914141
ENSMUSG00000031434 Morc4 -0.4749211 0.71950614
ENSMUSG00000037286 Stag1 -0.47450375 0.71971431
ENSMUSG00000044783 Hjurp -0.47431285 0.71980955
ENSMUSG00000086596 Susd5 -0.47426176 0.71983504
ENSMUSG00000005410 Mcm5 -0.47406871 0.71993137
ENSMUSG00000025812 Pard3 -0.47352872 0.72020089
ENSMUSG00000025608 Podxl -0.47331945 0.72030536
ENSMUSG00000021256 Vash1 -0.47319434 0.72036783
ENSMUSG00000004661 Arid3b -0.47249064 0.72071929
ENSMUSG00000055737 Ghr -0.47234302 0.72079304
ENSMUSG00000032554 Trf -0.47206206 0.72093342
ENSMUSG00000038357 Camp -0.47193627 0.72099628
ENSMUSG00000016552 Foxred2 -0.47193099 0.72099892
ENSMUSG00000028273 Pdlim5 -0.47078267 0.72157304
ENSMUSG00000034987 Hrh2 -0.4706898 0.72161948
ENSMUSG00000029206 Nsun7 -0.47028753 0.72182073
ENSMUSG00000020700 Map3k3 -0.46992501 0.72200213
ENSMUSG00000019874 Fabp7 -0.46887665 0.72252697
ENSMUSG00000042548 Asxl1 -0.46849074 0.72272027
ENSMUSG00000016918 Sulf1 -0.46820795 0.72286195
ENSMUSG00000046020 Pofut1 -0.46774069 0.72309611
ENSMUSG00000025648 Pfkfb4 -0.46753152 0.72320095
ENSMUSG00000039831 Arhgap29 -0.46722509 0.72335458
ENSMUSG00000027889 Ampd2 -0.46668066 0.7236276
ENSMUSG00000048058 Ldlrad3 -0.46650833 0.72371404
ENSMUSG00000019794 Katna1 -0.46632979 0.72380361
ENSMUSG00000021311 Mtr -0.46614533 0.72389616
ENSMUSG00000055240 Zfp101 -0.46588678 0.72402591
ENSMUSG00000023972 Ptk7 -0.46583638 0.7240512
ENSMUSG00000022604 Cep97 -0.46542518 0.7242576
ENSMUSG00000031283 Chrdl1 -0.46535257 0.72429405
ENSMUSG00000025199 Chuk -0.46498824 0.72447698
ENSMUSG00000022677 Fopnl -0.46482696 0.72455798
ENSMUSG00000038342 Mlxip -0.46473677 0.72460327
ENSMUSG00000037174 Elf2 -0.46453381 0.72470522
ENSMUSG00000020363 Gfpt2 -0.46436272 0.72479117
ENSMUSG00000005553 Atp4a -0.46436113 0.72479197
ENSMUSG00000028864 Hgf -0.46411475 0.72491576
ENSMUSG00000059005 Hnrnpa3 -0.46392363 0.7250118
ENSMUSG00000025239 Limd1 -0.46312546 0.72541302
ENSMUSG00000001918 Slc1a5 -0.46262291 0.72566575
ENSMUSG00000020362 Cnot6 -0.46245059 0.72575243
ENSMUSG00000028164 Manba -0.46224416 0.72585628
ENSMUSG00000023886 Smoc2 -0.46181584 0.72607182
ENSMUSG00000059273 Zc3h4 -0.46162602 0.72616736
ENSMUSG00000030592 Ryr1 -0.46149396 0.72623383
ENSMUSG00000031885 Cbfb -0.46082666 0.72656982
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ENSMUSG00000027164 Traf6 -0.46058437 0.72669185
ENSMUSG00000033382 Trappc8 -0.46020822 0.72688134
ENSMUSG00000017491 Rarb -0.46005754 0.72695726
ENSMUSG00000029249 Rest -0.45994847 0.72701222
ENSMUSG00000024219 Anks1 -0.45978228 0.72709598
ENSMUSG00000076435 Acsf2 -0.45966003 0.72715759
ENSMUSG00000039254 Pomt1 -0.45920485 0.72738705
ENSMUSG00000055480 Zfp458 -0.45890271 0.7275394
ENSMUSG00000022610 Mapk12 -0.4583515 0.72781743
ENSMUSG00000078202 Nrarp -0.45833126 0.72782764
ENSMUSG00000036246 Gmip -0.45827932 0.72785384
ENSMUSG00000029131 Dnajb6 -0.4579587 0.72801562
ENSMUSG00000042104 Uggt2 -0.45769001 0.72815122
ENSMUSG00000000976 Heatr6 -0.45755124 0.72822126
ENSMUSG00000027829 Ccnl1 -0.45747432 0.72826009
ENSMUSG00000032409 Atr -0.45678065 0.72861033
ENSMUSG00000041702 Btbd7 -0.45644354 0.7287806
ENSMUSG00000048832 Vps37c -0.45635484 0.72882541
ENSMUSG00000034799 Unc13a -0.45613958 0.72893416
ENSMUSG00000030393 Zik1 -0.45578805 0.7291118
ENSMUSG00000030002 Dusp11 -0.45504203 0.72948892
ENSMUSG00000056014 A430033K04Rik -0.45462625 0.72969918
ENSMUSG00000039804 Ncoa5 -0.45448732 0.72976946
ENSMUSG00000030231 Plekha5 -0.45368389 0.73017598
ENSMUSG00000024908 Ppp6r3 -0.45301838 0.73051288
ENSMUSG00000003382 Etv3 -0.45288859 0.73057861
ENSMUSG00000020100 Slc29a3 -0.45288692 0.73057945
ENSMUSG00000002428 Hltf -0.45278994 0.73062857
ENSMUSG00000032582 Rbm6 -0.45271828 0.73066486
ENSMUSG00000042408 Zmym6 -0.45169951 0.731181
ENSMUSG00000024534 Sncaip -0.45138287 0.7313415
ENSMUSG00000025188 Hps1 -0.45127786 0.73139473
ENSMUSG00000026814 Eng -0.45089325 0.73158974
ENSMUSG00000032607 Amt -0.45075231 0.73166122
ENSMUSG00000037313 Tacc3 -0.45061565 0.73173053
ENSMUSG00000053907 Mat2a -0.45053483 0.73177152
ENSMUSG00000074220 Zfp382 -0.45045534 0.73181184
ENSMUSG00000042207 Kdm5b -0.44985542 0.73211621
ENSMUSG00000053965 Pde5a -0.44972374 0.73218304
ENSMUSG00000029401 Rilpl2 -0.4491898 0.73245407
ENSMUSG00000054051 Ercc6 -0.44917848 0.73245982
ENSMUSG00000037752 Xkr8 -0.4490704 0.73251469
ENSMUSG00000018819 Lsp1 -0.44877612 0.73266413
ENSMUSG00000066571 4931406P16Rik -0.4487143 0.73269552
ENSMUSG00000035649 Zcchc7 -0.44865301 0.73272665
ENSMUSG00000024169 Ift140 -0.44845476 0.73282734
ENSMUSG00000063810 Alms1 -0.448234 0.73293949
ENSMUSG00000063796 Slc22a8 -0.44809554 0.73300983
ENSMUSG00000028465 Tln1 -0.44780528 0.73315733
ENSMUSG00000021390 Ogn -0.44780374 0.73315811
ENSMUSG00000026220 Slc16a14 -0.44743468 0.73334568
ENSMUSG00000026240 Cops7b -0.44743322 0.73334642
ENSMUSG00000021240 Abcd4 -0.44739346 0.73336663
ENSMUSG00000035293 G2e3 -0.44730892 0.73340961
ENSMUSG00000032911 Cspg4 -0.44707893 0.73352654
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ENSMUSG00000071256 Zfp213 -0.44684322 0.7336464
ENSMUSG00000026404 Ddx59 -0.44668654 0.73372608
ENSMUSG00000028019 Pdgfc -0.44658395 0.73377825
ENSMUSG00000030098 Grip2 -0.44621827 0.73396427
ENSMUSG00000036334 Igsf10 -0.44605384 0.73404792
ENSMUSG00000009741 Ubp1 -0.44594114 0.73410527
ENSMUSG00000001062 Vps9d1 -0.44593189 0.73410997
ENSMUSG00000028456 Unc13b -0.44574592 0.73420461
ENSMUSG00000046637 Ttc34 -0.44522673 0.73446888
ENSMUSG00000026305 Lrrfip1 -0.44516183 0.73450192
ENSMUSG00000023015 Racgap1 -0.44513881 0.73451364
ENSMUSG00000032126 Hmbs -0.4446051 0.73478542
ENSMUSG00000026657 Frmd4a -0.44432755 0.73492679
ENSMUSG00000038080 Kdm1b -0.44356257 0.73531658
ENSMUSG00000022822 Abcc5 -0.44337543 0.73541197
ENSMUSG00000048347 Pcdhb18 -0.44302751 0.73558934
ENSMUSG00000040187 Arntl2 -0.44224645 0.73598769
ENSMUSG00000022960 Donson -0.44171463 0.73625905
ENSMUSG00000024620 Pdgfrb -0.44167703 0.73627824
ENSMUSG00000035161 Ints6 -0.44163587 0.73629925
ENSMUSG00000071267 Zfp942 -0.44155042 0.73634286
ENSMUSG00000024033 Rsph1 -0.44139927 0.73642001
ENSMUSG00000020781 Tsen54 -0.44139242 0.7364235
ENSMUSG00000031706 Rfx1 -0.44130208 0.73646962
ENSMUSG00000015839 Nfe2l2 -0.44070314 0.73677543
ENSMUSG00000028521 Slc35d1 -0.43972917 0.737273
ENSMUSG00000020717 Pecam1 -0.43928912 0.73749792
ENSMUSG00000025723 Nmb -0.43891014 0.73769168
ENSMUSG00000049791 Fzd4 -0.43881615 0.73773974
ENSMUSG00000020709 Adap2 -0.43860773 0.73784632
ENSMUSG00000029587 Zfp12 -0.43827745 0.73801526
ENSMUSG00000053950 Adnp2 -0.43827571 0.73801615
ENSMUSG00000039087 Rreb1 -0.4379202 0.73819804
ENSMUSG00000022948 Setd4 -0.43763294 0.73834503
ENSMUSG00000031825 Crispld2 -0.43743116 0.73844831
ENSMUSG00000117748 Chtf8 -0.4372543 0.73853884
ENSMUSG00000004655 Aqp1 -0.43714804 0.73859324
ENSMUSG00000023952 Gtpbp2 -0.43705713 0.73863978
ENSMUSG00000048503 Tmem136 -0.43688417 0.73872834
ENSMUSG00000022718 Dgcr8 -0.43679251 0.73877527
ENSMUSG00000032580 Rbm5 -0.43676248 0.73879066
ENSMUSG00000035595 1600002K03Rik -0.43653218 0.7389086
ENSMUSG00000038593 Tctn1 -0.43644449 0.73895351
ENSMUSG00000022865 Cxadr -0.43630466 0.73902514
ENSMUSG00000020312 Shc2 -0.43596666 0.7391983
ENSMUSG00000028082 Sh3d19 -0.43560126 0.73938554
ENSMUSG00000053347 Zfp943 -0.43518935 0.73959668
ENSMUSG00000020423 Btg2 -0.43497032 0.73970897
ENSMUSG00000019856 Fam184a -0.43426651 0.74006992
ENSMUSG00000003824 Syce2 -0.43394722 0.74023373
ENSMUSG00000024610 Cd74 -0.43364487 0.74038888
ENSMUSG00000031520 Vegfc -0.43359478 0.74041458
ENSMUSG00000075229 Ccdc58 -0.43339589 0.74051667
ENSMUSG00000057551 Zfp317 -0.43336463 0.74053271
ENSMUSG00000031134 Rbmx -0.4328118 0.74081653
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ENSMUSG00000030826 Bcat2 -0.43239511 0.74103053
ENSMUSG00000001305 Rrp15 -0.43178664 0.74134313
ENSMUSG00000038697 Taf5l -0.43145569 0.74151322
ENSMUSG00000030042 Pole4 -0.43112028 0.74168563
ENSMUSG00000091712 Sec14l5 -0.43104159 0.74172608
ENSMUSG00000054893 Zfp667 -0.43082852 0.74183564
ENSMUSG00000030929 Eri2 -0.43078687 0.74185705
ENSMUSG00000004099 Dnmt1 -0.4303884 0.74206198
ENSMUSG00000028212 Ccne2 -0.43030017 0.74210737
ENSMUSG00000022529 Zfp263 -0.43009722 0.74221177
ENSMUSG00000004677 Myo9b -0.42964178 0.74244611
ENSMUSG00000029174 Tbc1d1 -0.42952163 0.74250795
ENSMUSG00000004665 Cnn2 -0.42894782 0.74280333
ENSMUSG00000033991 Ttc37 -0.4288311 0.74286342
ENSMUSG00000031378 Abcd1 -0.42830614 0.74313378
ENSMUSG00000060862 Zbtb40 -0.42756282 0.74351677
ENSMUSG00000008200 Fnbp4 -0.42745378 0.74357296
ENSMUSG00000016520 Lnx2 -0.42709376 0.74375854
ENSMUSG00000025403 Shmt2 -0.42694082 0.7438374
ENSMUSG00000023951 Vegfa -0.42693229 0.74384179
ENSMUSG00000064023 Klk8 -0.42679662 0.74391175
ENSMUSG00000029635 Cdk8 -0.42676496 0.74392807
ENSMUSG00000032803 Cdv3 -0.42665024 0.74398723
ENSMUSG00000045912 C2cd4c -0.42634348 0.74414544
ENSMUSG00000030522 Mtmr10 -0.42582598 0.74441241
ENSMUSG00000026516 Nvl -0.42560804 0.74452488
ENSMUSG00000042099 Kank3 -0.42552874 0.7445658
ENSMUSG00000034485 Uaca -0.42530354 0.74468203
ENSMUSG00000060716 Plekhh1 -0.42489614 0.74489236
ENSMUSG00000070564 Ntn5 -0.42474726 0.74496923
ENSMUSG00000028653 Trit1 -0.42436228 0.74516805
ENSMUSG00000031928 Mre11a -0.42430847 0.74519584
ENSMUSG00000049728 Zfp668 -0.42400947 0.7453503
ENSMUSG00000060568 Fam78b -0.42399367 0.74535846
ENSMUSG00000029127 Zbtb49 -0.42344012 0.74564451
ENSMUSG00000039577 Nphp4 -0.42329163 0.74572125
ENSMUSG00000019813 Cep57l1 -0.42328825 0.745723
ENSMUSG00000034218 Atm -0.42242967 0.74616693
ENSMUSG00000020752 Recql5 -0.42238651 0.74618925
ENSMUSG00000000881 Dlg3 -0.42232312 0.74622204
ENSMUSG00000031665 Sall1 -0.42160341 0.7465944
ENSMUSG00000030727 Rabep2 -0.42120532 0.74680044
ENSMUSG00000024201 Kdm4b -0.42101863 0.74689708
ENSMUSG00000043572 Pars2 -0.42098378 0.74691513
ENSMUSG00000030616 Sytl2 -0.42077079 0.74702541
ENSMUSG00000067594 Krt77 -0.42064869 0.74708863
ENSMUSG00000050234 Gja4 -0.42046534 0.74718358
ENSMUSG00000029427 Zcchc8 -0.42045315 0.7471899
ENSMUSG00000032374 Plod2 -0.42011045 0.74736741
ENSMUSG00000058486 Wdr91 -0.41982157 0.74751707
ENSMUSG00000027217 Tspan18 -0.41971423 0.74757269
ENSMUSG00000004151 Etv1 -0.41970157 0.74757925
ENSMUSG00000020063 Sirt1 -0.41951241 0.74767728
ENSMUSG00000054383 Pnma1 -0.41944118 0.74771419
ENSMUSG00000026389 Steap3 -0.41924397 0.74781641
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ENSMUSG00000068115 Ninl -0.41911659 0.74788244
ENSMUSG00000051439 Cd14 -0.41856798 0.74816689
ENSMUSG00000022297 Fzd6 -0.41855529 0.74817347
ENSMUSG00000034617 Mtrr -0.41778773 0.74857163
ENSMUSG00000024477 Pggt1b -0.41744264 0.7487507
ENSMUSG00000032350 Gclc -0.4173505 0.74879852
ENSMUSG00000031503 Col4a2 -0.4172642 0.74884332
ENSMUSG00000051427 Ccdc157 -0.41725388 0.74884867
ENSMUSG00000034903 Cobll1 -0.41705964 0.74894951
ENSMUSG00000035671 Zswim4 -0.41693745 0.74901294
ENSMUSG00000035151 Elmod2 -0.41690405 0.74903028
ENSMUSG00000019961 Tmpo -0.41674685 0.7491119
ENSMUSG00000054770 Kctd18 -0.41647559 0.74925277
ENSMUSG00000032834 Pwp2 -0.41631652 0.74933538
ENSMUSG00000038010 Ccdc138 -0.41618802 0.74940213
ENSMUSG00000030757 Zkscan2 -0.4158249 0.74959077
ENSMUSG00000034738 Nostrin -0.41576072 0.74962412
ENSMUSG00000024659 Anxa1 -0.41546327 0.74977869
ENSMUSG00000039738 Slx4 -0.41542059 0.74980087
ENSMUSG00000018412 Kansl1 -0.41540046 0.74981134
ENSMUSG00000026354 Lct -0.41535895 0.74983291
ENSMUSG00000032750 Gab3 0.591126413 1.50642246
ENSMUSG00000023067 Cdkn1a 0.591983622 1.5073178
ENSMUSG00000101972 Hist1h3i 0.599934705 1.51564797
ENSMUSG00000039754 Alkbh4 0.606198985 1.52224332
ENSMUSG00000000693 Loxl3 0.615827294 1.5324365
ENSMUSG00000003545 Fosb 0.616586792 1.53324345
ENSMUSG00000037722 Gnpnat1 0.617368319 1.53407426
ENSMUSG00000052430 Bmpr1b 0.617821526 1.53455625
ENSMUSG00000026831 1700007K13Rik 0.625993062 1.54327275
ENSMUSG00000029878 Dbpht2 0.626392946 1.54370057
ENSMUSG00000046330 Rpl37a 0.628931076 1.54641879
ENSMUSG00000037805 Rpl10a 0.629131902 1.54663407
ENSMUSG00000040258 Nxph4 0.632254652 1.54998543
ENSMUSG00000049112 Oxtr 0.633192687 1.55099355
ENSMUSG00000026189 Pecr 0.635430009 1.55340069
ENSMUSG00000034401 Spata6 0.637216969 1.55532596
ENSMUSG00000105827 Hist2h2bb 0.642198334 1.5607055
ENSMUSG00000074218 Cox7a1 0.642734861 1.56128603
ENSMUSG00000077450 Rab11b 0.64686015 1.56575681
ENSMUSG00000020562 Efcab10 0.659365671 1.57938804
ENSMUSG00000043822 Adamtsl5 0.663525036 1.58394807
ENSMUSG00000068874 Selenbp1 0.664614389 1.58514453
ENSMUSG00000026495 Efcab2 0.666610385 1.58733913
ENSMUSG00000027401 Tgm3 0.669489387 1.59050994
ENSMUSG00000033318 Gstt2 0.670645157 1.59178464
ENSMUSG00000040219 Ttc12 0.681262718 1.60354264
ENSMUSG00000045471 Hcrt 0.70125423 1.6259177
ENSMUSG00000017404 Rpl19 0.701995909 1.62675378
ENSMUSG00000029084 Cd38 0.707178741 1.63260835
ENSMUSG00000031548 Sfrp1 0.711367757 1.63735569
ENSMUSG00000046834 Krt1 0.737289632 1.66704105
ENSMUSG00000047344 Lancl3 0.763175262 1.69722197
ENSMUSG00000043687 1190005I06Rik 0.783220776 1.7209686
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ENSMUSG00000022820 Ndufb4 0.799833661 1.74090039
ENSMUSG00000109523 Gdf1 0.812670876 1.75646019
ENSMUSG00000020930 Ccdc103 0.840118796 1.79019755
ENSMUSG00000055799 Tcf7l1 0.840235323 1.79034215
ENSMUSG00000044287 Nrn1l 0.854734296 1.80842566
ENSMUSG00000003436 Dll3 0.878756324 1.83878949
ENSMUSG00000071553 Cpa2 0.881453289 1.84223012
ENSMUSG00000000263 Glra1 0.8942031 1.85858298
ENSMUSG00000062997 Rpl35 0.899020045 1.86479888
ENSMUSG00000047109 Cldn14 1.147332996 2.21504037
ENSMUSG00000062825 Actg1 1.157169955 2.23019515
ENSMUSG00000001504 Irx2 1.173836838 2.2561091
ENSMUSG00000006764 Tph2 1.667413227 3.17644541
ENSMUSG00000090862 Rps13 2.410211774 5.31552347
ENSMUSG00000039728 Slc6a5 3.321074023 9.99408178
ENSMUSG00000020838 Slc6a4 3.467887672 11.0646635
Appendix C
Table C.1 DTGs and associated statistics for shock
Ensembl gene ID Gene symbol log2 FC TE p-value TE ratio FDR
ENSMUSG00000020673 Tpo -3.617752 0.00065065 0.01736025
ENSMUSG00000051413 Plagl2 -2.18277 0.04154927 0.23021329 0.16465107
ENSMUSG00000073427 Gm4924 -2.0032794 0.01555409 0.25439324 0.10538542
ENSMUSG00000032089 Il10ra -1.9468426 0.00685571 0.35674873 0.06637575
ENSMUSG00000054150 Syne3 -1.5833004 0.01570886 0.50039441 0.10538542
ENSMUSG00000021098 4930447C04Rik -1.5441764 0.03879356 0.34545096 0.15814409
ENSMUSG00000037225 Fgf2 -1.5371617 0.04671031 0.35332057 0.177666
ENSMUSG00000037295 Ldlrap1 -1.5355105 0.01567658 0.43004305 0.10538542
ENSMUSG00000040270 Bach2 -1.4551975 0.01072688 0.39800847 0.08621983
ENSMUSG00000029563 Foxp2 -1.3571073 0.00355983 0.41147195 0.04832865
ENSMUSG00000032215 Rsl24d1 -1.2009474 0.02046833 0.56626841 0.11897913
ENSMUSG00000035184 Fam124a -1.1717076 0.00081294 0.48754796 0.01923966
ENSMUSG00000031872 Bean1 -1.1381437 0.034472 0.46725977 0.15147108
ENSMUSG00000068617 Efcab1 -1.0623766 0.00874065 0.53236214 0.0752226
ENSMUSG00000030556 Lrrc28 -1.0515188 5.66E-06 0.50472929 0.00089131
ENSMUSG00000050315 Synpo2 -1.0500884 0.02076282 0.54320911 0.11897913
ENSMUSG00000032308 Ulk3 -1.019798 0.00780614 0.5089679 0.07096997
ENSMUSG00000037366 Pafah2 -0.9740293 0.04866577 0.52044997 0.17949452
ENSMUSG00000024856 Cdk2ap2 -0.9732957 0.00141833 0.55700624 0.02767031
ENSMUSG00000047044 D030056L22Rik -0.9651352 0.02604158 0.51917536 0.13446927
ENSMUSG00000044468 Fam46c -0.9578993 0.01412092 0.52531396 0.09942998
ENSMUSG00000046573 Lyrm4 -0.9565538 4.57E-06 0.52091653 0.00089131
ENSMUSG00000032381 Fam96a -0.9440983 0.02943274 0.54034969 0.14405562
ENSMUSG00000021023 1110008L16Rik -0.9372473 0.00225441 0.5551357 0.03624074
ENSMUSG00000029130 Rnf32 -0.9299234 0.0175606 0.53237818 0.1108269
ENSMUSG00000026110 Mgat4a -0.9295378 6.28E-06 0.53844986 0.00089131
ENSMUSG00000020669 Sh3yl1 -0.9274534 0.03712627 0.52955239 0.15505678
ENSMUSG00000039831 Arhgap29 -0.9116953 0.00433148 0.54179241 0.05197781
ENSMUSG00000012422 Tmem167 -0.8988259 0.00134269 0.5522463 0.02723739
ENSMUSG00000027130 Slc12a6 -0.8709196 0.01811383 0.55358495 0.1121355
ENSMUSG00000045519 Zfp560 -0.8261663 0.01101141 0.57482165 0.08686779
ENSMUSG00000002205 Vrk3 -0.8251077 0.00431486 0.61470328 0.05197781
ENSMUSG00000008393 Carhsp1 -0.8205531 0.01495188 0.57806313 0.10441806
ENSMUSG00000036446 Lum -0.8039762 0.01792261 0.57222883 0.1121355
ENSMUSG00000032038 St3gal4 -0.7908166 0.02461796 0.5903489 0.13158856
ENSMUSG00000055202 Zfp811 -0.7900755 0.03332178 0.58950033 0.14942186
ENSMUSG00000030110 Ret -0.786577 0.01510014 0.64026865 0.10459611
ENSMUSG00000038146 Notch3 -0.7861747 0.03297079 0.63249489 0.14863022
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ENSMUSG00000078713 Tomm5 -0.7831322 0.01068922 0.58783659 0.08621983
ENSMUSG00000033272 Slc35a4 -0.779016 0.02833641 0.59036152 0.14082934
ENSMUSG00000056258 Kcnq3 -0.7525845 2.21E-06 0.6055939 0.0006288
ENSMUSG00000047409 Ctdspl -0.7482537 0.03608503 0.60893095 0.15372224
ENSMUSG00000015879 Fam184b -0.7429586 0.02752422 0.60881486 0.13958712
ENSMUSG00000026227 2810459M11Rik -0.7248579 0.03194453 0.60872213 0.14568411
ENSMUSG00000048915 Efna5 -0.7244378 0.03527671 0.623164 0.15147108
ENSMUSG00000022751 Nit2 -0.7211196 0.03091227 0.66587881 0.14405562
ENSMUSG00000047786 Lix1 -0.717511 0.00010908 0.6179273 0.00619581
ENSMUSG00000062376 Borcs7 -0.7057825 0.02023442 0.63943267 0.11897913
ENSMUSG00000031309 Rps6ka3 -0.7047946 0.00065203 0.63620767 0.01736025
ENSMUSG00000021366 Hivep1 -0.6971192 0.00953257 0.63459564 0.07885195
ENSMUSG00000030615 Tmem126a -0.6930184 0.00513542 0.62708765 0.05833832
ENSMUSG00000026679 Enkur -0.692925 0.04983858 0.63872508 0.18297718
ENSMUSG00000000711 Rab5b -0.6894744 0.01293343 0.62918602 0.09418191
ENSMUSG00000037370 Enpp1 -0.687979 0.03220555 0.66120765 0.14595282
ENSMUSG00000026500 Cox20 -0.6841982 0.01617464 0.6313655 0.10600607
ENSMUSG00000002881 Nab1 -0.6772515 0.01977901 0.63273532 0.11897913
ENSMUSG00000036533 Cdc42ep3 -0.6664647 0.0171872 0.63949095 0.10927984
ENSMUSG00000033953 Ppp3r1 -0.6663489 1.75E-06 0.64156938 0.0006288
ENSMUSG00000028744 Pqlc2 -0.6586411 0.0486229 0.64429428 0.17949452
ENSMUSG00000033417 Cacul1 -0.6549375 0.00387554 0.67566281 0.0485582
ENSMUSG00000037936 Scarb1 -0.6523707 0.01529475 0.67503822 0.10508976
ENSMUSG00000047216 Cdh19 -0.651156 0.01849876 0.65033179 0.1133881
ENSMUSG00000064370 mt-Cytb -0.6506543 0.00024832 0.64415663 0.00881531
ENSMUSG00000049764 Zfp280b -0.6439039 0.04197443 0.65153427 0.1654864
ENSMUSG00000020309 Chac2 -0.6431582 0.03512668 0.67655243 0.15147108
ENSMUSG00000024027 Glp1r -0.6406111 0.03450499 0.67087733 0.15147108
ENSMUSG00000064363 mt-Nd4 -0.640591 0.01261877 0.66377707 0.09268266
ENSMUSG00000042229 Rabif -0.6393728 0.00081143 0.6548105 0.01923966
ENSMUSG00000051978 Erich1 -0.6376937 0.03047831 0.68942734 0.14405562
ENSMUSG00000061273 Mmgt1 -0.6346574 0.00167798 0.65686717 0.02978415
ENSMUSG00000028191 Bcl10 -0.6341577 0.03662462 0.65610899 0.15447612
ENSMUSG00000075486 Commd6 -0.6283082 0.00085725 0.65838497 0.01934394
ENSMUSG00000064345 mt-Nd2 -0.6272921 0.01927426 0.65141666 0.11729761
ENSMUSG00000051146 Camk2n2 -0.6246307 0.0003923 0.67004349 0.01336952
ENSMUSG00000038982 Bloc1s5 -0.6064126 0.02245804 0.66637914 0.12424839
ENSMUSG00000035849 Krt222 -0.6062158 0.00188432 0.66837378 0.03160118
ENSMUSG00000044148 1810030O07Rik -0.6056433 0.00561813 0.66971098 0.0606913
ENSMUSG00000069806 Cacng7 -0.5938456 0.00086276 0.68394624 0.01934394
ENSMUSG00000036402 Gng12 -0.5922243 0.00641968 0.68384703 0.06522401
ENSMUSG00000028617 Lrrc42 0.59400178 0.01661087 1.6125374 0.10721565
ENSMUSG00000056895 Hist3h2ba 0.59904272 0.03373205 1.50274978 0.14968596
ENSMUSG00000001521 Tulp3 0.60111854 0.02836709 1.54893123 0.14082934
ENSMUSG00000071528 Usmg5 0.6040308 0.00147445 1.55125001 0.02791617
ENSMUSG00000035278 Plekhj1 0.61226875 0.00532611 1.56625885 0.05893305
ENSMUSG00000040860 Crocc 0.61277429 0.00830756 1.56648316 0.07372963
ENSMUSG00000024309 Pfdn6 0.61467579 0.00020373 1.55418422 0.00774337
ENSMUSG00000036833 Pnpla7 0.61596305 0.02527497 1.55027573 0.13292764
ENSMUSG00000028410 Dnaja1 0.61812326 0.00644679 1.56273056 0.06522401
ENSMUSG00000009927 Rps25 0.62171048 0.02843034 1.66582619 0.14082934
ENSMUSG00000026632 Tatdn3 0.62609318 0.04707898 1.57934177 0.17782411
ENSMUSG00000015542 Nat9 0.64299618 0.0386536 1.62718834 0.15814409
ENSMUSG00000054708 Ankrd24 0.64578255 0.03082994 1.63475686 0.14405562
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ENSMUSG00000026034 Clk1 0.64603577 0.00257503 1.59072662 0.040557
ENSMUSG00000030137 Tuba8 0.64973291 0.03197527 1.6165548 0.14568411
ENSMUSG00000061207 Stk19 0.65069631 0.04214853 1.58106834 0.1654864
ENSMUSG00000042148 Cox10 0.65343713 0.02433272 1.61012014 0.13142668
ENSMUSG00000015023 Ddx19a 0.65938616 0.01659467 1.61611722 0.10721565
ENSMUSG00000026021 Sumo1 0.66396365 0.00142898 1.6082923 0.02767031
ENSMUSG00000037742 Eef1a1 0.67030322 8.05E-06 1.64397569 0.00096025
ENSMUSG00000022574 Naprt 0.67101792 0.04849349 1.62385835 0.17949452
ENSMUSG00000027422 Rrbp1 0.67292529 0.00056371 1.63300154 0.01600932
ENSMUSG00000027378 Nphp1 0.67426133 0.01212445 1.62609737 0.09171589
ENSMUSG00000001930 Vwf 0.67437614 0.0121642 1.62248573 0.09171589
ENSMUSG00000031883 Car7 0.67896616 0.03949733 1.62916744 0.15988383
ENSMUSG00000030450 Oca2 0.68477204 0.03872318 1.62504646 0.15814409
ENSMUSG00000087260 Lamtor5 0.71284256 0.02550933 1.69012805 0.13333712
ENSMUSG00000091405 Hist2h4 0.71329506 0.00078653 1.65093969 0.01923966
ENSMUSG00000090553 Snrpe 0.71456416 0.01993048 1.6927484 0.11897913
ENSMUSG00000062006 Rpl34 0.71468971 0.03027346 1.65156051 0.14405562
ENSMUSG00000015656 Hspa8 0.71760177 9.02E-06 1.72015384 0.00096025
ENSMUSG00000033862 Cdk10 0.73276132 0.02437255 1.67867211 0.13142668
ENSMUSG00000039105 Atp6v1g1 0.73601757 0.00650709 1.70252039 0.06522401
ENSMUSG00000035048 Anapc13 0.73749573 0.00402396 1.67803599 0.0496871
ENSMUSG00000026333 Gin1 0.73939504 0.01686042 1.69255101 0.10800813
ENSMUSG00000024732 Ccdc86 0.74152618 0.02074998 1.72500977 0.11897913
ENSMUSG00000025156 Gps1 0.74424141 0.03371138 1.76047601 0.14968596
ENSMUSG00000026566 Mpzl1 0.75609883 0.01232495 1.71004219 0.09211279
ENSMUSG00000021773 Comtd1 0.75611936 0.01395874 1.7081012 0.09910704
ENSMUSG00000064254 Ethe1 0.75761018 0.00938197 1.71461531 0.07836704
ENSMUSG00000071984 Fndc1 0.75963205 0.01023388 1.75081755 0.0838391
ENSMUSG00000057176 Ccdc189 0.77358362 0.04811423 1.72884506 0.17949452
ENSMUSG00000029404 Arl6ip4 0.77713972 0.003043 1.7465363 0.04394292
ENSMUSG00000024830 Rps6kb2 0.77990173 0.02006149 1.755864 0.11897913
ENSMUSG00000034889 Cactin 0.7902478 0.00916223 1.77930511 0.07806217
ENSMUSG00000063765 Chadl 0.80174978 0.0280156 1.73999549 0.14082934
ENSMUSG00000041841 Rpl37 0.80821511 0.03094152 1.80440507 0.14405562
ENSMUSG00000029049 Morn1 0.8205632 0.02511993 1.74786868 0.13292764
ENSMUSG00000031388 Naa10 0.83266197 0.00576628 1.81591707 0.0606913
ENSMUSG00000039759 Thap3 0.83680758 0.03006537 1.93170173 0.14405562
ENSMUSG00000107877 Gm43951 0.84120086 0.02571148 1.83771004 0.13357426
ENSMUSG00000020680 Taf15 0.85210051 0.00014912 1.83228886 0.00705854
ENSMUSG00000049751 Rpl36al 0.85416641 0.00761031 1.78998134 0.07047809
ENSMUSG00000046792 Zfp787 0.86653495 0.02433498 1.8547978 0.13142668
ENSMUSG00000035759 Bbs10 0.87001482 0.03537881 1.8626403 0.15147108
ENSMUSG00000016319 Slc25a5 0.91541154 4.63E-05 1.89544729 0.0031243
ENSMUSG00000031949 Adat1 0.92967721 0.02363369 1.92440378 0.12990906
ENSMUSG00000007440 Pcdha11 0.95759275 0.01323107 2.02601869 0.0955328
ENSMUSG00000024121 Atp6v0c 0.95821031 0.02114505 2.00106683 0.11897913
ENSMUSG00000039001 Rps21 0.96468231 0.00288818 1.99863995 0.04317071
ENSMUSG00000052374 Actn2 0.96516404 0.0073888 2.01726633 0.06917867
ENSMUSG00000060093 Hist1h4a 0.97581113 0.01387034 2.00438613 0.09910704
ENSMUSG00000023861 Mpc1 0.99888386 0.03649927 2.40328144 0.15447612
ENSMUSG00000101972 Hist1h3i 1.08260144 0.02098792 2.09073064 0.11897913
ENSMUSG00000061315 Naca 1.08458243 0.00054746 2.24893793 0.01600932
ENSMUSG00000039179 Tekt5 1.15989278 0.0067127 2.26667393 0.06578942
ENSMUSG00000045903 Npas4 1.18281207 0.00012239 2.39749099 0.0065172
ENSMUSG00000027360 Hdc 1.18411849 0.02033109 2.37196702 0.11897913
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ENSMUSG00000037266 Rsrp1 1.47878496 2.05E-29 2.8414 1.75E-26
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Table C.2 DTGs and associated statistics for CFC
Ensembl gene ID Gene symbol log2 FC TE p-value TE ratio FDR
ENSMUSG00000023159 Psg29 -6.2262903 0.04314977 0.33053106
ENSMUSG00000020673 Tpo -2.6698702 0.01313988 0.21023809
ENSMUSG00000020374 Rasgef1c -1.7937871 0.00905926 0.40784678 0.19042474
ENSMUSG00000035067 Xkr6 -1.3580433 0.02787854 0.38663624 0.29544429
ENSMUSG00000035184 Fam124a -1.2739209 0.00041743 0.4467533 0.06010944
ENSMUSG00000050315 Synpo2 -1.2616656 0.01040711 0.43876942 0.20388084
ENSMUSG00000062372 Otof -1.2193356 0.03943895 0.40237731 0.32785138
ENSMUSG00000038146 Notch3 -1.1634471 0.00271277 0.46281779 0.14935555
ENSMUSG00000037936 Scarb1 -1.1575633 3.68E-05 0.46434005 0.01588077
ENSMUSG00000034771 Tle2 -1.1510067 0.00262339 0.45235485 0.14935555
ENSMUSG00000039153 Runx2 -1.0440489 0.00524099 0.49687474 0.14935555
ENSMUSG00000028848 Gpn2 -1.0434147 0.03984305 0.49159172 0.32785138
ENSMUSG00000020914 Top2a -1.0221269 0.03894606 0.49434631 0.32785138
ENSMUSG00000110195 Pde2a -1.0037565 0.00205896 0.49190571 0.1368415
ENSMUSG00000019803 Nr2e1 -0.9768454 0.00018071 0.50653333 0.03903355
ENSMUSG00000031149 Praf2 -0.944592 0.00412237 0.51355986 0.14935555
ENSMUSG00000005949 Ctns -0.930225 0.00465958 0.56472696 0.14935555
ENSMUSG00000032308 Ulk3 -0.9028882 0.01308814 0.55116493 0.21023809
ENSMUSG00000002205 Vrk3 -0.8579277 0.00386162 0.58821709 0.14935555
ENSMUSG00000022194 Pabpn1 -0.8557817 0.02731306 0.51191315 0.29544429
ENSMUSG00000102206 Pcdha11 -0.8391648 0.04183974 0.55947664 0.33053106
ENSMUSG00000031196 F8 -0.8155063 0.04413383 0.57029624 0.33053106
ENSMUSG00000002983 Relb -0.8078747 0.02232338 0.56403873 0.29427512
ENSMUSG00000022098 Bmp1 -0.7980051 0.00107759 0.57293311 0.11265356
ENSMUSG00000024170 Telo2 -0.7795944 0.00130882 0.57642471 0.1130817
ENSMUSG00000037370 Enpp1 -0.7789996 0.04248057 0.57454432 0.33053106
ENSMUSG00000036820 Amdhd2 -0.7787194 0.0310293 0.61384833 0.30203566
ENSMUSG00000039824 Myl6b -0.7719903 0.04121707 0.59402877 0.33053106
ENSMUSG00000074405 Zfp865 -0.7499963 0.00535882 0.58866357 0.14935555
ENSMUSG00000050511 Oprd1 -0.7410161 0.0412376 0.59603504 0.33053106
ENSMUSG00000059552 Trp53 -0.7198707 0.00534075 0.60401998 0.14935555
ENSMUSG00000027777 Schip1 -0.719105 0.00727704 0.61849568 0.17464894
ENSMUSG00000039137 Whrn -0.7141203 0.02230195 0.61139491 0.29427512
ENSMUSG00000009995 Taz -0.7014611 0.0156908 0.6104483 0.23762621
ENSMUSG00000024856 Cdk2ap2 -0.6930992 0.02247935 0.66090056 0.29427512
ENSMUSG00000048796 Cyb561d1 -0.687836 0.03000744 0.60811184 0.2980049
ENSMUSG00000035545 Leng8 -0.6342135 0.00400717 0.62913505 0.14935555
ENSMUSG00000006456 Rbm14 -0.6059123 0.03434738 0.65280526 0.30315041
ENSMUSG00000015377 Dennd6b -0.6039434 0.01194161 0.65619413 0.20836388
ENSMUSG00000045083 Lingo2 -0.5953069 0.01595176 0.65517079 0.23762621
ENSMUSG00000063145 Bbs5 -0.5935867 0.00874055 0.65937951 0.19042474
ENSMUSG00000032246 Calml4 0.5929731 0.0069313 1.50306992 0.17110413
ENSMUSG00000055963 Triqk 0.61054622 0.03970877 1.55178144 0.32785138
ENSMUSG00000043716 Rpl7 0.62930297 0.03302978 1.52133698 0.30203566
ENSMUSG00000035910 Dcdc2a 0.62962378 0.03448669 1.54437091 0.30315041
ENSMUSG00000021716 Srek1ip1 0.6312135 0.00535796 1.53310213 0.14935555
ENSMUSG00000026021 Sumo1 0.63370225 0.00408794 1.54638425 0.14935555
ENSMUSG00000022364 Tbc1d31 0.6355712 0.04950783 1.53370948 0.3368092
ENSMUSG00000031980 Agt 0.63675046 0.01080903 1.53348732 0.20388084
ENSMUSG00000034566 Atp5h 0.64287186 0.00321552 1.5300344 0.14935555
ENSMUSG00000029557 Mrm2 0.6571988 0.02797575 1.5811072 0.29544429
ENSMUSG00000067367 Lyar 0.67302048 0.02764616 1.58514745 0.29544429
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ENSMUSG00000036834 Plch1 0.7014496 0.02600837 1.63446514 0.29544429
ENSMUSG00000046441 Cmtr2 0.70587952 0.04250671 1.63250538 0.33053106
ENSMUSG00000028494 Plin2 0.71050511 0.02859666 1.62390433 0.29544429
ENSMUSG00000038437 Mllt6 0.71231791 0.01104539 1.61622355 0.20388084
ENSMUSG00000039552 Rsph4a 0.72334493 0.04437686 1.60766841 0.33053106
ENSMUSG00000040822 1700123O20Rik 0.72812658 0.00421813 1.67119838 0.14935555
ENSMUSG00000021606 Ndufs6 0.72875632 0.00012245 1.64828477 0.03526589
ENSMUSG00000029249 Rest 0.73490282 0.02872317 1.63479067 0.29544429
ENSMUSG00000024079 Eif2ak2 0.74339196 0.02724764 1.69286567 0.29544429
ENSMUSG00000045903 Npas4 0.75355707 0.0272996 1.72899875 0.29544429
ENSMUSG00000046718 Bst2 0.76201549 0.02736035 1.7200181 0.29544429
ENSMUSG00000041323 Ak7 0.76313833 0.02939023 1.67239125 0.29544429
ENSMUSG00000043987 Cep164 0.77092752 0.03156144 1.70253154 0.30203566
ENSMUSG00000072949 Acot1 0.77889823 0.04790181 1.70107602 0.33568312
ENSMUSG00000026565 Pou2f1 0.79618469 0.04352108 1.72557913 0.33053106
ENSMUSG00000028081 Rps3a1 0.79847509 0.00445295 1.71919227 0.14935555
ENSMUSG00000036461 Elf1 0.84122584 0.0214233 1.77804324 0.29427512
ENSMUSG00000025362 Rps26 0.94136474 0.02514138 1.84422001 0.29544429
ENSMUSG00000008318 Relt 0.94902077 0.00589639 1.87695806 0.1543782
ENSMUSG00000025578 Cbx8 0.95431714 0.0019705 1.83535854 0.1368415
ENSMUSG00000041841 Rpl37 0.95676672 0.0121249 1.94834551 0.20836388
ENSMUSG00000040943 Tet2 0.96500141 0.00814702 1.95563148 0.19024383
ENSMUSG00000030922 Lyrm1 0.97865686 0.03277972 1.95528415 0.30203566
ENSMUSG00000055148 Klf2 1.00454628 0.04649168 1.98488657 0.33474011
ENSMUSG00000074698 Csnk2a1 1.00473079 0.03748036 1.95833871 0.32220766
ENSMUSG00000053093 Myh7 1.00948232 0.04856527 2.07118274 0.33568312
ENSMUSG00000037266 Rsrp1 1.02765508 9.16E-13 2.00781266 7.91E-10
ENSMUSG00000091537 Tma7 1.1904695 0.00117347 2.13697084 0.11265356
ENSMUSG00000026492 Tfb2m 1.2103635 0.04529655 2.33758378 0.33346643
ENSMUSG00000037752 Xkr8 1.89714576 0.00376591 3.27816031 0.14935555
ENSMUSG00000046364 Rpl27a 2.06672019 0.04554287 4.14587128 0.33346643
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Table C.3 DEGs and associated statistics for shock
Ensembl gene ID Gene symbol avg homecage avg shock only Ratio log2 ratio z-score p-value FDR
ENSMUSG00000027517 Ankrd60 1.49664375 0.23947912 0.16001077 -2.6437591 -6.6500193 2.93E-11 5.20E-09
ENSMUSG00000093806 Asmt 1.01033582 0.34187436 0.33837696 -1.5632968 -3.5462711 0.00039072 0.00554828
ENSMUSG00000038717 Atp5l 35.914678 16.7166203 0.46545371 -1.1032904 -3.7032747 0.00021283 0.0037716
ENSMUSG00000044518 Foxe3 1.57081092 0.76040049 0.48408149 -1.0466782 -2.677272 0.00742243 0.03647709
ENSMUSG00000062372 Otof 13.4813528 6.98955113 0.51846066 -0.9476936 -3.5318664 0.00041264 0.00563409
ENSMUSG00000024186 Rgs11 1.85091642 1.01738083 0.5496633 -0.8633799 -2.4327989 0.01498262 0.05540449
ENSMUSG00000041378 Cldn5 157.420008 88.4131595 0.56163864 -0.8322859 -3.9549622 7.65E-05 0.00198987
ENSMUSG00000040860 Crocc 140.464883 79.8051198 0.56814998 -0.8156563 -4.6152754 3.93E-06 0.00019909
ENSMUSG00000099583 Hist1h3d 9.41283483 5.37115031 0.57061984 -0.8093982 -3.379154 0.00072709 0.00860393
ENSMUSG00000053552 Ebf4 7.71236419 4.73569083 0.6140388 -0.7035983 -3.5704569 0.00035636 0.00527114
ENSMUSG00000107877 Gm43951 2.22414848 1.38001061 0.62046694 -0.6885737 -2.2153922 0.02673316 0.07300209
ENSMUSG00000047810 Ccdc88b 5.5421786 3.49105462 0.62990655 -0.6667903 -2.7517177 0.00592836 0.03394465
ENSMUSG00000044349 Snhg11 34.7975302 21.9778378 0.63159189 -0.6629354 -3.1926644 0.00140967 0.01283158
ENSMUSG00000042401 Crtac1 5.50453985 3.47871741 0.63197243 -0.6620665 -2.7316082 0.0063026 0.03442192
ENSMUSG00000031503 Col4a2 77.5216481 49.1363982 0.63384099 -0.6578071 -2.686943 0.00721093 0.03647709
ENSMUSG00000022574 Naprt 0.49609978 0.315522 0.63600511 -0.6528897 -2.0343219 0.04191915 0.08946265
ENSMUSG00000011751 Sptbn4 236.632157 153.250671 0.64763248 -0.6267527 -3.3901441 0.00069856 0.00855133
ENSMUSG00000062997 Rpl35 9.75040704 6.38761913 0.65511307 -0.6101842 -2.6059276 0.00916258 0.03966728
ENSMUSG00000063511 Snrnp70 74.0454876 48.5708198 0.65595921 -0.608322 -2.5962689 0.00942423 0.04030844
ENSMUSG00000007440 Pcdha11 11.3017135 7.49656222 0.66331201 -0.5922405 -2.9100551 0.00361365 0.02467012
ENSMUSG00000034616 Ssh3 25.672315 17.0374487 0.66365066 -0.5915041 -2.8733269 0.00406174 0.02670216
ENSMUSG00000017778 Cox7c 6.6405394 4.41164852 0.66435093 -0.5899826 -2.6843384 0.00726735 0.03647709
ENSMUSG00000010607 Pigyl 5.31010356 3.53717668 0.66612198 -0.5861417 -2.408392 0.01602297 0.05851277
ENSMUSG00000031210 Gpr165 3.86833173 5.80739291 1.50126549 0.58617913 2.26958834 0.02323257 0.06820706
ENSMUSG00000020090 Npffr1 50.7177363 77.0022768 1.51825145 0.60241075 2.84631891 0.00442279 0.02803732
ENSMUSG00000090223 Pcp4 28.5947111 43.4659842 1.52007076 0.60413848 3.28420996 0.00102269 0.01037297
ENSMUSG00000025255 Zfhx4 13.4985978 20.6591504 1.53046641 0.61397138 2.27688288 0.02279322 0.06820706
ENSMUSG00000063354 Slc39a4 5.19827302 7.95892669 1.53107131 0.61454148 1.97824307 0.04790129 0.09582224
ENSMUSG00000046139 Patl1 10.6760897 16.3736851 1.53367811 0.61699572 2.02178171 0.04319891 0.09128341
ENSMUSG00000039081 Zfp503 39.8036376 61.3027805 1.5401301 0.62305223 2.99983662 0.00270124 0.02130982
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Ensembl gene ID Gene symbol avg homecage avg shock only Ratio log2 ratio z-score p-value FDR
ENSMUSG00000030110 Ret 10.0424186 15.477451 1.54120752 0.62406113 2.84634365 0.00442244 0.02803732
ENSMUSG00000038370 Pcp4l1 16.1424197 25.0259313 1.55032094 0.63256691 2.93273266 0.00335993 0.02338775
ENSMUSG00000026238 Ptma 131.424943 204.861134 1.55876905 0.64040719 3.10831002 0.00188161 0.01629195
ENSMUSG00000031283 Chrdl1 62.6560143 97.9777014 1.56373977 0.64500045 2.94022581 0.00327973 0.02338775
ENSMUSG00000028753 Vwa5b1 95.1576922 149.459452 1.57065024 0.65136195 3.21263398 0.00131524 0.01261917
ENSMUSG00000031075 Ano1 0.90791943 1.42638571 1.57104876 0.65172796 2.13008639 0.03316448 0.08057244
ENSMUSG00000022512 Cldn1 3.77150996 5.95309032 1.57843686 0.65849655 2.55915974 0.01049255 0.04331228
ENSMUSG00000020309 Chac2 4.54258845 7.1705697 1.57852066 0.65857314 2.46168447 0.01382863 0.05167539
ENSMUSG00000029563 Foxp2 11.5087406 18.1771823 1.5794241 0.65939861 2.96315489 0.00304503 0.02299972
ENSMUSG00000031367 Ap1s2 67.7122346 108.191195 1.59780867 0.67609466 3.77254488 0.00016159 0.0035853
ENSMUSG00000047996 Prrg1 13.7924964 22.0641881 1.59972404 0.67782305 3.21745231 0.00129335 0.01261917
ENSMUSG00000056870 Gulp1 1.68901227 2.71182677 1.60556961 0.68308522 2.10727743 0.03509354 0.0828723
ENSMUSG00000021848 Otx2 107.840678 174.228004 1.6156056 0.69207506 3.59738956 0.00032143 0.00496115
ENSMUSG00000019970 Sgk1 23.5282022 38.3367071 1.62939381 0.70433533 3.17558968 0.00149532 0.01327099
ENSMUSG00000034936 Arl4d 0.6553064 1.07337946 1.63798103 0.71191865 2.28696831 0.02219767 0.06820706
ENSMUSG00000019851 Perp 5.80677399 9.55023934 1.64467213 0.71780001 3.3052493 0.00094892 0.01032045
ENSMUSG00000017057 Il13ra1 14.9703798 24.7081547 1.65046946 0.72287644 3.19382125 0.00140403 0.01283158
ENSMUSG00000022820 Ndufb4 0.93243649 1.55272882 1.66523817 0.73572853 2.35946553 0.01830128 0.06269025
ENSMUSG00000052837 Junb 433.155423 729.167595 1.68338559 0.75136567 4.6598278 3.16E-06 0.00018725
ENSMUSG00000032501 Trib1 1.05467075 1.78016992 1.68789162 0.75522227 1.97400144 0.04838158 0.09595229
ENSMUSG00000031355 Arhgap6 2.14815384 3.62658903 1.68823525 0.75551595 2.21672528 0.02664187 0.07300209
ENSMUSG00000024190 Dusp1 37.4516559 63.8238561 1.70416647 0.76906627 3.70013324 0.00021549 0.0037716
ENSMUSG00000064341 mt-Nd1 926.522007 1582.75367 1.70827423 0.77253959 3.87515744 0.00010656 0.00252182
ENSMUSG00000064367 mt-Nd5 1.33521829 2.28201621 1.70909598 0.77323342 2.66510411 0.00769645 0.03647709
ENSMUSG00000005268 Prlr 25.9219824 44.4368308 1.7142528 0.77757988 3.72619466 0.00019439 0.0037716
ENSMUSG00000068859 Sp9 0.61767726 1.0767462 1.74321812 0.8017531 2.39187097 0.01676273 0.06010879
ENSMUSG00000036972 Zic4 0.73692849 1.29039831 1.75104956 0.80821992 2.10703174 0.03511483 0.0828723
ENSMUSG00000059743 Fdps 7.19574324 12.7739814 1.77521362 0.82799264 3.01295989 0.00258713 0.02087344
ENSMUSG00000032511 Scn5a 28.6335433 51.3545769 1.79351107 0.84278665 3.65660931 0.00025557 0.00412403
ENSMUSG00000064370 mt-Cytb 190.09145 343.133366 1.80509627 0.85207578 4.11139443 3.93E-05 0.00116344
ENSMUSG00000047139 Cd24a 2.21339159 4.01386059 1.8134435 0.8587318 2.61505909 0.0089212 0.0390991
ENSMUSG00000047507 Baiap3 3.0149701 5.48296946 1.8185817 0.86281374 2.82587288 0.0047152 0.02892511
ENSMUSG00000064351 mt-Co1 933.694228 1705.43175 1.82654203 0.86911495 4.35467132 1.33E-05 0.00052566
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ENSMUSG00000020423 Btg2 2.49491306 4.63852832 1.85919438 0.89467761 2.97164056 0.00296213 0.02285994
ENSMUSG00000090698 Apold1 0.7744406 1.44187805 1.86183168 0.89672265 2.35816368 0.01836559 0.06269025
ENSMUSG00000048562 Sp8 12.1227452 22.9191345 1.89058947 0.91883613 3.40551695 0.00066039 0.00837279
ENSMUSG00000061524 Zic2 69.4077063 133.923502 1.9295192 0.9482414 4.27400596 1.92E-05 0.00068157
ENSMUSG00000064363 mt-Nd4 345.862782 679.629295 1.96502582 0.97454827 5.15130002 2.59E-07 2.11E-05
ENSMUSG00000024027 Glp1r 0.29817512 0.5896959 1.97768313 0.98381129 2.51299719 0.01197103 0.04721906
ENSMUSG00000071341 Egr4 1.15099253 2.28099184 1.98176077 0.98678282 4.16063072 3.17E-05 0.00102424
ENSMUSG00000022602 Arc 1.46946269 2.94568817 2.00460222 1.00331598 3.35110615 0.00080489 0.00921734
ENSMUSG00000064345 mt-Nd2 53.6028366 108.157711 2.01776097 1.01275528 4.42941377 9.45E-06 0.0004193
ENSMUSG00000087075 A230065H16Rik 0.48402078 0.97849119 2.02158919 1.01548985 2.73421869 0.00625285 0.03442192
ENSMUSG00000040856 Dlk1 0.55688563 1.15966616 2.08241349 1.05825656 3.29379739 0.00098844 0.01032045
ENSMUSG00000055214 Pld5 0.30508892 0.63644532 2.08609776 1.06080677 3.02148839 0.00251535 0.02076629
ENSMUSG00000028195 Cyr61 0.24070864 0.50268973 2.08837424 1.06238027 2.31162891 0.02079814 0.06592268
ENSMUSG00000023034 Nr4a1 0.98093302 2.05548297 2.09543663 1.06725089 2.63437526 0.00842923 0.0374047
ENSMUSG00000050299 Gm9843 2.45299085 5.16400362 2.10518666 1.07394816 3.47731728 0.00050646 0.00665899
ENSMUSG00000026247 Ecel1 0.17973225 0.37985026 2.11342299 1.07958155 2.21677903 0.0266382 0.07300209
ENSMUSG00000032368 Zic1 2.366102 5.06985595 2.14270388 1.09943249 3.69130226 0.00022311 0.0037716
ENSMUSG00000038418 Egr1 4.25003835 9.22772069 2.17120881 1.11849848 3.94901453 7.85E-05 0.00198987
ENSMUSG00000003545 Fosb 2.69346479 5.92444158 2.19956155 1.13721597 3.73832794 0.00018525 0.0037716
ENSMUSG00000074170 Plekhf1 0.10278278 0.23664957 2.3024243 1.20315373 1.9812484 0.04756342 0.09582224
ENSMUSG00000067860 Zic3 6.64228216 15.6636712 2.35817613 1.23767147 5.12523192 2.97E-07 2.11E-05
ENSMUSG00000021250 Fos 0.305344 1.2605271 4.12821962 2.04551973 5.43010252 5.63E-08 6.66E-06
ENSMUSG00000037868 Egr2 5.53068308 31.0999154 5.62315991 2.49138108 7.89339885 2.94E-15 1.04E-12
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Table C.4 DEGs and associated statistics for CFC
Ensembl gene ID Gene symbol avg homecage avg training Ratio log2 ratio z-score p-value FDR
ENSMUSG00000021032 Ngb 0.782748286 0.2778284 0.35493965 -1.49435436 -3.6721712 0.0002405 0.00328109
ENSMUSG00000038112 AW551984 1.51547842 0.562119738 0.370919 -1.43082393 -3.8920235 9.94E-05 0.00180834
ENSMUSG00000038760 Trhr 6.065528811 2.32303721 0.38299005 -1.38462117 -5.8064514 6.38E-09 1.22E-06
ENSMUSG00000069372 Ctxn3 0.4359629 0.173890339 0.39886499 -1.32602759 -3.0263385 0.00247535 0.01331808
ENSMUSG00000040856 Dlk1 0.556885635 0.229380666 0.41189905 -1.27963728 -2.6457173 0.00815179 0.02994215
ENSMUSG00000026247 Ecel1 0.179732245 0.076368514 0.42490158 -1.2347994 -2.0712851 0.03833216 0.08464096
ENSMUSG00000087075 A230065H16Rik 0.484020785 0.208731023 0.43124393 -1.21342396 -2.7008845 0.00691554 0.02723438
ENSMUSG00000029335 Bmp3 30.02193101 13.62200447 0.45373512 -1.14007776 -3.8523902 0.00011697 0.00186178
ENSMUSG00000068696 Gpr88 1.575073617 0.742490135 0.47140027 -1.0849755 -3.2873842 0.00101123 0.0085842
ENSMUSG00000093806 Asmt 1.01033582 0.483121465 0.47817909 -1.06437704 -3.6244902 0.00028953 0.00371459
ENSMUSG00000067578 Cbln4 6.241854498 3.145795655 0.50398414 -0.98854977 -2.2988515 0.02151337 0.05912308
ENSMUSG00000027517 Ankrd60 1.496643745 0.756167574 0.5052422 -0.98495296 -2.5089918 0.01210763 0.04021839
ENSMUSG00000003657 Calb2 7.033694085 3.667154674 0.52136966 -0.93962147 -2.8967169 0.0037709 0.01714861
ENSMUSG00000048562 Sp8 12.12274523 6.498355198 0.5360465 -0.89956993 -3.5398091 0.00040042 0.00439677
ENSMUSG00000048281 Dleu7 26.72191967 14.35215272 0.53709288 -0.89675651 -3.7007024 0.000215 0.0030419
ENSMUSG00000031355 Arhgap6 2.148153838 1.163179371 0.54147862 -0.88502373 -2.5992361 0.00934315 0.03244621
ENSMUSG00000005087 Cd44 2.690689824 1.457604734 0.54172158 -0.88437654 -2.0964508 0.03604222 0.08299575
ENSMUSG00000032511 Scn5a 28.63354328 15.73813322 0.54963974 -0.86344178 -3.8773367 0.00010561 0.00183371
ENSMUSG00000047507 Baiap3 3.014970103 1.677551537 0.55640735 -0.84578661 -2.8024646 0.00507138 0.02176704
ENSMUSG00000038115 Ano2 2.68012537 1.493625335 0.55729682 -0.84348218 -2.0039095 0.04507976 0.09139334
ENSMUSG00000009376 Met 1.800710349 1.046629089 0.58123123 -0.78281588 -2.1991073 0.02787029 0.07050631
ENSMUSG00000020374 Rasgef1c 8.765642666 5.153544904 0.58792551 -0.76629473 -2.4604226 0.01387735 0.04492497
ENSMUSG00000061702 Tmem91 16.70702554 9.880666258 0.59140786 -0.75777467 -3.2036022 0.0013572 0.01016568
ENSMUSG00000040536 Necab1 39.16523212 23.18330115 0.59193575 -0.7564875 -3.6067425 0.00031007 0.0038208
ENSMUSG00000031654 Cbln1 9.548563555 5.691781742 0.59608775 -0.74640338 -3.0174229 0.00254934 0.01352566
ENSMUSG00000047261 Gap43 996.4855721 597.3235347 0.59943019 -0.73833635 -4.4542706 8.42E-06 0.00035729
ENSMUSG00000026479 Lamc2 9.399754729 5.664252607 0.60259579 -0.73073751 -2.9571769 0.0031047 0.0156052
ENSMUSG00000046719 Nxph3 56.61535104 34.49324016 0.60925596 -0.71487963 -3.05944 0.00221751 0.01228032
ENSMUSG00000048001 Hes5 7.638948519 4.680107328 0.61266381 -0.70683245 -2.0534201 0.04003185 0.08496606
ENSMUSG00000066705 Fxyd6 12.1071616 7.488715098 0.61853598 -0.69307057 -2.6647639 0.00770424 0.02967152
ENSMUSG00000022372 Sla 46.34881766 28.87760682 0.62304948 -0.68258135 -3.129197 0.00175285 0.01121833
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ENSMUSG00000029334 Prkg2 26.194891 16.34498599 0.6239761 -0.68043732 -2.2911547 0.02195447 0.05947948
ENSMUSG00000024517 Grp 76.0322018 47.48392643 0.62452389 -0.67917133 -3.2653568 0.00109326 0.00870757
ENSMUSG00000067786 Nnat 483.1917315 302.1689785 0.62536041 -0.67724021 -4.0370359 5.41E-05 0.00114878
ENSMUSG00000004791 Pgf 36.85877997 23.26440822 0.63117684 -0.66388383 -2.9359814 0.00332494 0.0158766
ENSMUSG00000040016 Ptger3 58.4357897 36.91841246 0.63177742 -0.66251172 -3.0723659 0.00212369 0.01210822
ENSMUSG00000062151 Unc13c 59.50314642 37.67928717 0.63323184 -0.65919429 -3.1532234 0.00161478 0.01120828
ENSMUSG00000036834 Plch1 30.73841034 19.5483629 0.63595881 -0.65299476 -2.9530075 0.00314694 0.01561211
ENSMUSG00000021278 Amn 7.266728708 4.636661094 0.63806718 -0.64821977 -2.6520611 0.00800021 0.02994215
ENSMUSG00000036699 Zcchc12 246.2857432 157.3149449 0.6387497 -0.64667738 -3.1969217 0.00138903 0.010204
ENSMUSG00000039395 Mreg 5.313859787 3.400234908 0.63988043 -0.64412574 -2.1540539 0.03123595 0.07648803
ENSMUSG00000022235 Cmbl 54.26609654 34.96480159 0.64432129 -0.63414782 -2.6564886 0.00789591 0.02986374
ENSMUSG00000031980 Agt 8.10551771 5.223145891 0.64439387 -0.63398533 -2.1155135 0.0343862 0.08209706
ENSMUSG00000034295 Fhod3 253.1996424 163.6056899 0.64615293 -0.63005244 -3.1161826 0.00183209 0.01128803
ENSMUSG00000036815 Dpp10 208.1715667 135.1692886 0.64931677 -0.62300563 -3.1265462 0.00176873 0.01121833
ENSMUSG00000032368 Zic1 2.366102003 1.539599737 0.65069035 -0.61995694 -2.0362206 0.04172821 0.08710478
ENSMUSG00000051920 Rspo2 35.55954745 23.15114562 0.65105288 -0.61915338 -2.8565028 0.00428336 0.01880741
ENSMUSG00000094500 Smim18 95.7121494 62.33547908 0.65128074 -0.61864854 -3.0943722 0.0019723 0.01159105
ENSMUSG00000033585 Ndn 559.1080731 364.6194424 0.65214484 -0.61673569 -3.1806806 0.0014693 0.0103939
ENSMUSG00000053004 Hrh1 0.783079977 0.511759475 0.65352134 -0.61369375 -2.0580172 0.03958848 0.08496606
ENSMUSG00000034379 Wdr5b 2.330847796 1.526146323 0.65476018 -0.61096151 -2.0094596 0.04448841 0.09088007
ENSMUSG00000032492 Pth1r 46.22961104 30.42080972 0.65803733 -0.60375867 -2.940739 0.0032743 0.0158766
ENSMUSG00000052565 Hist1h1d 188.4895938 124.4199607 0.66008928 -0.59926692 -3.2708502 0.00107225 0.00870757
ENSMUSG00000053819 Camk2d 55.84294016 36.8657198 0.66016796 -0.59909498 -2.7641295 0.00570749 0.02319426
ENSMUSG00000046321 Hs3st2 3.906219464 2.587358663 0.662369 -0.59429295 -2.3799927 0.01731298 0.0511927
ENSMUSG00000042115 Klhdc8a 107.9327593 71.76999127 0.66495095 -0.58868016 -2.6259735 0.00864015 0.0304395
ENSMUSG00000035493 Tgfbi 2.07022 3.109148301 1.50184439 0.586735343 2.08085552 0.03744713 0.08464096
ENSMUSG00000055235 Wdr86 20.97252523 31.4980741 1.50187322 0.586763038 2.09580292 0.03609968 0.08299575
ENSMUSG00000024610 Cd74 5.598566216 8.408566823 1.50191433 0.586802522 2.06448486 0.03897177 0.08496606
ENSMUSG00000005501 Usp40 18.05667729 27.12209918 1.50205371 0.586936405 2.67081757 0.00756668 0.02949459
ENSMUSG00000034156 Bzrap1 50.00183934 75.13361302 1.50261698 0.587477314 2.6369664 0.00836511 0.03014597
ENSMUSG00000033705 Stard9 344.9074859 519.5766564 1.50642325 0.591127173 3.04018193 0.00236435 0.01290261
ENSMUSG00000042625 Safb2 74.19308585 111.8979224 1.50819879 0.592826599 2.78425959 0.00536501 0.02251503
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ENSMUSG00000032849 Abcc4 2.192947045 3.311987092 1.5102905 0.594826076 2.45189326 0.01421068 0.04523733
ENSMUSG00000048546 Tob2 43.02829964 65.3923302 1.51975167 0.603835603 3.1059172 0.0018969 0.01150183
ENSMUSG00000038930 Rccd1 57.23699816 87.00496357 1.52008258 0.604149697 3.14465917 0.0016628 0.01120828
ENSMUSG00000033855 Ston1 9.084255774 13.81863327 1.52116295 0.605174701 2.02144668 0.04323355 0.0897566
ENSMUSG00000027284 Cdan1 13.91739029 21.21223501 1.52415321 0.608007927 2.79551355 0.00518173 0.02199358
ENSMUSG00000028248 Pnisr 32.74671103 49.98341302 1.52636437 0.610099402 3.07867731 0.00207922 0.01203426
ENSMUSG00000023473 Celsr3 4.382292431 6.703422861 1.52966124 0.613212185 2.66201618 0.00776741 0.02967152
ENSMUSG00000023191 P3h3 89.31349665 136.7613112 1.53125022 0.614710049 3.81554095 0.00013588 0.00207632
ENSMUSG00000038593 Tctn1 20.10023149 30.80662269 1.53265014 0.616028413 2.777291 0.00548141 0.02251503
ENSMUSG00000029068 Ccnl2 233.7536395 358.7315405 1.53465649 0.617915768 3.01308153 0.00258609 0.01353271
ENSMUSG00000014158 Trpv4 2.839459103 4.364402447 1.53705417 0.620168008 2.38969869 0.0168622 0.05071937
ENSMUSG00000026814 Eng 5.121634811 7.876642627 1.53791571 0.620976433 2.92252938 0.00347201 0.01617448
ENSMUSG00000005268 Prlr 25.9219824 40.09086562 1.54659721 0.629097515 2.93894521 0.00329331 0.0158766
ENSMUSG00000068323 Slc4a5 6.404611309 9.913435165 1.54785899 0.630274044 2.88306654 0.00393824 0.01769892
ENSMUSG00000028957 Per3 356.3002217 552.2048168 1.54983012 0.632110091 3.12279758 0.00179141 0.01121833
ENSMUSG00000041354 Rgl2 63.65744837 98.74046463 1.55112194 0.633312104 3.8647742 0.00011119 0.00184675
ENSMUSG00000020423 Btg2 2.494913057 3.874747914 1.5530593 0.635112913 2.75311375 0.00590314 0.02373683
ENSMUSG00000031503 Col4a2 77.52164815 120.5752024 1.5553746 0.637262083 3.62254258 0.00029172 0.00371459
ENSMUSG00000032855 Pkd1 104.3803804 162.5085925 1.5568883 0.638665437 3.45004394 0.0005605 0.00563445
ENSMUSG00000027829 Ccnl1 7.765478458 12.09409082 1.55741734 0.639155597 2.9181684 0.00352094 0.01620481
ENSMUSG00000059851 Kmt5c 42.06143198 65.89005511 1.56651954 0.647562766 3.33074651 0.00086613 0.00777276
ENSMUSG00000030592 Ryr1 29.37778526 46.02489065 1.56665624 0.647688656 3.05935074 0.00221817 0.01228032
ENSMUSG00000073434 Wdr90 0.320712893 0.502773856 1.56767584 0.648627277 2.00261926 0.04521817 0.09139334
ENSMUSG00000079436 Kcnj13 220.6601059 346.7991576 1.57164412 0.652274572 3.36592194 0.00076288 0.00710784
ENSMUSG00000015377 Dennd6b 2.953217669 4.651453708 1.57504601 0.655393974 2.62418673 0.00868562 0.0304395
ENSMUSG00000019970 Sgk1 23.52820225 37.09899905 1.57678851 0.656989172 2.98123593 0.00287088 0.01462232
ENSMUSG00000020385 Clk4 37.30154619 58.92253056 1.57962703 0.659583958 3.53821296 0.00040285 0.00439677
ENSMUSG00000058145 Adamts17 0.946481949 1.495967242 1.58055549 0.660431688 2.07764831 0.03774176 0.08464096
ENSMUSG00000025138 Sirt7 192.3437087 304.0127772 1.58057042 0.660445317 4.37179603 1.23E-05 0.00042243
ENSMUSG00000029127 Zbtb49 3.189796531 5.047956262 1.58253237 0.662235009 2.04023279 0.04132715 0.08674159
ENSMUSG00000044349 Snhg11 34.7975302 55.13057276 1.5843243 0.663867677 2.85188193 0.00434612 0.01886613
ENSMUSG00000020941 Map3k14 1.063161512 1.691831194 1.59132096 0.670224845 2.29224649 0.02189142 0.05947948
ENSMUSG00000071337 Tia1 5.924202657 9.439536297 1.59338511 0.672094997 2.62738942 0.00860428 0.0304395
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ENSMUSG00000031706 Rfx1 2.610973525 4.169732725 1.59700307 0.675367083 2.40434228 0.0162016 0.04951208
ENSMUSG00000040511 Pvr 6.136652881 9.839262899 1.60335986 0.681098261 2.78016443 0.00543314 0.02251503
ENSMUSG00000029439 Sfswap 16.14710775 25.95365791 1.60732549 0.684662112 2.27492541 0.0229104 0.06120122
ENSMUSG00000052861 Dnah6 82.00214196 132.6706861 1.61789294 0.69411614 4.2345912 2.29E-05 0.00062476
ENSMUSG00000089922 Gm43517 15.29341008 25.09015242 1.64058587 0.714211105 2.87539167 0.00403527 0.01792409
ENSMUSG00000028763 Hspg2 47.85038465 78.54017725 1.64136982 0.714900332 3.23073155 0.00123474 0.00962592
ENSMUSG00000029381 Shroom3 6.704322964 11.02616394 1.64463496 0.717767403 3.14073587 0.00168524 0.01120828
ENSMUSG00000025350 Rdh5 1.405905331 2.318345548 1.64900545 0.721596164 3.31579799 0.00091382 0.00793361
ENSMUSG00000039153 Runx2 3.217503399 5.328332892 1.65604577 0.727742546 2.11639685 0.03431107 0.08209706
ENSMUSG00000041187 Prkd2 0.771817271 1.282715732 1.66194225 0.732870252 2.07321074 0.03815267 0.08464096
ENSMUSG00000056763 Cspp1 0.835204598 1.393748636 1.66875115 0.738768834 2.09396304 0.03626327 0.08299575
ENSMUSG00000052512 Nav2 3.128992055 5.234252925 1.67282397 0.742285643 2.30772726 0.02101431 0.058768
ENSMUSG00000041144 Dnah7b 0.529893159 0.887943771 1.6757034 0.744766818 1.97289674 0.04850733 0.09650937
ENSMUSG00000028047 Thbs3 1.218580994 2.045807234 1.67884387 0.747468069 2.01452816 0.04395411 0.0907593
ENSMUSG00000052837 Junb 433.1554228 728.3868341 1.68158309 0.749820066 4.46226829 8.11E-06 0.00035729
ENSMUSG00000032501 Trib1 1.054670754 1.776956102 1.68484439 0.752615351 2.33205939 0.01969757 0.05573682
ENSMUSG00000015647 Lama5 4.584559458 7.729075581 1.68589276 0.753512766 2.23683947 0.02529683 0.06529318
ENSMUSG00000006958 Chrd 17.1193027 28.95180051 1.69117873 0.758029133 3.49596207 0.00047236 0.00501222
ENSMUSG00000035576 L3mbtl1 0.759669994 1.296734792 1.70697119 0.771438707 2.19140395 0.02842257 0.07096355
ENSMUSG00000020836 Coro6 8.821442132 15.05876431 1.70706378 0.771516958 4.10268149 4.08E-05 0.00104003
ENSMUSG00000048794 Cfap100 0.774602743 1.325411891 1.71108598 0.774912252 2.20204864 0.02766187 0.07044557
ENSMUSG00000031502 Col4a1 9.856235399 16.88684995 1.71331642 0.776791617 3.45834051 0.00054351 0.00561141
ENSMUSG00000033327 Tnxb 6.808812797 11.69274881 1.71729627 0.780138956 3.21105382 0.00132249 0.01010384
ENSMUSG00000070427 Il18bp 3.595135513 6.190396587 1.72188129 0.783985686 2.48629116 0.01290823 0.04250814
ENSMUSG00000063354 Slc39a4 5.198273025 8.955794973 1.72284044 0.784789091 2.30386317 0.02123033 0.058768
ENSMUSG00000002625 Akap8l 456.6289068 787.3255365 1.72421309 0.78593808 4.06197402 4.87E-05 0.00114878
ENSMUSG00000032586 Traip 3.707352128 6.405615817 1.72781424 0.788948124 2.59058242 0.00958137 0.03297372
ENSMUSG00000038418 Egr1 4.250038353 7.343624599 1.72789608 0.789016451 3.1813051 0.00146613 0.0103939
ENSMUSG00000030276 Ttll3 50.28969808 87.1205777 1.73237424 0.792750629 2.14767344 0.03173971 0.07722655
ENSMUSG00000024830 Rps6kb2 0.478200941 0.835814956 1.7478321 0.805566605 2.40082794 0.01635803 0.04959338
ENSMUSG00000043410 Hfm1 6.62164512 11.6139518 1.75393752 0.810597353 3.09912075 0.00194096 0.0115851
ENSMUSG00000003545 Fosb 2.693464791 4.740574694 1.76002846 0.81559876 3.40166652 0.00066976 0.00656024
ENSMUSG00000024190 Dusp1 37.45165594 66.55210757 1.77701375 0.829454844 4.35560209 1.33E-05 0.00042243
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ENSMUSG00000059854 Hydin 4.128448162 7.369529548 1.78506045 0.835972934 3.36793339 0.00075734 0.00710784
ENSMUSG00000031167 Rbm3 13.97432283 25.08422097 1.79502229 0.844001759 2.92418674 0.00345357 0.01617448
ENSMUSG00000071341 Egr4 1.150992528 2.096561504 1.82152486 0.865146685 2.36901302 0.01783563 0.05200923
ENSMUSG00000030409 Dmpk 18.84626508 35.73936186 1.89636311 0.923235234 3.32792811 0.00087494 0.00777276
ENSMUSG00000031328 Flna 101.9779363 194.001863 1.90239056 0.927813458 4.85814703 1.18E-06 7.54E-05
ENSMUSG00000051747 Ttn 1.453788245 2.770222406 1.90551988 0.930184662 2.00978658 0.04445378 0.09088007
ENSMUSG00000072647 Adam1a 3.912717894 7.506229101 1.91841817 0.939917228 4.00776188 6.13E-05 0.00123239
ENSMUSG00000026034 Clk1 221.0027775 428.2025458 1.93754373 0.954228872 5.32925211 9.86E-08 9.42E-06
ENSMUSG00000024299 Adamts10 17.76723154 34.426315 1.93762967 0.954292862 4.3047306 1.67E-05 0.00049128
ENSMUSG00000025409 Mbd6 1.123160897 2.1992787 1.95811545 0.969465825 2.64194039 0.00824326 0.02998975
ENSMUSG00000002227 Mov10 1.368932741 2.687016226 1.96285482 0.972953468 2.70261398 0.00687966 0.02723438
ENSMUSG00000080316 Spaca6 5.542247347 10.89687214 1.96614685 0.975371076 3.97378457 7.07E-05 0.00135113
ENSMUSG00000047021 Ccdc108 3.241822942 6.384717175 1.96948362 0.977817416 3.57600209 0.00034889 0.00403865
ENSMUSG00000043923 Ccdc84 1.92089804 3.792230858 1.97419685 0.981265849 4.04159736 5.31E-05 0.00114878
ENSMUSG00000048602 Morc2b 2.298919927 4.953067749 2.15451947 1.107366138 3.26512821 0.00109415 0.00870757
ENSMUSG00000040441 Slc26a10 0.173006127 0.377855091 2.18405612 1.12700993 2.05569115 0.0398123 0.08496606
ENSMUSG00000095041 AC149090.1 8.26293972 18.43677813 2.23126136 1.157859515 4.67891717 2.88E-06 0.00015738
ENSMUSG00000023034 Nr4a1 0.980933015 2.217213156 2.26031046 1.176520946 3.13787397 0.00170178 0.01120828
ENSMUSG00000074170 Plekhf1 0.102782781 0.238562906 2.32103962 1.214771147 2.5289895 0.01143914 0.03867038
ENSMUSG00000022602 Arc 1.469462691 3.431101616 2.33493619 1.223383124 3.78189407 0.00015564 0.0022867
ENSMUSG00000035545 Leng8 35.53806298 86.13086657 2.42362299 1.277165298 5.37757817 7.55E-08 9.42E-06
ENSMUSG00000024186 Rgs11 1.850916416 4.491798237 2.42679691 1.279053379 3.58178978 0.00034125 0.00403865
ENSMUSG00000032128 Robo3 3.103241502 8.210104303 2.64565433 1.403624575 4.37247379 1.23E-05 0.00042243
ENSMUSG00000027966 Col11a1 3.931506307 11.01462582 2.80162995 1.486266412 5.11806076 3.09E-07 2.36E-05
ENSMUSG00000021250 Fos 0.305344003 0.906103504 2.9674842 1.569240349 3.00446411 0.00266049 0.01373389
ENSMUSG00000037868 Egr2 5.530683077 20.64306149 3.73246147 1.900127367 6.56237518 5.30E-11 2.02E-08
